Assay_Type	AssemblyName	AvgSpotLen	BioProject	BioSample	Center_Name	Consent	DATASTORE_filetype	Experiment	InsertSize	Instrument	LibraryLayout	LibrarySelection	LibrarySource	Library_Name	LoadDate	MBases	MBytes	ReleaseDate	Run	SRA_Sample	SRA_Study	Sample_Name	analyte_type	bait_set	biospecimen_repository	biospecimen_repository_sample_id	body_site	data_type	flowcell_barcode	gap_accession	histological_type	instrument_name	is_tumor	library_type	molecular_data_type	run_barcode	study_design	study_disease	study_name	submitted_subject_id	work_request_or_pdo	DATASTORE_provider	Organism	Platform	sex	subject_is_affected
WXS		202	PRJNA283923	SAMN03997489	NCI-PHS000915	DS-CA-MDS	sra	SRX5125294	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_4742	2018-12-14	21453	14306	2018-12-14	SRR8311838	SRS1187418	SRP063692	05115024-T-A-2_SI_4742	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115024-T-A-2_SI_4742				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115024		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN09076047	NCI-PHS000915	DS-CA-MDS	sra	SRX5125295	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_4814	2018-12-14	14074	9110	2019-02-15	SRR8311839	SRS4138595	SRP063692	05115025-T-A-1_SI_4814	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115025-T-A-1_SI_4814				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115025		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN09076030	NCI-PHS000915	DS-CA-MDS	sra	SRX5125296	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_4815	2018-12-14	23432	15072	2019-02-15	SRR8311840	SRS4138596	SRP063692	05115025-T-A-1_SI_4815	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115025-T-A-1_SI_4815				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115025		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN09076168	NCI-PHS000915	DS-CA-MDS	sra	SRX5125297	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_4826	2018-12-14	16484	10617	2019-02-15	SRR8311841	SRS4138597	SRP063692	05115025-T-A-1_SI_4826	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115025-T-A-1_SI_4826				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115025		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997302	NCI-PHS000915	DS-CA-MDS	sra	SRX5125298	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_4882	2018-12-14	19965	13179	2018-12-14	SRR8311842	SRS1187233	SRP063692	06115012-T-C-5_SI_4882	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	06115012-T-C-5_SI_4882				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	06115012		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997446	NCI-PHS000915	DS-CA-MDS	sra	SRX5125299	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_4966	2018-12-14	12616	8646	2018-12-14	SRR8311843	SRS1187409	SRP063692	05115026-T-A-1_SI_4966	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115026-T-A-1_SI_4966				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115026		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997395	NCI-PHS000915	DS-CA-MDS	sra	SRX5125300	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_4971	2018-12-14	16840	11158	2018-12-14	SRR8311844	SRS1187405	SRP063692	05115026-T-A-2_SI_4971	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115026-T-A-2_SI_4971				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115026		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997477	NCI-PHS000915	DS-CA-MDS	sra	SRX5125301	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_4988	2018-12-14	14188	9546	2018-12-14	SRR8311845	SRS1187402	SRP063692	05115026-W-1_SI_4988	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115026-W-1_SI_4988				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115026		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997423	NCI-PHS000915	DS-CA-MDS	sra	SRX5125302	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_4989	2018-12-14	20502	13646	2018-12-14	SRR8311846	SRS1187406	SRP063692	05115026-T-A-1_SI_4989	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115026-T-A-1_SI_4989				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115026		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997336	NCI-PHS000915	DS-CA-MDS	sra	SRX5125303	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5092	2018-12-14	18355	12371	2018-12-14	SRR8311847	SRS1187401	SRP063692	05115027-T-A-2_SI_5092	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115027-T-A-2_SI_5092				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115027		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997376	NCI-PHS000915	DS-CA-MDS	sra	SRX5125304	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5094	2018-12-14	18066	12211	2018-12-14	SRR8311848	SRS1187404	SRP063692	05115027-T-A-2_SI_5094	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115027-T-A-2_SI_5094				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115027		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997480	NCI-PHS000915	DS-CA-MDS	sra	SRX5125305	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5122	2018-12-14	17885	12382	2018-12-14	SRR8311849	SRS1187403	SRP063692	05115027-T-A-1_SI_5122	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115027-T-A-1_SI_5122				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115027		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997369	NCI-PHS000915	DS-CA-MDS	sra	SRX5125306	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5123	2018-12-14	19331	13390	2018-12-14	SRR8311850	SRS1187407	SRP063692	05115027-W-1_SI_5123	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115027-W-1_SI_5123				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115027		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997418	NCI-PHS000915	DS-CA-MDS	sra	SRX5125307	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5258	2018-12-14	18964	13199	2018-12-14	SRR8311851	SRS1187399	SRP063692	05115028-T-A-1_SI_5258	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115028-T-A-1_SI_5258				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115028		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997322	NCI-PHS000915	DS-CA-MDS	sra	SRX5125308	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5263	2018-12-14	19750	13415	2018-12-14	SRR8311852	SRS1187408	SRP063692	05115028-T-A-1_SI_5263	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115028-T-A-1_SI_5263				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115028		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997485	NCI-PHS000915	DS-CA-MDS	sra	SRX5125309	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5264	2018-12-14	13872	9470	2018-12-14	SRR8311853	SRS1187396	SRP063692	05115028-W-1_SI_5264	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115028-W-1_SI_5264				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115028		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997463	NCI-PHS000915	DS-CA-MDS	sra	SRX5125310	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5277	2018-12-14	18635	13019	2018-12-14	SRR8311854	SRS1187400	SRP063692	05115028-T-A-1_SI_5277	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115028-T-A-1_SI_5277				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115028		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997482	NCI-PHS000915	DS-CA-MDS	sra	SRX5125311	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5410	2018-12-14	19980	13647	2018-12-14	SRR8311855	SRS1187397	SRP063692	05115029-T-A-1_SI_5410	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115029-T-A-1_SI_5410				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115029		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997473	NCI-PHS000915	DS-CA-MDS	sra	SRX5125312	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5433	2018-12-14	21348	14538	2018-12-14	SRR8311856	SRS1187394	SRP063692	05115029-T-A-1_SI_5433	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115029-T-A-1_SI_5433				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115029		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997351	NCI-PHS000915	DS-CA-MDS	sra	SRX5125313	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5440	2018-12-14	22222	15404	2018-12-14	SRR8311857	SRS1187393	SRP063692	05115029-T-A-1_SI_5440	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115029-T-A-1_SI_5440				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115029		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997367	NCI-PHS000915	DS-CA-MDS	sra	SRX5125314	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5441	2018-12-14	16815	11659	2018-12-14	SRR8311858	SRS1187392	SRP063692	05115029-W-1_SI_5441	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115029-W-1_SI_5441				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115029		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997420	NCI-PHS000915	DS-CA-MDS	sra	SRX5125315	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5498	2018-12-14	19174	12682	2018-12-14	SRR8311859	SRS1187417	SRP063692	05115022-T-A-1_SI_5498	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115022-T-A-1_SI_5498				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115002		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997470	NCI-PHS000915	DS-CA-MDS	sra	SRX5125316	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5499	2018-12-14	16162	10625	2018-12-14	SRR8311860	SRS1187414	SRP063692	05115022-W-1_SI_5499	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115022-W-1_SI_5499				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115022		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997314	NCI-PHS000915	DS-CA-MDS	sra	SRX5125317	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5500	2018-12-14	12816	8586	2018-12-14	SRR8311861	SRS1187415	SRP063692	05115022-T-A-1_SI_5500	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115022-T-A-1_SI_5500				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115002		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997399	NCI-PHS000915	DS-CA-MDS	sra	SRX5125318	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5551	2018-12-14	12806	8426	2018-12-14	SRR8311862	SRS1187391	SRP063692	05115030-T-A-1_SI_5551	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115030-T-A-1_SI_5551				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115030		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997434	NCI-PHS000915	DS-CA-MDS	sra	SRX5125319	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5555	2018-12-14	14508	9620	2018-12-14	SRR8311863	SRS1187390	SRP063692	05115030-T-A-1_SI_5555	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115030-T-A-1_SI_5555				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115030		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997371	NCI-PHS000915	DS-CA-MDS	sra	SRX5125320	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5565	2018-12-14	21722	14374	2018-12-14	SRR8311864	SRS1187388	SRP063692	05115030-T-A-1_SI_5565	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115030-T-A-1_SI_5565				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115030		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997494	NCI-PHS000915	DS-CA-MDS	sra	SRX5125321	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5566	2018-12-14	15100	9945	2018-12-14	SRR8311865	SRS1187386	SRP063692	05115030-W-1_SI_5566	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115030-W-1_SI_5566				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115030		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997496	NCI-PHS000915	DS-CA-MDS	sra	SRX5125322	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5594	2018-12-14	10547	6834	2018-12-14	SRR8311866	SRS1187387	SRP063692	05115031-T-C-1_SI_5594	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115031-T-C-1_SI_5594				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115031		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997429	NCI-PHS000915	DS-CA-MDS	sra	SRX5125323	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5604	2018-12-14	11500	7485	2018-12-14	SRR8311867	SRS1187385	SRP063692	05115031-T-C-1_SI_5604	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115031-T-C-1_SI_5604				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115031		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997460	NCI-PHS000915	DS-CA-MDS	sra	SRX5125324	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5624	2018-12-14	21118	13603	2018-12-14	SRR8311868	SRS1187398	SRP063692	05115031-T-C-1_SI_5624	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115031-T-C-1_SI_5624				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115031		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997362	NCI-PHS000915	DS-CA-MDS	sra	SRX5125325	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5625	2018-12-14	12563	8162	2018-12-14	SRR8311869	SRS1187384	SRP063692	05115031-W-1_SI_5625	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115031-W-1_SI_5625				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115031		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997435	NCI-PHS000915	DS-CA-MDS	sra	SRX5125326	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5665	2018-12-14	15733	10681	2018-12-14	SRR8311870	SRS1187389	SRP063692	05115032-T-A-2_SI_5665	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115032-T-A-2_SI_5665				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115032		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997491	NCI-PHS000915	DS-CA-MDS	sra	SRX5125327	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5668	2018-12-14	14595	9833	2018-12-14	SRR8311871	SRS1187381	SRP063692	05115033-T-A-1_SI_5668	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115033-T-A-1_SI_5668				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115033		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997324	NCI-PHS000915	DS-CA-MDS	sra	SRX5125328	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5671	2018-12-14	21786	14355	2018-12-14	SRR8311872	SRS1187382	SRP063692	05115032-T-A-1_SI_5671	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115032-T-A-1_SI_5671				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115032		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997383	NCI-PHS000915	DS-CA-MDS	sra	SRX5125329	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5672	2018-12-14	15046	9882	2018-12-14	SRR8311873	SRS1187395	SRP063692	05115032-W-1_SI_5672	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115032-W-1_SI_5672				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115032		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997431	NCI-PHS000915	DS-CA-MDS	sra	SRX5125330	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5673	2018-12-14	21386	14188	2018-12-14	SRR8311874	SRS1187348	SRP063692	05115098-T-A-1_SI_5673	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115098-T-A-1_SI_5673				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115098		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997408	NCI-PHS000915	DS-CA-MDS	sra	SRX5125331	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5674	2018-12-14	17326	11545	2018-12-14	SRR8311875	SRS1187355	SRP063692	05115098-W-1_SI_5674	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115098-W-1_SI_5674				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115098		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997296	NCI-PHS000915	DS-CA-MDS	sra	SRX5125332	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5679	2018-12-14	27071	18341	2018-12-14	SRR8311876	SRS1187376	SRP063692	05115033-T-A-2_SI_5679	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115033-T-A-2_SI_5679				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115033		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997455	NCI-PHS000915	DS-CA-MDS	sra	SRX5125333	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5680	2018-12-14	15375	10429	2018-12-14	SRR8311877	SRS1187375	SRP063692	05115033-W-1_SI_5680	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115033-W-1_SI_5680				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115033		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997299	NCI-PHS000915	DS-CA-MDS	sra	SRX5125334	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5684	2018-12-14	9932	6603	2018-12-14	SRR8311878	SRS1187380	SRP063692	05115032-T-A-2_SI_5684	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115032-T-A-2_SI_5684				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115032		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997334	NCI-PHS000915	DS-CA-MDS	sra	SRX5125335	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5685	2018-12-14	12674	8643	2018-12-14	SRR8311879	SRS1187349	SRP063692	05115098-T-A-1_SI_5685	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115098-T-A-1_SI_5685				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115098		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997454	NCI-PHS000915	DS-CA-MDS	sra	SRX5125336	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5688	2018-12-14	13786	9315	2018-12-14	SRR8311880	SRS1187379	SRP063692	05115033-T-A-1_SI_5688	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115033-T-A-1_SI_5688				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115033		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN09075931	NCI-PHS000915	DS-CA-MDS	sra	SRX5125340	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5771	2018-12-14	14570	10190	2019-02-15	SRR8311884	SRS4138601	SRP063692	05115056-T-A-1_SI_5771	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115056-T-A-1_SI_5771				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115056		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN09076176	NCI-PHS000915	DS-CA-MDS	sra	SRX5125341	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5815	2018-12-14	25532	17749	2019-02-15	SRR8311885	SRS4138602	SRP063692	05115056-T-A-1_SI_5815	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115056-T-A-1_SI_5815				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115056		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN09076201	NCI-PHS000915	DS-CA-MDS	sra	SRX5125342	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5816	2018-12-14	15392	10736	2019-02-15	SRR8311886	SRS4138603	SRP063692	05115056-T-A-1_SI_5816	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115056-T-A-1_SI_5816				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115056		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997357	NCI-PHS000915	DS-CA-MDS	sra	SRX5125345	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5873	2018-12-14	12567	8435	2018-12-14	SRR8311889	SRS1187369	SRP063692	05115057-T-A-2_SI_5873	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115057-T-A-2_SI_5873				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115057		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997368	NCI-PHS000915	DS-CA-MDS	sra	SRX5125347	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5888	2018-12-14	22963	15285	2018-12-14	SRR8311891	SRS1187377	SRP063692	05115057-T-A-1_SI_5888	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115057-T-A-1_SI_5888				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115057		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997500	NCI-PHS000915	DS-CA-MDS	sra	SRX5125348	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5889	2018-12-14	15062	10039	2018-12-14	SRR8311892	SRS1187372	SRP063692	05115057-W-1_SI_5889	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115057-W-1_SI_5889				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115057		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997462	NCI-PHS000915	DS-CA-MDS	sra	SRX5125349	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5900	2018-12-14	12608	8297	2018-12-14	SRR8311893	SRS1187371	SRP063692	05115057-T-A-2_SI_5900	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115057-T-A-2_SI_5900				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115057		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997433	NCI-PHS000915	DS-CA-MDS	sra	SRX5125350	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5924	2018-12-14	8779	5969	2018-12-14	SRR8311894	SRS1187374	SRP063692	05115034-T-A-1_SI_5924	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115034-T-A-1_SI_5924				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115034		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997340	NCI-PHS000915	DS-CA-MDS	sra	SRX5125351	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5939	2018-12-14	13801	9139	2018-12-14	SRR8311895	SRS1187373	SRP063692	05115034-T-A-1_SI_5939	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115034-T-A-1_SI_5939				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115034		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997374	NCI-PHS000915	DS-CA-MDS	sra	SRX5125352	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5954	2018-12-14	25645	17211	2018-12-14	SRR8311896	SRS1210193	SRP063692	05115034_T-A-2_SI_5954	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115034_T-A-2_SI_5954				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115034		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997344	NCI-PHS000915	DS-CA-MDS	sra	SRX5125353	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5955	2018-12-14	15632	10526	2018-12-14	SRR8311897	SRS1187378	SRP063692	05115034-W-1_SI_5955	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115034-W-1_SI_5955				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115034		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997385	NCI-PHS000915	DS-CA-MDS	sra	SRX5125354	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_5993	2018-12-14	14422	9727	2018-12-14	SRR8311898	SRS1187343	SRP063692	05115127-W-1_SI_5993	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115127-W-1_SI_5993				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115127		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997439	NCI-PHS000915	DS-CA-MDS	sra	SRX5125355	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6048	2018-12-14	16442	10437	2018-12-14	SRR8311899	SRS1187361	SRP063692	05115073-W-1_SI_6048	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115073-W-1_SI_6048				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115073		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997305	NCI-PHS000915	DS-CA-MDS	sra	SRX5125356	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6059	2018-12-14	12411	7900	2018-12-14	SRR8311900	SRS1187364	SRP063692	05115073-T-C-1_SI_6059	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115073-T-C-1_SI_6059				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115073		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997415	NCI-PHS000915	DS-CA-MDS	sra	SRX5125357	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6061	2018-12-14	12848	8588	2018-12-14	SRR8311901	SRS1187272	SRP063692	05115258-T-A-4_SI_6061	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115258-T-A-4_SI_6061				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115258		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997315	NCI-PHS000915	DS-CA-MDS	sra	SRX5125358	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6072	2018-12-14	13589	8699	2018-12-14	SRR8311902	SRS1187363	SRP063692	05115073-T-C-1_SI_6072	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115073-T-C-1_SI_6072				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115073		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997350	NCI-PHS000915	DS-CA-MDS	sra	SRX5125359	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6074	2018-12-14	11958	7988	2018-12-14	SRR8311903	SRS1187270	SRP063692	05115258-T-A-4_SI_6074	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115258-T-A-4_SI_6074				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115258		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997303	NCI-PHS000915	DS-CA-MDS	sra	SRX5125360	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6086	2018-12-14	24042	15332	2018-12-14	SRR8311904	SRS1187362	SRP063692	05115073-T-C-1_SI_6086	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115073-T-C-1_SI_6086				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115073		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997424	NCI-PHS000915	DS-CA-MDS	sra	SRX5125361	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6088	2018-12-14	24841	16538	2018-12-14	SRR8311905	SRS1187269	SRP063692	05115258-T-A-4_SI_6088	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115258-T-A-4_SI_6088				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115258		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997327	NCI-PHS000915	DS-CA-MDS	sra	SRX5125362	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6144	2018-12-14	15583	10327	2018-12-14	SRR8311906	SRS1187267	SRP063692	05115258-W-1_SI_6144	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115258-W-1_SI_6144				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115258		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997390	NCI-PHS000915	DS-CA-MDS	sra	SRX5125363	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6173	2018-12-14	15381	9955	2018-12-14	SRR8311907	SRS1187368	SRP063692	05115058-T-A-1_SI_6173	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115058-T-A-1_SI_6173				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115058		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997459	NCI-PHS000915	DS-CA-MDS	sra	SRX5125364	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6174	2018-12-14	9224	5948	2018-12-14	SRR8311908	SRS1187365	SRP063692	05115058-W-1_SI_6174	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115058-W-1_SI_6174				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115058		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997326	NCI-PHS000915	DS-CA-MDS	sra	SRX5125365	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6189	2018-12-14	22884	14858	2018-12-14	SRR8311909	SRS1187359	SRP063692	05115075-T-A-1_SI_6189	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115075-T-A-1_SI_6189				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115075		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997436	NCI-PHS000915	DS-CA-MDS	sra	SRX5125366	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6190	2018-12-14	15161	9885	2018-12-14	SRR8311910	SRS1187370	SRP063692	05115075-W-1_SI_6190	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115075-W-1_SI_6190				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115075		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997475	NCI-PHS000915	DS-CA-MDS	sra	SRX5125367	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6193	2018-12-14	20994	13491	2018-12-14	SRR8311911	SRS1187356	SRP063692	05115076-T-C-2_SI_6193	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115076-T-C-2_SI_6193				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115076		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997304	NCI-PHS000915	DS-CA-MDS	sra	SRX5125368	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6194	2018-12-14	14835	9551	2018-12-14	SRR8311912	SRS1187353	SRP063692	05115076-W-1_SI_6194	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115076-W-1_SI_6194				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115076		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997378	NCI-PHS000915	DS-CA-MDS	sra	SRX5125369	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6209	2018-12-14	12380	8360	2018-12-14	SRR8311913	SRS1187360	SRP063692	05115075-T-A-1_SI_6209	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115075-T-A-1_SI_6209				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115075		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997348	NCI-PHS000915	DS-CA-MDS	sra	SRX5125370	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6218	2018-12-14	12039	7662	2018-12-14	SRR8311914	SRS1187367	SRP063692	05115058-T-A-1_SI_6218	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115058-T-A-1_SI_6218				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115058		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997380	NCI-PHS000915	DS-CA-MDS	sra	SRX5125371	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6223	2018-12-14	17158	11557	2018-12-14	SRR8311915	SRS1187357	SRP063692	05115076-T-C-2_SI_6223	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115076-T-C-2_SI_6223				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115076		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN09076189	NCI-PHS000915	DS-CA-MDS	sra	SRX5125372	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6241	2018-12-14	21354	13473	2019-02-15	SRR8311916	SRS4138607	SRP063692	05115077-T-C-1_SI_6241	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115077-T-C-1_SI_6241				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115077		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN09075818	NCI-PHS000915	DS-CA-MDS	sra	SRX5125373	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6242	2018-12-14	12036	7654	2019-02-15	SRR8311917	SRS4138608	SRP063692	05115077-T-C-1_SI_6242	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115077-T-C-1_SI_6242				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115077		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997450	NCI-PHS000915	DS-CA-MDS	sra	SRX5125374	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6271	2018-12-14	12037	7665	2018-12-14	SRR8311918	SRS1187366	SRP063692	05115058-T-A-1_SI_6271	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115058-T-A-1_SI_6271				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115058		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997401	NCI-PHS000915	DS-CA-MDS	sra	SRX5125376	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6321	2018-12-14	10976	6661	2018-12-14	SRR8311920	SRS1187346	SRP063692	05115127-T-A-1_SI_6321	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115127-T-A-1_SI_6321				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115127		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997388	NCI-PHS000915	DS-CA-MDS	sra	SRX5125377	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6325	2018-12-14	16158	9850	2018-12-14	SRR8311921	SRS1187358	SRP063692	05115078-T-C-1_SI_6325	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115078-T-C-1_SI_6325				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115078		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997411	NCI-PHS000915	DS-CA-MDS	sra	SRX5125378	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6344	2018-12-14	12202	7649	2018-12-14	SRR8311922	SRS1187347	SRP063692	05115127-T-A-1_SI_6344	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115127-T-A-1_SI_6344				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115127		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997406	NCI-PHS000915	DS-CA-MDS	sra	SRX5125379	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6351	2018-12-14	12217	7632	2018-12-14	SRR8311923	SRS1187354	SRP063692	05115078-T-C-1_SI_6351	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115078-T-C-1_SI_6351				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115078		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN09076195	NCI-PHS000915	DS-CA-MDS	sra	SRX5125380	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6359	2018-12-14	21242	13121	2019-02-15	SRR8311924	SRS4138610	SRP063692	05115192-T-A-1_SI_6359	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115192-T-A-1_SI_6359				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115192		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN09076099	NCI-PHS000915	DS-CA-MDS	sra	SRX5125381	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6360	2018-12-14	16109	9898	2019-02-15	SRR8311925	SRS4138611	SRP063692	05115192-T-A-1_SI_6360	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115192-T-A-1_SI_6360				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115192		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997372	NCI-PHS000915	DS-CA-MDS	sra	SRX5125382	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6371	2018-12-14	23575	14585	2018-12-14	SRR8311926	SRS1187351	SRP063692	05115078-T-C-1_SI_6371	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115078-T-C-1_SI_6371				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115078		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997339	NCI-PHS000915	DS-CA-MDS	sra	SRX5125383	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6372	2018-12-14	16741	10370	2018-12-14	SRR8311927	SRS1187352	SRP063692	05115078-W-1_SI_6372	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115078-W-1_SI_6372				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115078		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997331	NCI-PHS000915	DS-CA-MDS	sra	SRX5125386	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6443	2018-12-14	20452	13254	2018-12-14	SRR8311930	SRS1187344	SRP063692	05115127-T-A-1_SI_6443	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115127-T-A-1_SI_6443				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115127		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997448	NCI-PHS000915	DS-CA-MDS	sra	SRX5125387	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6520	2018-12-14	22839	14300	2018-12-14	SRR8311931	SRS1187266	SRP063692	05115259-T-C-2_SI_6520	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115259-T-C-2_SI_6520				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115259		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997318	NCI-PHS000915	DS-CA-MDS	sra	SRX5125388	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6521	2018-12-14	17992	11290	2018-12-14	SRR8311932	SRS1187265	SRP063692	05115259-W-1_SI_6521	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115259-W-1_SI_6521				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115259		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997487	NCI-PHS000915	DS-CA-MDS	sra	SRX5125389	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6522	2018-12-14	22822	13794	2018-12-14	SRR8311933	SRS1187330	SRP063692	05115152-T-A-1_SI_6522	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115152-T-A-1_SI_6522				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115152		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997410	NCI-PHS000915	DS-CA-MDS	sra	SRX5125390	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6523	2018-12-14	15682	9485	2018-12-14	SRR8311934	SRS1187328	SRP063692	05115152-W-1_SI_6523	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115152-W-1_SI_6523				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115152		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997333	NCI-PHS000915	DS-CA-MDS	sra	SRX5125391	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6535	2018-12-14	17162	10549	2018-12-14	SRR8311935	SRS1187291	SRP063692	05115199-T-A-1_SI_6535	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115199-T-A-1_SI_6535				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115199		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997447	NCI-PHS000915	DS-CA-MDS	sra	SRX5125392	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6537	2018-12-14	15550	9516	2018-12-14	SRR8311936	SRS1187287	SRP063692	05115199-W-1_SI_6537	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115199-W-1_SI_6537				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115199		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997458	NCI-PHS000915	DS-CA-MDS	sra	SRX5125393	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6554	2018-12-14	13199	8151	2018-12-14	SRR8311937	SRS1187268	SRP063692	05115259-T-C-2_SI_6554	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115259-T-C-2_SI_6554				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115259		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997343	NCI-PHS000915	DS-CA-MDS	sra	SRX5125394	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6566	2018-12-14	11764	7188	2018-12-14	SRR8311938	SRS1187264	SRP063692	05115259-T-C-2_SI_6566	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115259-T-C-2_SI_6566				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115259		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997453	NCI-PHS000915	DS-CA-MDS	sra	SRX5125395	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6567	2018-12-14	15916	9743	2018-12-14	SRR8311939	SRS1187331	SRP063692	05115152-T-A-1_SI_6567	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115152-T-A-1_SI_6567				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115152		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997465	NCI-PHS000915	DS-CA-MDS	sra	SRX5125396	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6573	2018-12-14	9964	6386	2018-12-14	SRR8311940	SRS1187288	SRP063692	05115199-T-A-1_SI_6573	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115199-T-A-1_SI_6573				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115199		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997469	NCI-PHS000915	DS-CA-MDS	sra	SRX5125400	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6667	2018-12-14	22508	14578	2018-12-14	SRR8311944	SRS1187319	SRP063692	05115186-T-A-1_SI_6667	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115186-T-A-1_SI_6667				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115186		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997311	NCI-PHS000915	DS-CA-MDS	sra	SRX5125401	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6668	2018-12-14	16121	10417	2018-12-14	SRR8311945	SRS1187316	SRP063692	05115186-W-1_SI_6668	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115186-W-1_SI_6668				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115186		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997384	NCI-PHS000915	DS-CA-MDS	sra	SRX5125402	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6673	2018-12-14	21224	13668	2018-12-14	SRR8311946	SRS1187339	SRP063692	05115129-T-A-1_SI_6673	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115129-T-A-1_SI_6673				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115129		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997323	NCI-PHS000915	DS-CA-MDS	sra	SRX5125403	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6674	2018-12-14	16082	10405	2018-12-14	SRR8311947	SRS1187335	SRP063692	05115129-W-1_SI_6674	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115129-W-1_SI_6674				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115129		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		220	PRJNA283923	SAMN03997320	NCI-PHS000915	DS-CA-MDS	sra	SRX5125404	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6690	2018-12-14	9132	5821	2018-12-14	SRR8311948	SRS1187337	SRP063692	05115129-T-A-1_SI_6690	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115129-T-A-1_SI_6690				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115129		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		220	PRJNA283923	SAMN03997316	NCI-PHS000915	DS-CA-MDS	sra	SRX5125405	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6695	2018-12-14	10616	6496	2018-12-14	SRR8311949	SRS1187334	SRP063692	05115130-T-A-1_SI_6695	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115130-T-A-1_SI_6695				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115130		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997310	NCI-PHS000915	DS-CA-MDS	sra	SRX5125406	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6698	2018-12-14	5699	3497	2018-12-14	SRR8311950	SRS1187320	SRP063692	05115186-T-A-1_SI_6698	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115186-T-A-1_SI_6698				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115186		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		220	PRJNA283923	SAMN03997404	NCI-PHS000915	DS-CA-MDS	sra	SRX5125407	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6701	2018-12-14	9508	5993	2018-12-14	SRR8311951	SRS1187336	SRP063692	05115129-T-A-1_SI_6701	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115129-T-A-1_SI_6701				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115129		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		220	PRJNA283923	SAMN03997498	NCI-PHS000915	DS-CA-MDS	sra	SRX5125408	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6706	2018-12-14	9197	5649	2018-12-14	SRR8311952	SRS1187333	SRP063692	05115130-T-A-1_SI_6706	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115130-T-A-1_SI_6706				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115130		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		220	PRJNA283923	SAMN03997417	NCI-PHS000915	DS-CA-MDS	sra	SRX5125409	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6711	2018-12-14	19113	11775	2018-12-14	SRR8311953	SRS1187332	SRP063692	05115130-T-A-1_SI_6711	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115130-T-A-1_SI_6711				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115130		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		220	PRJNA283923	SAMN03997394	NCI-PHS000915	DS-CA-MDS	sra	SRX5125410	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6712	2018-12-14	14966	9153	2018-12-14	SRR8311954	SRS1187338	SRP063692	05115130-W-1_SI_6712	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115130-W-1_SI_6712				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115130		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		220	PRJNA283923	SAMN03997325	NCI-PHS000915	DS-CA-MDS	sra	SRX5125411	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6848	2018-12-14	14729	9300	2018-12-14	SRR8311955	SRS1187318	SRP063692	05115186-T-A-2_SI_6848	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115186-T-A-2_SI_6848				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115186		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		220	PRJNA283923	SAMN03997386	NCI-PHS000915	DS-CA-MDS	sra	SRX5125412	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6851	2018-12-14	12033	7537	2018-12-14	SRR8311956	SRS1187342	SRP063692	05115128-T-A-1_SI_6851	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115128-T-A-1_SI_6851				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115128		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		220	PRJNA283923	SAMN03997352	NCI-PHS000915	DS-CA-MDS	sra	SRX5125413	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6860	2018-12-14	8820	5530	2018-12-14	SRR8311957	SRS1187341	SRP063692	05115128-T-A-1_SI_6860	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115128-T-A-1_SI_6860				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115128		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		220	PRJNA283923	SAMN03997347	NCI-PHS000915	DS-CA-MDS	sra	SRX5125414	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6875	2018-12-14	21383	13411	2018-12-14	SRR8311958	SRS1187345	SRP063692	05115128-T-A-1_SI_6875	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115128-T-A-1_SI_6875				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115128		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		220	PRJNA283923	SAMN03997440	NCI-PHS000915	DS-CA-MDS	sra	SRX5125415	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6876	2018-12-14	14304	8995	2018-12-14	SRR8311959	SRS1187340	SRP063692	05115128-W-1_SI_6876	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115128-W-1_SI_6876				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115128		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997444	NCI-PHS000915	DS-CA-MDS	sra	SRX5125416	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7010	2018-12-14	10226	6242	2018-12-14	SRR8311960	SRS1187327	SRP063692	05115158-T-B-1_SI_7010	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115158-T-B-1_SI_7010				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115158		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997392	NCI-PHS000915	DS-CA-MDS	sra	SRX5125417	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7018	2018-12-14	9589	5840	2018-12-14	SRR8311961	SRS1187329	SRP063692	05115158-T-B-1_SI_7018	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115158-T-B-1_SI_7018				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115158		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997501	NCI-PHS000915	DS-CA-MDS	sra	SRX5125418	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7028	2018-12-14	20649	12325	2018-12-14	SRR8311962	SRS1187326	SRP063692	05115158-T-B-1_SI_7028	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115158-T-B-1_SI_7028				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115158		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997502	NCI-PHS000915	DS-CA-MDS	sra	SRX5125419	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7029	2018-12-14	14173	8450	2018-12-14	SRR8311963	SRS1187325	SRP063692	05115158-W-1_SI_7029	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115158-W-1_SI_7029				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115158		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997342	NCI-PHS000915	DS-CA-MDS	sra	SRX5125420	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7068	2018-12-14	6468	4065	2018-12-14	SRR8311964	SRS1187285	SRP063692	05115203-T-A-1_SI_7068	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115203-T-A-1_SI_7068				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115203		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997360	NCI-PHS000915	DS-CA-MDS	sra	SRX5125421	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7070	2018-12-14	6908	4247	2018-12-14	SRR8311965	SRS1187307	SRP063692	05115194-T-A-1_SI_7070	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115194-T-A-1_SI_7070				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115194		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997419	NCI-PHS000915	DS-CA-MDS	sra	SRX5125422	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7073	2018-12-14	8774	5536	2018-12-14	SRR8311966	SRS1187284	SRP063692	05115203-T-A-1_SI_7073	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115203-T-A-1_SI_7073				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115203		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997457	NCI-PHS000915	DS-CA-MDS	sra	SRX5125423	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7075	2018-12-14	8532	5300	2018-12-14	SRR8311967	SRS1187310	SRP063692	05115194-T-A-1_SI_7075	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115194-T-A-1_SI_7075				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115194		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997313	NCI-PHS000915	DS-CA-MDS	sra	SRX5125424	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7079	2018-12-14	15870	9354	2018-12-14	SRR8311968	SRS1187283	SRP063692	05115203-T-A-1_SI_7079	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115203-T-A-1_SI_7079				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115203		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997307	NCI-PHS000915	DS-CA-MDS	sra	SRX5125425	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7080	2018-12-14	11561	6788	2018-12-14	SRR8311969	SRS1187282	SRP063692	05115203-W-1_SI_7080	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115203-W-1_SI_7080				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115203		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997422	NCI-PHS000915	DS-CA-MDS	sra	SRX5125426	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7083	2018-12-14	26389	16448	2018-12-14	SRR8311970	SRS1187350	SRP063692	05115194-T-A-1_SI_7083	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115194-T-A-1_SI_7083				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115194		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997370	NCI-PHS000915	DS-CA-MDS	sra	SRX5125427	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7084	2018-12-14	12707	7972	2018-12-14	SRR8311971	SRS1187305	SRP063692	05115194-W-1_SI_7084	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115194-W-1_SI_7084				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115194		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997425	NCI-PHS000915	DS-CA-MDS	sra	SRX5125428	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7118	2018-12-14	9375	5916	2018-12-14	SRR8311972	SRS1187304	SRP063692	05115195-T-A-1_SI_7118	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115195-T-A-1_SI_7118				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115195		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997472	NCI-PHS000915	DS-CA-MDS	sra	SRX5125429	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7134	2018-12-14	9399	5943	2018-12-14	SRR8311973	SRS1187301	SRP063692	05115195-T-A-1_SI_7134	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115195-T-A-1_SI_7134				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115195		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997478	NCI-PHS000915	DS-CA-MDS	sra	SRX5125430	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7150	2018-12-14	21420	13413	2018-12-14	SRR8311974	SRS1187303	SRP063692	05115195-T-A-1_SI_7150	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115195-T-A-1_SI_7150				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115195		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997377	NCI-PHS000915	DS-CA-MDS	sra	SRX5125431	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7151	2018-12-14	15070	9422	2018-12-14	SRR8311975	SRS1187302	SRP063692	05115195-W-1_SI_7151	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115195-W-1_SI_7151				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115195		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997332	NCI-PHS000915	DS-CA-MDS	sra	SRX5125432	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7203	2018-12-14	11508	7368	2018-12-14	SRR8311976	SRS1187323	SRP063692	05115160-T-A-1_SI_7203	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115160-T-A-1_SI_7203				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115160		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997389	NCI-PHS000915	DS-CA-MDS	sra	SRX5125433	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7212	2018-12-14	9558	6138	2018-12-14	SRR8311977	SRS1187324	SRP063692	05115160-T-A-1_SI_7212	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115160-T-A-1_SI_7212				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115160		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997359	NCI-PHS000915	DS-CA-MDS	sra	SRX5125434	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7225	2018-12-14	20505	13099	2018-12-14	SRR8311978	SRS1187321	SRP063692	05115160-T-A-1_SI_7225	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115160-T-A-1_SI_7225				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115160		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997461	NCI-PHS000915	DS-CA-MDS	sra	SRX5125435	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7226	2018-12-14	14294	9123	2018-12-14	SRR8311979	SRS1187322	SRP063692	05115160-W-1_SI_7226	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115160-W-1_SI_7226				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115160		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997306	NCI-PHS000915	DS-CA-MDS	sra	SRX5125436	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7233	2018-12-14	12323	7614	2018-12-14	SRR8311980	SRS1187298	SRP063692	05115196-T-A-1_SI_7233	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115196-T-A-1_SI_7233				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115196		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997375	NCI-PHS000915	DS-CA-MDS	sra	SRX5125437	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7237	2018-12-14	12762	7988	2018-12-14	SRR8311981	SRS1187296	SRP063692	05115197-T-A-1_SI_7237	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115197-T-A-1_SI_7237				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115197		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997379	NCI-PHS000915	DS-CA-MDS	sra	SRX5125438	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7263	2018-12-14	12742	7808	2018-12-14	SRR8311982	SRS1187299	SRP063692	05115196-T-A-1_SI_7263	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115196-T-A-1_SI_7263				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115196		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997346	NCI-PHS000915	DS-CA-MDS	sra	SRX5125439	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7267	2018-12-14	12223	7600	2018-12-14	SRR8311983	SRS1187300	SRP063692	05115197-T-A-1_SI_7267	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115197-T-A-1_SI_7267				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115197		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997341	NCI-PHS000915	DS-CA-MDS	sra	SRX5125440	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7269	2018-12-14	19868	11843	2018-12-14	SRR8311984	SRS1187306	SRP063692	05115196-T-A-1_SI_7269	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115196-T-A-1_SI_7269				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115196		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997451	NCI-PHS000915	DS-CA-MDS	sra	SRX5125441	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7270	2018-12-14	12738	7643	2018-12-14	SRR8311985	SRS1187297	SRP063692	05115196-W-1_SI_7270	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115196-W-1_SI_7270				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115196		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997405	NCI-PHS000915	DS-CA-MDS	sra	SRX5125442	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7277	2018-12-14	23050	13958	2018-12-14	SRR8311986	SRS1187293	SRP063692	05115197-T-A-1_SI_7277	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115197-T-A-1_SI_7277				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115197		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997468	NCI-PHS000915	DS-CA-MDS	sra	SRX5125443	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7278	2018-12-14	13913	8442	2018-12-14	SRR8311987	SRS1187292	SRP063692	05115197-W-1_SI_7278	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115197-W-1_SI_7278				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115197		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997337	NCI-PHS000915	DS-CA-MDS	sra	SRX5125444	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7398	2018-12-14	12708	7871	2018-12-14	SRR8311988	SRS1187315	SRP063692	05115187-T-A-1_SI_7398	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115187-T-A-1_SI_7398				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115187		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997364	NCI-PHS000915	DS-CA-MDS	sra	SRX5125445	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7404	2018-12-14	11919	7456	2018-12-14	SRR8311989	SRS1187314	SRP063692	05115187-T-A-1_SI_7404	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115187-T-A-1_SI_7404				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115187		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997479	NCI-PHS000915	DS-CA-MDS	sra	SRX5125446	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7405	2018-12-14	13272	8580	2018-12-14	SRR8311990	SRS1187290	SRP063692	05115198-T-A-1_SI_7405	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115198-T-A-1_SI_7405				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115198		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997412	NCI-PHS000915	DS-CA-MDS	sra	SRX5125447	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7416	2018-12-14	24839	15578	2018-12-14	SRR8311991	SRS1187317	SRP063692	05115187-T-A-1_SI_7416	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115187-T-A-1_SI_7416				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115187		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997409	NCI-PHS000915	DS-CA-MDS	sra	SRX5125448	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7417	2018-12-14	15268	9636	2018-12-14	SRR8311992	SRS1187313	SRP063692	05115187-W-1_SI_7417	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115187-W-1_SI_7417				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115187		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997397	NCI-PHS000915	DS-CA-MDS	sra	SRX5125449	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7418	2018-12-14	22168	13671	2018-12-14	SRR8311993	SRS1187295	SRP063692	05115198-T-A-1_SI_7418	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115198-T-A-1_SI_7418				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115198		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997483	NCI-PHS000915	DS-CA-MDS	sra	SRX5125450	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7419	2018-12-14	16841	10414	2018-12-14	SRR8311994	SRS1187289	SRP063692	05115198-W-1_SI_7419	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115198-W-1_SI_7419				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115198		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997432	NCI-PHS000915	DS-CA-MDS	sra	SRX5125451	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7585	2018-12-14	14292	8946	2018-12-14	SRR8311995	SRS1187311	SRP063692	05115193-T-A-1_SI_7585	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115193-T-A-1_SI_7585				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115193		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997430	NCI-PHS000915	DS-CA-MDS	sra	SRX5125452	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7590	2018-12-14	11848	7268	2018-12-14	SRR8311996	SRS1187259	SRP063692	05115261-T-A-2_SI_7590	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115261-T-A-2_SI_7590				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115261		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997349	NCI-PHS000915	DS-CA-MDS	sra	SRX5125453	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7596	2018-12-14	12720	8006	2018-12-14	SRR8311997	SRS1187309	SRP063692	05115193-T-A-1_SI_7596	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115193-T-A-1_SI_7596				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115193		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997484	NCI-PHS000915	DS-CA-MDS	sra	SRX5125454	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7602	2018-12-14	12533	7722	2018-12-14	SRR8311998	SRS1187258	SRP063692	05115261-T-A-2_SI_7602	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115261-T-A-2_SI_7602				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115261		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997416	NCI-PHS000915	DS-CA-MDS	sra	SRX5125455	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7609	2018-12-14	23641	14833	2018-12-14	SRR8311999	SRS1187312	SRP063692	05115193-T-A-1_SI_7609	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115193-T-A-1_SI_7609				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115193		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997373	NCI-PHS000915	DS-CA-MDS	sra	SRX5125456	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7610	2018-12-14	15388	9687	2018-12-14	SRR8312000	SRS1187308	SRP063692	05115193-W-1_SI_7610	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115193-W-1_SI_7610				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115193		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997471	NCI-PHS000915	DS-CA-MDS	sra	SRX5125457	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7642	2018-12-14	20798	12682	2018-12-14	SRR8312001	SRS1187257	SRP063692	05115261-T-A-2_SI_7642	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115261-T-A-2_SI_7642				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115261		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997382	NCI-PHS000915	DS-CA-MDS	sra	SRX5125458	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7643	2018-12-14	14009	8575	2018-12-14	SRR8312002	SRS1187256	SRP063692	05115261-W-1_SI_7643	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115261-W-1_SI_7643				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115261		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997414	NCI-PHS000915	DS-CA-MDS	sra	SRX5125459	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7821	2018-12-14	11404	7103	2018-12-14	SRR8312003	SRS1187280	SRP063692	05115254-T-A-1_SI_7821	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115254-T-A-1_SI_7821				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115254		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997345	NCI-PHS000915	DS-CA-MDS	sra	SRX5125460	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7828	2018-12-14	22990	14417	2018-12-14	SRR8312004	SRS1187294	SRP063692	05115254-T-A-1_SI_7828	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115254-T-A-1_SI_7828				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115254		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997381	NCI-PHS000915	DS-CA-MDS	sra	SRX5125461	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7829	2018-12-14	13629	8584	2018-12-14	SRR8312005	SRS1187279	SRP063692	05115254-W-1_SI_7829	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115254-W-1_SI_7829				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115254		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997413	NCI-PHS000915	DS-CA-MDS	sra	SRX5125462	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7848	2018-12-14	13834	8637	2018-12-14	SRR8312006	SRS1187278	SRP063692	05115254-T-A-1_SI_7848	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115254-T-A-1_SI_7848				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115254		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997443	NCI-PHS000915	DS-CA-MDS	sra	SRX5125467	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7956	2018-12-14	13097	8209	2018-12-14	SRR8312011	SRS1187275	SRP063692	05115256-T-C-2_SI_7956	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115256-T-C-2_SI_7956				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115256		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997298	NCI-PHS000915	DS-CA-MDS	sra	SRX5125468	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7976	2018-12-14	12148	7616	2018-12-14	SRR8312012	SRS1187274	SRP063692	05115256-T-C-2_SI_7976	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115256-T-C-2_SI_7976				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115256		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997464	NCI-PHS000915	DS-CA-MDS	sra	SRX5125469	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7977	2018-12-14	15260	9509	2018-12-14	SRR8312013	SRS1187271	SRP063692	05115256-W-1_SI_7977	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115256-W-1_SI_7977				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115256		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997421	NCI-PHS000915	DS-CA-MDS	sra	SRX5125472	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7993	2018-12-14	21931	13652	2018-12-14	SRR8312016	SRS1187273	SRP063692	05115256-T-C-2_SI_7993	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115256-T-C-2_SI_7993				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115256		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN03997300	NCI-PHS000915	DS-CA-MDS	sra	SRX5125476	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_8246	2018-12-14	12785	6608	2018-12-14	SRR8312020	SRS1187263	SRP063692	05115260-T-A-1_SI_8246	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115260-T-A-1_SI_8246				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115260		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN03997361	NCI-PHS000915	DS-CA-MDS	sra	SRX5125477	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_8256	2018-12-14	11104	5323	2018-12-14	SRR8312021	SRS1187262	SRP063692	05115260-T-A-1_SI_8256	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115260-T-A-1_SI_8256				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115260		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN03997437	NCI-PHS000915	DS-CA-MDS	sra	SRX5125478	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_8270	2018-12-14	19062	8852	2018-12-14	SRR8312022	SRS1187261	SRP063692	05115260-T-A-1_SI_8270	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115260-T-A-1_SI_8270				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115260		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN03997428	NCI-PHS000915	DS-CA-MDS	sra	SRX5125479	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_8271	2018-12-14	14103	6337	2018-12-14	SRR8312023	SRS1187260	SRP063692	05115260-W-1_SI_8271	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115260-W-1_SI_8271				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115260		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN03997329	NCI-PHS000915	DS-CA-MDS	sra	SRX5125480	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_8294	2018-12-14	12502	6170	2018-12-14	SRR8312024	SRS1187286	SRP063692	05115255-T-A-2_SI_8294	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115255-T-A-2_SI_8294				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115255		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN03997309	NCI-PHS000915	DS-CA-MDS	sra	SRX5125481	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_8296	2018-12-14	12788	6393	2018-12-14	SRR8312025	SRS1187251	SRP063692	05115290-T-A-1_SI_8296	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115290-T-A-1_SI_8296				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115290		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN03997301	NCI-PHS000915	DS-CA-MDS	sra	SRX5125482	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_8318	2018-12-14	13435	6517	2018-12-14	SRR8312026	SRS1187276	SRP063692	05115255-T-A-2_SI_8318	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115255-T-A-2_SI_8318				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115255		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN03997493	NCI-PHS000915	DS-CA-MDS	sra	SRX5125483	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_8320	2018-12-14	11822	5819	2018-12-14	SRR8312027	SRS1187250	SRP063692	05115290-T-A-1_SI_8320	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115290-T-A-1_SI_8320				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115290		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN03997438	NCI-PHS000915	DS-CA-MDS	sra	SRX5125484	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_8331	2018-12-14	23189	11351	2018-12-14	SRR8312028	SRS1187277	SRP063692	05115255-T-A-2_SI_8331	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115255-T-A-2_SI_8331				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115255		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN03997402	NCI-PHS000915	DS-CA-MDS	sra	SRX5125485	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_8332	2018-12-14	16995	8165	2018-12-14	SRR8312029	SRS1187281	SRP063692	05115255-W-1_SI_8332	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115255-W-1_SI_8332				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115255		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN03997396	NCI-PHS000915	DS-CA-MDS	sra	SRX5125486	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_8335	2018-12-14	24750	12137	2018-12-14	SRR8312030	SRS1187249	SRP063692	05115290-T-A-1_SI_8335	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115290-T-A-1_SI_8335				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115290		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN03997354	NCI-PHS000915	DS-CA-MDS	sra	SRX5125487	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_8336	2018-12-14	17847	8723	2018-12-14	SRR8312031	SRS1187248	SRP063692	05115290-W-1_SI_8336	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115290-W-1_SI_8336				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115290		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997400	NCI-PHS000915	DS-CA-MDS	sra	SRX5125492	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_8398	2018-12-14	11166	7237	2018-12-14	SRR8312036	SRS1187255	SRP063692	05115276-T-A-1_SI_8398	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115276-T-A-1_SI_8398				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115276		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		220	PRJNA283923	SAMN03997403	NCI-PHS000915	DS-CA-MDS	sra	SRX5125493	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_8399	2018-12-14	15202	9436	2018-12-14	SRR8312037	SRS1187247	SRP063692	05115291-T-C-1_SI_8399	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115291-T-C-1_SI_8399				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115291		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997490	NCI-PHS000915	DS-CA-MDS	sra	SRX5125494	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_8407	2018-12-14	13464	8474	2018-12-14	SRR8312038	SRS1187254	SRP063692	05115276-T-A-1_SI_8407	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115276-T-A-1_SI_8407				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115276		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		220	PRJNA283923	SAMN03997481	NCI-PHS000915	DS-CA-MDS	sra	SRX5125495	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_8408	2018-12-14	13911	8582	2018-12-14	SRR8312039	SRS1187246	SRP063692	05115291-T-C-1_SI_8408	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115291-T-C-1_SI_8408				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115291		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997426	NCI-PHS000915	DS-CA-MDS	sra	SRX5125496	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_8420	2018-12-14	22547	14489	2018-12-14	SRR8312040	SRS1187253	SRP063692	05115276-T-A-1_SI_8420	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115276-T-A-1_SI_8420				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115276		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997499	NCI-PHS000915	DS-CA-MDS	sra	SRX5125497	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_8421	2018-12-14	15485	9965	2018-12-14	SRR8312041	SRS1187252	SRP063692	05115276-W-1_SI_8421	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115276-W-1_SI_8421				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115276		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		220	PRJNA283923	SAMN03997427	NCI-PHS000915	DS-CA-MDS	sra	SRX5125498	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_8422	2018-12-14	23357	14683	2018-12-14	SRR8312042	SRS1187245	SRP063692	05115291-T-C-1_SI_8422	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115291-T-C-1_SI_8422				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115291		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		220	PRJNA283923	SAMN03997407	NCI-PHS000915	DS-CA-MDS	sra	SRX5125499	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_8423	2018-12-14	16495	10309	2018-12-14	SRR8312043	SRS1187244	SRP063692	05115291-W-1_SI_8423	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115291-W-1_SI_8423				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115291		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997476	NCI-PHS000915	DS-CA-MDS	sra	SRX5125500	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_8527	2018-12-14	11517	7337	2018-12-14	SRR8312044	SRS1187243	SRP063692	05115327-T-A-1_SI_8527	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115327-T-A-1_SI_8527				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115327		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997495	NCI-PHS000915	DS-CA-MDS	sra	SRX5125501	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_8540	2018-12-14	20803	13205	2018-12-14	SRR8312045	SRS1187242	SRP063692	05115327-T-A-1_SI_8540	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115327-T-A-1_SI_8540				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115327		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997308	NCI-PHS000915	DS-CA-MDS	sra	SRX5125502	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_8541	2018-12-14	15990	10151	2018-12-14	SRR8312046	SRS1187240	SRP063692	05115327-W-1_SI_8541	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115327-W-1_SI_8541				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115327		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997338	NCI-PHS000915	DS-CA-MDS	sra	SRX5125503	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_8556	2018-12-14	12886	8034	2018-12-14	SRR8312047	SRS1187241	SRP063692	05115327-T-A-1_SI_8556	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115327-T-A-1_SI_8556				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115327		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN03997445	NCI-PHS000915	DS-CA-MDS	sra	SRX5125504	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_9074	2018-12-14	18256	9397	2018-12-14	SRR8312048	SRS1187239	SRP063692	05115359-T-A-1_SI_9074	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115359-T-A-1_SI_9074				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115359		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN03997387	NCI-PHS000915	DS-CA-MDS	sra	SRX5125505	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_9102	2018-12-14	33185	17272	2018-12-14	SRR8312049	SRS1187238	SRP063692	05115359-T-A-1_SI_9102	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115359-T-A-1_SI_9102				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115359		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN03997330	NCI-PHS000915	DS-CA-MDS	sra	SRX5125506	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_9103	2018-12-14	20034	10243	2018-12-14	SRR8312050	SRS1187236	SRP063692	05115359-W-1_SI_9103	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115359-W-1_SI_9103				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115359		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN03997488	NCI-PHS000915	DS-CA-MDS	sra	SRX5125507	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_9124	2018-12-14	13036	6981	2018-12-14	SRR8312051	SRS1187237	SRP063692	05115359-T-A-1_SI_9124	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115359-T-A-1_SI_9124				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115359		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09075755	NCI-PHS000915	DS-CA-MDS	sra	SRX5125520	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_9309	2018-12-14	12052	6162	2019-02-15	SRR8312064	SRS4138642	SRP063692	05115406-T-B-1_SI_9309	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115406-T-B-1_SI_9309				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115406		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09075872	NCI-PHS000915	DS-CA-MDS	sra	SRX5125521	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_9310	2018-12-14	16597	8144	2019-02-15	SRR8312065	SRS4138643	SRP063692	5115407_SI_9310	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115407_SI_9310				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115407		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09076129	NCI-PHS000915	DS-CA-MDS	sra	SRX5125522	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_9314	2018-12-14	15615	7500	2019-02-15	SRR8312066	SRS4138644	SRP063692	05115406-T-B-1_SI_9314	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115406-T-B-1_SI_9314				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115406		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09075785	NCI-PHS000915	DS-CA-MDS	sra	SRX5125523	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_9315	2018-12-14	18495	8963	2019-02-15	SRR8312067	SRS4138646	SRP063692	5115407_SI_9315	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115407_SI_9315				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115407		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076123	NCI-PHS000915	DS-CA-MDS	sra	SRX5125524	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_9324	2018-12-14	30036	15333	2019-02-15	SRR8312068	SRS4138645	SRP063692	05115406-T-B-1_SI_9324	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115406-T-B-1_SI_9324				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115406		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075989	NCI-PHS000915	DS-CA-MDS	sra	SRX5125525	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_9325	2018-12-14	21462	10886	2019-02-15	SRR8312069	SRS4138647	SRP063692	05115406-T-B-1_SI_9325	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115406-T-B-1_SI_9325				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115406		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076002	NCI-PHS000915	DS-CA-MDS	sra	SRX5125526	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_9326	2018-12-14	29820	14517	2019-02-15	SRR8312070	SRS4138648	SRP063692	5115407SI_9326	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115407SI_9326				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115407		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075712	NCI-PHS000915	DS-CA-MDS	sra	SRX5125527	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_9327	2018-12-14	19366	9394	2019-02-15	SRR8312071	SRS4138649	SRP063692	5115407SI_9327	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115407SI_9327				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115407		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09075899	NCI-PHS000915	DS-CA-MDS	sra	SRX5125528	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_9377	2018-12-14	20982	10453	2019-02-15	SRR8312072	SRS4138650	SRP063692	05115405-T-A-1_SI_9377	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115405-T-A-1_SI_9377				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115405		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09075962	NCI-PHS000915	DS-CA-MDS	sra	SRX5125529	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_9383	2018-12-14	14080	6466	2019-02-15	SRR8312073	SRS4138651	SRP063692	05115405-T-A-1_SI_9383	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115405-T-A-1_SI_9383				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115405		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075973	NCI-PHS000915	DS-CA-MDS	sra	SRX5125531	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_9397	2018-12-14	29999	14744	2019-02-15	SRR8312075	SRS4138653	SRP063692	05115405-T-A-1_SI_9397	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115405-T-A-1_SI_9397				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115405		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075941	NCI-PHS000915	DS-CA-MDS	sra	SRX5125532	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_9398	2018-12-14	16898	8259	2019-02-15	SRR8312076	SRS4138654	SRP063692	05115405-T-A-1_SI_9398	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115405-T-A-1_SI_9398				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115405		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09075946	NCI-PHS000915	DS-CA-MDS	sra	SRX5125544	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_9793	2018-12-14	12805	7571	2019-02-15	SRR8312088	SRS4138666	SRP063692	5115408_SI_9793	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115408_SI_9793				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115408		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09076147	NCI-PHS000915	DS-CA-MDS	sra	SRX5125551	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_9808	2018-12-14	15438	7960	2019-02-15	SRR8312095	SRS4138673	SRP063692	5115408_SI_9808	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115408_SI_9808				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115408		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075760	NCI-PHS000915	DS-CA-MDS	sra	SRX5125552	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_9820	2018-12-14	26653	14141	2019-02-15	SRR8312096	SRS4138674	SRP063692	5115408SI_9820	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115408SI_9820				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115408		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075862	NCI-PHS000915	DS-CA-MDS	sra	SRX5125553	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_9821	2018-12-14	18800	9764	2019-02-15	SRR8312097	SRS4138675	SRP063692	5115408SI_9821	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115408SI_9821				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115408		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09076004	NCI-PHS000915	DS-CA-MDS	sra	SRX5125566	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_9988	2018-12-14	13974	6717	2019-02-15	SRR8312110	SRS4138688	SRP063692	05115501-T-A-1_SI_9988	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115501-T-A-1_SI_9988				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115501		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09075877	NCI-PHS000915	DS-CA-MDS	sra	SRX5125567	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_9992	2018-12-14	15833	7641	2019-02-15	SRR8312111	SRS4138689	SRP063692	05115501-T-A-1_SI_9992	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115501-T-A-1_SI_9992				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115501		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075762	BI	DS-CA-MDS	sra	SRX5129408	172	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148912022_tagged_866	2018-12-14	17909	9298	2019-02-15	SRR8316704	SRS4142504	SRP063692	06115321-T-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115321-T-B-1		Exome	HAB3KADXX, HAB5JADXX, HAB5LADXX, HAB62ADXX	phs000915		SL-HDC, SL-HDB	Yes	HybridSelection		HAB3KADXX140917, HAB5JADXX140917, HAB5LADXX140917, HAB62ADXX140917	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115321	PDO-4605	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075671	BI	DS-CA-MDS	sra	SRX5129409	140	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656485_Illumina_P5-Zafec_P7-Defin	2018-12-14	9988	4742	2019-02-15	SRR8316705	SRS4142505	SRP063692	06115381-T-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115381-T-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115381	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075879	BI	DS-CA-MDS	sra	SRX5129410	180	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0164095150_tagged_498	2018-12-14	11401	5591	2019-02-15	SRR8316706	SRS4142506	SRP063692	06115322-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115322-B-1		Exome	HABDCADXX, HAAFBADXX, HABJ1ADXX, HABHVADXX, HAAL2ADXX, HA5U2ADXX, HAB16ADXX	phs000915		SL-HDH, SL-HDD, SL-HDG, SL-HDF	No	HybridSelection		HABJ1ADXX140917, HAAFBADXX140917, HABHVADXX140917, HABDCADXX140917, HAAL2ADXX140917, HAB16ADXX140917, HA5U2ADXX140917	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115322	PDO-4605	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075895	BI	DS-CA-MDS	sra	SRX5129411	173	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0164095166_tagged_564	2018-12-14	15276	7255	2019-02-15	SRR8316707	SRS4142507	SRP063692	06115323-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115323-B-1		Exome	HABDCADXX, HAAFBADXX, HABJ1ADXX, HABHVADXX, HAAL2ADXX, HA5U2ADXX, HAB16ADXX	phs000915		SL-HDD, SL-HDH, SL-HDF, SL-HDG	No	HybridSelection		HABJ1ADXX140917, HAAFBADXX140917, HABHVADXX140917, HABDCADXX140917, HAAL2ADXX140917, HAB16ADXX140917, HA5U2ADXX140917	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115323	PDO-4605	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075991	BI	DS-CA-MDS	sra	SRX5129412	188	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656480_Illumina_P5-Kalex_P7-Hawix	2018-12-14	27937	12767	2019-02-15	SRR8316708	SRS4142508	SRP063692	06115381-T-A-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115381-T-A-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HDC, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115381	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076177	BI	DS-CA-MDS	sra	SRX5129413	171	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148912020_tagged_250	2018-12-14	13994	7358	2019-02-15	SRR8316709	SRS4142509	SRP063692	06115323-T-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115323-T-B-1		Exome	HAB62ADXX, HAB5LADXX, HAB5JADXX, HAB3KADXX	phs000915		SL-HDC, SL-HDB	Yes	HybridSelection		HAB62ADXX140917, HAB5LADXX140917, HAB5JADXX140917, HAB3KADXX140917	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115323	PDO-4605	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075784	BI	DS-CA-MDS	sra	SRX5129414	173	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0173433080_tagged_289	2018-12-14	18715	9634	2019-02-15	SRR8316710	SRS4142510	SRP063692	06115322-T-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115322-T-B-1		Exome	HAB62ADXX, HAB5JADXX, HAB3KADXX, HAB5LADXX	phs000915		SL-HDC, SL-HDB	Yes	HybridSelection		HAB62ADXX140917, HAB5JADXX140917, HAB3KADXX140917, HAB5LADXX140917	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115322	PDO-4605	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075683	BI	DS-CA-MDS	sra	SRX5129457	173	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0180656482_Illumina_P5-Kenaw_P7-Liyik	2018-12-14	20393	8342	2019-02-15	SRR8316753	SRS4142553	SRP063692	06115383-T-A-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115383-T-A-1		Exome	HJLCJADXX, HJKKFADXX	phs000915		SL-HCD	Yes	HybridSelection		HJLCJADXX150423, HJKKFADXX150423	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115383	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075787	BI	DS-CA-MDS	sra	SRX5129458	177	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656462_Illumina_P5-Rowol_P7-Nekoy	2018-12-14	19916	9204	2019-02-15	SRR8316754	SRS4142554	SRP063692	06115385-T-A-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115385-T-A-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HDC, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115385	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075814	BI	DS-CA-MDS	sra	SRX5129459	182	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656457_Illumina_P5-Xepaw_P7-Zixof	2018-12-14	24294	11184	2019-02-15	SRR8316755	SRS4142555	SRP063692	06115387-T-C-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115387-T-C-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HDC, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115387	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075826	BI	DS-CA-MDS	sra	SRX5129460	183	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0177197960_Illumina_P5-Yahih_P7-Zepon	2018-12-14	20482	8511	2019-02-15	SRR8316756	SRS4142556	SRP063692	06115388-T-C-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115388-T-C-1		Exome	HJLCMADXX, HJJH5ADXX, HJVHFADXX, HJLCHADXX	phs000915		SL-HDJ, SL-HBU	Yes	HybridSelection		HJLCMADXX150506, HJJH5ADXX150506, HJVHFADXX150506, HJLCHADXX150506	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115388	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075963	BI	DS-CA-MDS	sra	SRX5129461	173	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656533_Illumina_P5-Yezec_P7-Cotax	2018-12-14	26332	12015	2019-02-15	SRR8316757	SRS4142557	SRP063692	06115389-T-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115389-T-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HDC, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115389	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076019	BI	DS-CA-MDS	sra	SRX5129462	164	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656470_Illumina_P5-Worox_P7-Xinay	2018-12-14	21953	9882	2019-02-15	SRR8316758	SRS4142558	SRP063692	06115386-T-A-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115386-T-A-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HDC, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115386	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076181	BI	DS-CA-MDS	sra	SRX5129463	161	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656481_Illumina_P5-Hilec_P7-Layet	2018-12-14	23761	10915	2019-02-15	SRR8316759	SRS4142559	SRP063692	06115382-T-B-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115382-T-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HDC, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115382	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075684	BI	DS-CA-MDS	sra	SRX5129615	170	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180657194_Illumina_P5-Zehil_P7-Hefel	2018-12-14	21411	8863	2019-02-15	SRR8316910	SRS4142710	SRP063692	06115395-T-B-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115395-T-B-1		Exome	HJLCMADXX, HJVHFADXX, HJLCHADXX, HJJH5ADXX	phs000915		SL-HDJ, SL-HBU	Yes	HybridSelection		HJLCMADXX150506, HJVHFADXX150506, HJLCHADXX150506, HJJH5ADXX150506	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115395	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075839	BI	DS-CA-MDS	sra	SRX5129619	173	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656461_Illumina_P5-Poheh_P7-Nofeh	2018-12-14	23194	10447	2019-02-15	SRR8316915	SRS4142714	SRP063692	06115392-T-A-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115392-T-A-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HDC, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115392	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075845	BI	DS-CA-MDS	sra	SRX5129622	183	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180657201_Illumina_P5-Poded_P7-Rojan	2018-12-14	20566	8647	2019-02-15	SRR8316918	SRS4142717	SRP063692	06115390-T-C-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115390-T-C-1		Exome	HJVHFADXX, HJJH5ADXX, HJLCMADXX, HJLCHADXX	phs000915		SL-HDJ, SL-HBU	Yes	HybridSelection		HJVHFADXX150506, HJJH5ADXX150506, HJLCMADXX150506, HJLCHADXX150506	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115390	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076102	BI	DS-CA-MDS	sra	SRX5129623	188	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656467_Illumina_P5-Pojif_P7-Xedeb	2018-12-14	27550	12583	2019-02-15	SRR8316919	SRS4142718	SRP063692	06115394-T-C-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115394-T-C-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HDC, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115394	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076197	BI	DS-CA-MDS	sra	SRX5129624	178	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0180657213_Illumina_P5-Wexoj_P7-Pahol	2018-12-14	20589	8393	2019-02-15	SRR8316920	SRS4142719	SRP063692	06115393-T-C-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115393-T-C-1		Exome	HJLCHADXX, HJJH5ADXX, HJVHFADXX, HJLCMADXX	phs000915		SL-HBU, SL-HDJ	Yes	HybridSelection		HJLCHADXX150506, HJJH5ADXX150506, HJVHFADXX150506, HJLCMADXX150506	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115393	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075961	BI	DS-CA-MDS	sra	SRX5129625	177	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656450_Illumina_P5-Razac_P7-Folar	2018-12-14	23868	10847	2019-02-15	SRR8316921	SRS4142720	SRP063692	06115399-T-A-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115399-T-A-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HDC, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115399	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075975	BI	DS-CA-MDS	sra	SRX5129626	175	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0177198023_Illumina_P5-Depob_P7-Binot	2018-12-14	20125	8180	2019-02-15	SRR8316922	SRS4142721	SRP063692	06115397-T-C-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115397-T-C-1		Exome	HJVHFADXX, HJLCHADXX, HJLCMADXX, HJJH5ADXX	phs000915		SL-HDJ, SL-HBU	Yes	HybridSelection		HJVHFADXX150506, HJLCHADXX150506, HJLCMADXX150506, HJJH5ADXX150506	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115397	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076069	BI	DS-CA-MDS	sra	SRX5129627	181	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0177197956_Illumina_P5-Paroy_P7-Debox	2018-12-14	19026	8001	2019-02-15	SRR8316923	SRS4142722	SRP063692	06115391-T-B-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115391-T-B-1		Exome	HJLCMADXX, HJLCHADXX, HJJH5ADXX, HJVHFADXX	phs000915		SL-HDJ, SL-HBU	Yes	HybridSelection		HJLCMADXX150506, HJLCHADXX150506, HJJH5ADXX150506, HJVHFADXX150506	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115391	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076101	BI	DS-CA-MDS	sra	SRX5129628	176	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0180657166_Illumina_P5-Wizap_P7-Jatod	2018-12-14	17099	6996	2019-02-15	SRR8316924	SRS4142723	SRP063692	06115396-T-A-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115396-T-A-1		Exome	HJLCHADXX, HJJH5ADXX, HJVHFADXX, HJLCMADXX	phs000915		SL-HBU, SL-HDJ	Yes	HybridSelection		HJLCHADXX150506, HJJH5ADXX150506, HJVHFADXX150506, HJLCMADXX150506	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115396	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076222	BI	DS-CA-MDS	sra	SRX5129629	179	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656449_Illumina_P5-Hewij_P7-Zidel	2018-12-14	28339	12859	2019-02-15	SRR8316925	SRS4142724	SRP063692	06115398-T-B-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115398-T-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HDC, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115398	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076107	BI	DS-CA-MDS	sra	SRX5129630	210	Illumina HiSeq 4000	PAIRED	Hybrid Selection	GENOMIC	0191736182_Illumina_P5-Belez_P7-Yoxen	2018-12-14	24796	5328	2019-02-15	SRR8316926	SRS4142725	SRP063692	06115392-T-B-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115392-T-B-1		Exome	HC3CGBBXX, HC3GJBBXX	phs000915		SL-HFC	Yes	HybridSelection		HC3CGBBXX160425, HC3GJBBXX160425	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115392	PDO-8519	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076039	BI	DS-PC-MDS	sra	SRX5133505	159	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911957_Illumina_P5-Hojor_P7-Jocef	2018-12-14	14363	6340	2019-02-15	SRR8321236	SRS4146403	SRP063692	DFCI.10-448.P31_base_formalin_A	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	DFCI.10-448.P31_base_formalin_A		Exome	H7J3HADXX, H7J0PADXX, H7J33ADXX, H7J0TADXX, H7J1HADXX, H7J0RADXX, H7HW1ADXX, H7GKUADXX, H7J0VADXX, H7HWGADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HDH, SL-HDD, SL-HDE	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115309	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076066	BI	DS-PC-MDS	sra	SRX5133506	180	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148912005_Illumina_P5-Pifoc_P7-Hoden	2018-12-14	10528	4909	2019-02-15	SRR8321237	SRS4146404	SRP063692	DFCI.10-448.P40_base_PAX_A1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	DFCI.10-448.P40_base_PAX_A1		Exome	H7J3HADXX, H7J0PADXX, H7J33ADXX, H7J0TADXX, H7J1HADXX, H7J0RADXX, H7HW1ADXX, H7GKUADXX, H7J0VADXX, H7HWGADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HDH, SL-HDD, SL-HDE	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115190	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076163	BI	DS-PC-MDS	sra	SRX5133508	178	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911937_Illumina_P5-Hewij_P7-Zidel	2018-12-14	11849	5566	2019-02-15	SRR8321239	SRS4146405	SRP063692	DFCI.10-448.P30_base_PAX_2	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	DFCI.10-448.P30_base_PAX_2		Exome	H7J3HADXX, H7J0PADXX, H7J33ADXX, H7J0TADXX, H7J1HADXX, H7J0RADXX, H7HW1ADXX, H7GKUADXX, H7J0VADXX, H7HWGADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HDH, SL-HDD, SL-HDE	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115313	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076194	BI	DS-PC-MDS	sra	SRX5133510	182	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911942_Illumina_P5-Reboc_P7-Yeyey	2018-12-14	11267	4918	2019-02-15	SRR8321241	SRS4146408	SRP063692	DFCI.10-448.P38_base_OCT_A	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	DFCI.10-448.P38_base_OCT_A		Exome	H7J3HADXX, H7J0PADXX, H7J33ADXX, H7J0TADXX, H7J1HADXX, H7J0RADXX, H7HW1ADXX, H7GKUADXX, H7J0VADXX, H7HWGADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HDH, SL-HDD, SL-HDE	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115311	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075915	BI	DS-PC-MDS	sra	SRX5133512	167	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148912015_Illumina_P5-Hapow_P7-Halex	2018-12-14	15462	6659	2019-02-15	SRR8321243	SRS4146409	SRP063692	DFCI.10-448.P41_base_formalin	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	DFCI.10-448.P41_base_formalin		Exome	H7J3HADXX, H7J0PADXX, H7J33ADXX, H7J0TADXX, H7J1HADXX, H7J0RADXX, H7HW1ADXX, H7GKUADXX, H7J0VADXX, H7HWGADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HDH, SL-HDD, SL-HDE	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115153	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075820	BI	DS-PC-MDS	sra	SRX5133880	179	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911961_Illumina_P5-Yalor_P7-Doyez	2018-12-14	10424	4771	2019-02-15	SRR8321661	SRS4146772	SRP063692	DFCI.10-448.P29_base_PAX_1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	DFCI.10-448.P29_base_PAX_1		Exome	H7J3HADXX, H7J0PADXX, H7J33ADXX, H7J0TADXX, H7J1HADXX, H7J0RADXX, H7HW1ADXX, H7GKUADXX, H7J0VADXX, H7HWGADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HDH, SL-HDD, SL-HDE	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115308	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075737	BI	DS-PC-MDS	sra	SRX5133881	185	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911959_Illumina_P5-Wizap_P7-Jatod	2018-12-14	11144	4800	2019-02-15	SRR8321662	SRS4146773	SRP063692	DFCI.10-448.P29_base_OCT_A	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	DFCI.10-448.P29_base_OCT_A		Exome	H7J3HADXX, H7J0PADXX, H7J33ADXX, H7J0TADXX, H7J1HADXX, H7J0RADXX, H7HW1ADXX, H7GKUADXX, H7J0VADXX, H7HWGADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HDH, SL-HDD, SL-HDE	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115308	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075830	BI	DS-PC-MDS	sra	SRX5133882	168	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911962_Illumina_P5-Zitey_P7-Fapix	2018-12-14	10171	4809	2019-02-15	SRR8321663	SRS4146774	SRP063692	DFCI.10-448.P22_base_PAX_2	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	DFCI.10-448.P22_base_PAX_2		Exome	H7J3HADXX, H7J0PADXX, H7J33ADXX, H7J0TADXX, H7J1HADXX, H7J0RADXX, H7HW1ADXX, H7GKUADXX, H7J0VADXX, H7HWGADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HDH, SL-HDD, SL-HDE	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115314	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075923	BI	DS-PC-MDS	sra	SRX5133883	165	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911986_Illumina_P5-Boyij_P7-Jofij	2018-12-14	14358	6338	2019-02-15	SRR8321664	SRS4146775	SRP063692	DFCI.10-448.P27_base_formalin_A	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	DFCI.10-448.P27_base_formalin_A		Exome	H7J3HADXX, H7J0PADXX, H7J33ADXX, H7J0TADXX, H7J1HADXX, H7J0RADXX, H7HW1ADXX, H7GKUADXX, H7J0VADXX, H7HWGADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HDH, SL-HDD, SL-HDE	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115307	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075711	BI	DS-PC-MDS	sra	SRX5133884	161	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911958_Illumina_P5-Worox_P7-Xinay	2018-12-14	13302	5887	2019-02-15	SRR8321665	SRS4146776	SRP063692	DFCI.10-448.P29_base_formalin_A	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	DFCI.10-448.P29_base_formalin_A		Exome	H7J3HADXX, H7J0PADXX, H7J33ADXX, H7J0TADXX, H7J1HADXX, H7J0RADXX, H7HW1ADXX, H7GKUADXX, H7J0VADXX, H7HWGADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HDH, SL-HDD, SL-HDE	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115308	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075919	BI	DS-CA-MDS	sra	SRX5136428	184	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656465_Illumina_P5-Jaxah_P7-Nehin	2018-12-14	10990	5119	2019-02-15	SRR8324610	SRS4148770	SRP063692	6115402-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	6115402-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115402	PDO-5957	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076000	BI	DS-CA-MDS	sra	SRX5136429	164	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656490_Illumina_P5-Pinez_P7-Xokix	2018-12-14	8595	4128	2019-02-15	SRR8324611	SRS4148771	SRP063692	6115391-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	6115391-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115391	PDO-5957	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076048	BI	DS-CA-MDS	sra	SRX5136430	186	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656527_Illumina_P5-Hapow_P7-Halex	2018-12-14	12747	5934	2019-02-15	SRR8324612	SRS4148772	SRP063692	6115400-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	6115400-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115400	PDO-5957	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076167	BI	DS-CA-MDS	sra	SRX5136431	170	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656468_Illumina_P5-Boleh_P7-Nanat	2018-12-15	12773	5819	2019-02-15	SRR8324613	SRS4148773	SRP063692	6115403-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	6115403-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115403	PDO-5957	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075674	BI	DS-CA-MDS	sra	SRX5136432	142	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656522_Illumina_P5-Lahoy_P7-Difew	2018-12-15	9532	4433	2019-02-15	SRR8324614	SRS4148774	SRP063692	6115395-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	6115395-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115395	PDO-5957	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075819	BI	DS-CA-MDS	sra	SRX5136433	183	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0180656463_Illumina_P5-Yewow_P7-Tehed	2018-12-14	9761	4583	2019-02-15	SRR8324615	SRS4148775	SRP063692	6115390-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	6115390-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115390	PDO-5957	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075951	BI	DS-CA-MDS	sra	SRX5136434	174	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656525_Illumina_P5-Nalok_P7-Teyay	2018-12-15	9234	4264	2019-02-15	SRR8324616	SRS4148776	SRP063692	6115398-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	6115398-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115398	PDO-5957	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076023	BI	DS-CA-MDS	sra	SRX5136435	167	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656537_Illumina_P5-Jotef_P7-Bepaz	2018-12-14	10704	5009	2019-02-15	SRR8324617	SRS4148777	SRP063692	6115387-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	6115387-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115387	PDO-5957	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076213	BI	DS-PC-MDS	sra	SRX5136436	176	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911987_Illumina_P5-Loroh_P7-Hinij	2018-12-15	11005	4855	2019-02-15	SRR8324618	SRS4148778	SRP063692	DFCI.10-448.P15_base_OCT_C	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	DFCI.10-448.P15_base_OCT_C		Exome	H7J3HADXX, H7J0PADXX, H7J33ADXX, H7J0TADXX, H7J1HADXX, H7J0RADXX, H7HW1ADXX, H7GKUADXX, H7J0VADXX, H7HWGADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HDH, SL-HDD, SL-HDE	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115305	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075992	BI	DS-PC-MDS	sra	SRX5136437	174	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911981_Illumina_P5-Boyez_P7-Yokif	2018-12-15	10784	4870	2019-02-15	SRR8324619	SRS4148779	SRP063692	DFCI.10-448.P20_base_pull	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	DFCI.10-448.P20_base_pull		Exome	H7J3HADXX, H7J0PADXX, H7J33ADXX, H7J0TADXX, H7J1HADXX, H7J0RADXX, H7HW1ADXX, H7GKUADXX, H7J0VADXX, H7HWGADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HDH, SL-HDD, SL-HDE	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115306	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq	GCA_000001405.13	202	PRJNA283923	SAMN03997474	BI	DS-PC-MDS	sra	SRX1244906	500	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	Solexa-260509	2019-05-01	15639	9490	2016-01-16	SRR2403929	SRS1068568	SRP063692	01115202-TA1	DNA; RNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115202-TA1		RNA	C4KMTACXX	phs000915		SL-HEL	Yes	cDNAShotgunStrandAgnostic	SNV (.MAF)	C4KMTACXX140715	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	01115202		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN03997452	BI	DS-PC-MDS	sra	SRX1244909	207	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0167755415_Illumina_P5-Wizap_P7-Jatod	2015-09-15	9365	4110	2016-01-16	SRR2403935	SRS1068567	SRP063692	01115183-B-1	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115183-B-1		Exome	H9GV8ADXX	phs000915			No			H9GV8ADXX140625	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	01115183		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq	GCA_000001405.13	202	PRJNA283923	SAMN03997393	BI	DS-PC-MDS	sra	SRX1244916	500	Illumina HiSeq 2000	PAIRED	cDNA	TRANSCRIPTOMIC	Solexa-229011	2019-05-01	8974	3603	2016-01-16	SRR2403950	SRS1068578	SRP063692	01115156-TA3	DNA; RNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115156-TA3		RNA	H7HF5ADXX	phs000915		SL-HBV	Yes	cDNAShotgunStrandAgnostic	SNV (.MAF)	H7HF5ADXX140307	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	01115156		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq	GCA_000001405.13	202	PRJNA283923	SAMN03997353	BI	DS-PC-MDS	sra	SRX1244921	500	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	Solexa-260497	2019-05-01	15088	9109	2016-01-16	SRR2403964	SRS1068574	SRP063692	01115161-TA1	DNA; RNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115161-TA1		RNA	C4KMTACXX	phs000915		SL-HEL	Yes	cDNAShotgunStrandAgnostic	SNV (.MAF)	C4KMTACXX140715	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	01115161		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq	GCA_000001405.13	202	PRJNA283923	SAMN03997467	BI	DS-PC-MDS	sra	SRX1244918	500	Illumina HiSeq 2000	PAIRED	cDNA	TRANSCRIPTOMIC	Solexa-229010	2019-05-01	7571	3038	2016-01-16	SRR2403970	SRS1068576	SRP063692	01115154-TA3	DNA; RNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115154-TA3		RNA	H7HFDADXX	phs000915		SL-HBV	Yes	cDNAShotgunStrandAgnostic	SNV (.MAF)	H7HFDADXX140307	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	01115154		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq	GCA_000001405.13	202	PRJNA283923	SAMN03997312	BI	DS-PC-MDS	sra	SRX1244923	500	Illumina HiSeq 2000	PAIRED	cDNA	TRANSCRIPTOMIC	Solexa-229012	2019-05-01	9492	3846	2016-01-16	SRR2403980	SRS1068579	SRP063692	01115157-TA2	DNA; RNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115157-TA2		RNA	H7HFDADXX	phs000915		SL-HBV	Yes	cDNAShotgunStrandAgnostic	SNV (.MAF)	H7HFDADXX140307	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	01115157		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq	GCA_000001405.13	202	PRJNA283923	SAMN03997441	BI	DS-PC-MDS	sra	SRX1244929	500	Illumina HiSeq 2000	PAIRED	cDNA	TRANSCRIPTOMIC	Solexa-229009	2019-05-01	7457	3007	2016-01-16	SRR2403991	SRS1068582	SRP063692	01115153-TA2	DNA; RNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115153-TA2		RNA	H7HF5ADXX	phs000915		SL-HBV	Yes	cDNAShotgunStrandAgnostic	SNV (.MAF)	H7HF5ADXX140307	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115153		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN03997319	BI	DS-PC-MDS	sra	SRX1244936	174	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0150675756_Illumina_P5-Kefaz_P7-Honok	2015-09-15	19835	8609	2016-01-16	SRR2404007	SRS1068587	SRP063692	01115153-B-1	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115153-B-1		Exome	H7HBEADXX	phs000915			No			H7HBEADXX140225	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115153		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN03997393	BI	DS-PC-MDS	sra	SRX1244942	177	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0154850215_Illumina_P5-Wizap_P7-Jatod	2015-09-15	17996	7892	2016-01-16	SRR2404024	SRS1068578	SRP063692	01115156-TA3	DNA; RNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115156-TA3		Exome	H7FMBADXX	phs000915			Yes		SNV (.MAF)	H7FMBADXX140225	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	01115156		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq	GCA_000001405.13	202	PRJNA283923	SAMN03997321	BI	DS-PC-MDS	sra	SRX1244956	500	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	Solexa-260512	2019-05-01	13789	8369	2016-01-16	SRR2404058	SRS1068593	SRP063692	01115244-TA4	DNA; RNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115244-TA4		RNA	C4KMTACXX	phs000915		SL-HEL	Yes	cDNAShotgunStrandAgnostic	SNV (.MAF)	C4KMTACXX140715	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	01115244		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN03997441	BI	DS-PC-MDS	sra	SRX1244963	174	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0154850262_Illumina_P5-Boyez_P7-Yokif	2015-09-15	21313	9356	2016-01-16	SRR2404067	SRS1068582	SRP063692	01115153-TA2	DNA; RNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115153-TA2		Exome	H7FPLADXX	phs000915			Yes		SNV (.MAF)	H7FPLADXX140225	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115153		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN03997353	BI	DS-PC-MDS	sra	SRX1244970	179	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0167755414_Illumina_P5-Worox_P7-Xinay	2015-09-15	12139	5151	2016-01-16	SRR2404095	SRS1068574	SRP063692	01115161-TA1	DNA; RNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115161-TA1		Exome	H9G9JADXX	phs000915			Yes		SNV (.MAF)	H9G9JADXX140625	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	01115161		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq	GCA_000001405.13	202	PRJNA283923	SAMN03997492	BI	DS-PC-MDS	sra	SRX1244974	500	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	Solexa-260503	2019-05-01	16158	9811	2016-01-16	SRR2404107	SRS1068551	SRP063692	01115183-TA2	DNA; RNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115183-TA2		RNA	C4KMTACXX	phs000915		SL-HEL	Yes	cDNAShotgunStrandAgnostic	SNV (.MAF)	C4KMTACXX140715	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	01115183		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN03997356	BI	DS-PC-MDS	sra	SRX1244977	174	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0154850273_Illumina_P5-Poded_P7-Rojan	2015-09-15	24511	10806	2016-01-16	SRR2404128	SRS1068608	SRP063692	01115156-B-1	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115156-B-1		Exome	H7H85ADXX	phs000915			No			H7H85ADXX140225	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	01115156		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCF_000001405.25	152	PRJNA283923	SAMN03997449	BI	DS-PC-MDS	sra	SRX1244991	170	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0150675766_Illumina_P5-Hojor_P7-Jocef	2015-09-16	27149	11611	2016-01-16	SRR2404158	SRS1068613	SRP063692	01115154-B-1	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115154-B-1		Exome	H7HBCADXX	phs000915			No			H7HBCADXX140225	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	01115154		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN03997312	BI	DS-PC-MDS	sra	SRX1245008	175	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0154850296_Illumina_P5-Zehil_P7-Hefel	2015-09-15	21234	9443	2016-01-16	SRR2404185	SRS1068579	SRP063692	01115157-TA2	DNA; RNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115157-TA2		Exome	H7FMBADXX	phs000915			Yes		SNV (.MAF)	H7FMBADXX140225	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	01115157		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN03997297	BI	DS-PC-MDS	sra	SRX1245021	175	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0154850267_Illumina_P5-Razac_P7-Folar	2015-09-15	22215	9581	2016-01-16	SRR2404207	SRS1068627	SRP063692	01115157-B-1	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115157-B-1		Exome	H7HBCADXX	phs000915			No			H7HBCADXX140225	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	01115157		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN03997467	BI	DS-PC-MDS	sra	SRX1245025	171	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0154850211_Illumina_P5-Depob_P7-Binot	2015-10-14	26008	11201	2016-01-16	SRR2404230	SRS1068576	SRP063692	01115154-TA3	DNA; RNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115154-TA3		Exome	H7H7DADXX	phs000915			Yes		SNV (.MAF)	H7H7DADXX140225	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	01115154		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN03997358	BI	DS-PC-MDS	sra	SRX1245038	189	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0167755440_Illumina_P5-Yahih_P7-Zepon	2015-09-15	12995	5801	2016-01-16	SRR2404257	SRS1068635	SRP063692	01115244-B-1	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115244-B-1		Exome	H7U9LADXX	phs000915			No			H7U9LADXX140625	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	01115244		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN03997474	BI	DS-PC-MDS	sra	SRX1245042	185	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0167755486_Illumina_P5-Kizez_P7-Cakax	2015-09-15	12266	5278	2016-01-16	SRR2404278	SRS1068568	SRP063692	01115202-TA1	DNA; RNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115202-TA1		Exome	H9GT6ADXX	phs000915			Yes		SNV (.MAF)	H9GT6ADXX140625	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	01115202		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN03997317	BI	DS-PC-MDS	sra	SRX1245047	177	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0167755439_Illumina_P5-Paroy_P7-Debox	2015-10-14	11691	5093	2016-01-16	SRR2404284	SRS1068638	SRP063692	01115202-B-1	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115202-B-1		Exome	H9GV8ADXX	phs000915			No			H9GV8ADXX140625	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	01115202		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN03997321	BI	DS-PC-MDS	sra	SRX1245051	185	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0167755417_Illumina_P5-Yalor_P7-Doyez	2015-09-15	13024	5472	2016-01-16	SRR2404302	SRS1068593	SRP063692	01115244-TA4	DNA; RNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115244-TA4		Exome	H9GT6ADXX	phs000915			Yes		SNV (.MAF)	H9GT6ADXX140625	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	01115244		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN03997492	BI	DS-PC-MDS	sra	SRX1244896	173	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0167755438_Illumina_P5-Polez_P7-Bezic	2015-09-15	15850	6767	2016-01-16	SRR2407078	SRS1068551	SRP063692	01115183-TA2	DNA; RNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115183-TA2		Exome	H9GVWADXX	phs000915			Yes		SNV (.MAF)	H9GVWADXX140625	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	01115183		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN03997503	BI	DS-PC-MDS	sra	SRX1244888	197	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0167755418_Illumina_P5-Zitey_P7-Fapix	2015-10-14	7550	3408	2016-01-16	SRR2407084	SRS1068556	SRP063692	01115161-B-1	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	01115161-B-1		Exome	H9G9NADXX	phs000915			No			H9G9NADXX140625	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	01115161		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997420	UM-MCTP	DS-CA-MDS	sra	SRX1459771	238	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5498	2015-12-16	19174	12549	2016-01-16	SRR3018010	SRS1187417	SRP063692	05115022-T-A-1_SI_5498	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115022-T-A-1_SI_5498				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115002		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997314	UM-MCTP	DS-CA-MDS	sra	SRX1459772	254	Illumina HiSeq 2000	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5500	2015-12-16	12816	8492	2016-01-16	SRR3018011	SRS1187415	SRP063692	05115022-T-A-1_SI_5500	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115022-T-A-1_SI_5500				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115002		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997470	UM-MCTP	DS-CA-MDS	sra	SRX1459773	219	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5499	2015-12-16	16162	10509	2016-01-16	SRR3018012	SRS1187414	SRP063692	05115022-W-1_SI_5499	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115022-W-1_SI_5499				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115022		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997466	UM-MCTP	DS-CA-MDS	sra	SRX1459774	272	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_4603	2015-12-16	24154	15357	2016-01-16	SRR3018013	SRS1187413	SRP063692	05115023-T-A-1_SI_4603	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115023-T-A-1_SI_4603				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115023		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997365	UM-MCTP	DS-CA-MDS	sra	SRX1459775	260	Illumina HiSeq 2000	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_4733	2015-12-16	10524	7018	2016-01-16	SRR3018014	SRS1187412	SRP063692	05115023-T-A-2_SI_4733	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115023-T-A-2_SI_4733				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115023		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997363	UM-MCTP	DS-CA-MDS	sra	SRX1459776	278	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_4602	2015-12-16	14155	9068	2016-01-16	SRR3018015	SRS1187411	SRP063692	05115023-W-1_SI_4602	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115023-W-1_SI_4602				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115023		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997366	UM-MCTP	DS-CA-MDS	sra	SRX1459777	261	Illumina HiSeq 2000	PAIRED	PolyA	TRANSCRIPTOMIC	SI_4737	2015-12-16	12180	8053	2016-01-16	SRR3018016	SRS1187416	SRP063692	05115024-T-A-1_SI_4737	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115024-T-A-1_SI_4737				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115024		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997489	UM-MCTP	DS-CA-MDS	sra	SRX1459778	216	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_4742	2015-12-16	21453	14147	2016-01-16	SRR3018017	SRS1187418	SRP063692	05115024-T-A-2_SI_4742	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115024-T-A-2_SI_4742				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115024		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997328	UM-MCTP	DS-CA-MDS	sra	SRX1459779	229	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_4741	2015-12-16	15456	10193	2016-01-16	SRR3018018	SRS1187410	SRP063692	05115024-W-1_SI_4741	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115024-W-1_SI_4741				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115024		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997446	UM-MCTP	DS-CA-MDS	sra	SRX1459780	269	Illumina HiSeq 2000	PAIRED	PolyA	TRANSCRIPTOMIC	SI_4966	2015-12-16	12616	8546	2016-01-16	SRR3018019	SRS1187409	SRP063692	05115026-T-A-1_SI_4966	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115026-T-A-1_SI_4966				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115026		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997423	UM-MCTP	DS-CA-MDS	sra	SRX1459781	224	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_4989	2015-12-16	20502	13492	2016-01-16	SRR3018020	SRS1187406	SRP063692	05115026-T-A-1_SI_4989	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115026-T-A-1_SI_4989				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115026		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997395	UM-MCTP	DS-CA-MDS	sra	SRX1459782	256	Illumina HiSeq 2000	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_4971	2015-12-16	16840	11029	2016-01-16	SRR3018021	SRS1187405	SRP063692	05115026-T-A-2_SI_4971	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115026-T-A-2_SI_4971				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115026		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997477	UM-MCTP	DS-CA-MDS	sra	SRX1459783	241	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_4988	2015-12-16	14188	9433	2016-01-16	SRR3018022	SRS1187402	SRP063692	05115026-W-1_SI_4988	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115026-W-1_SI_4988				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115026		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997480	UM-MCTP	DS-CA-MDS	sra	SRX1459784	209	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5122	2015-12-16	17885	12251	2016-01-16	SRR3018023	SRS1187403	SRP063692	05115027-T-A-1_SI_5122	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115027-T-A-1_SI_5122				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115027		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997336	UM-MCTP	DS-CA-MDS	sra	SRX1459785	243	Illumina HiSeq 2000	PAIRED	PolyA	TRANSCRIPTOMIC	SI_5092	2015-12-16	18355	12235	2016-01-16	SRR3018024	SRS1187401	SRP063692	05115027-T-A-2_SI_5092	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115027-T-A-2_SI_5092				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115027		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997376	UM-MCTP	DS-CA-MDS	sra	SRX1459786	253	Illumina HiSeq 2000	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5094	2015-12-16	18066	12075	2016-01-16	SRR3018025	SRS1187404	SRP063692	05115027-T-A-2_SI_5094	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115027-T-A-2_SI_5094				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115027		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997369	UM-MCTP	DS-CA-MDS	sra	SRX1459787	231	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5123	2015-12-16	19331	13250	2016-01-16	SRR3018026	SRS1187407	SRP063692	05115027-W-1_SI_5123	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115027-W-1_SI_5123				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115027		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997418	UM-MCTP	DS-CA-MDS	sra	SRX1459788	272	Illumina HiSeq 2000	PAIRED	PolyA	TRANSCRIPTOMIC	SI_5258	2015-12-16	18964	13071	2016-01-16	SRR3018027	SRS1187399	SRP063692	05115028-T-A-1_SI_5258	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115028-T-A-1_SI_5258				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115028		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997322	UM-MCTP	DS-CA-MDS	sra	SRX1459789	238	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5263	2015-12-16	19750	13280	2016-01-16	SRR3018028	SRS1187408	SRP063692	05115028-T-A-1_SI_5263	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115028-T-A-1_SI_5263				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115028		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997463	UM-MCTP	DS-CA-MDS	sra	SRX1459790	267	Illumina HiSeq 2000	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5277	2015-12-16	18635	12892	2016-01-16	SRR3018029	SRS1187400	SRP063692	05115028-T-A-1_SI_5277	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115028-T-A-1_SI_5277				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115028		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997485	UM-MCTP	DS-CA-MDS	sra	SRX1459791	252	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5264	2015-12-16	13872	9368	2016-01-16	SRR3018030	SRS1187396	SRP063692	05115028-W-1_SI_5264	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115028-W-1_SI_5264				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115028		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997482	UM-MCTP	DS-CA-MDS	sra	SRX1459792	256	Illumina HiSeq 2000	PAIRED	PolyA	TRANSCRIPTOMIC	SI_5410	2015-12-16	19980	13510	2016-01-16	SRR3018031	SRS1187397	SRP063692	05115029-T-A-1_SI_5410	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115029-T-A-1_SI_5410				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115029		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997473	UM-MCTP	DS-CA-MDS	sra	SRX1459793	228	Illumina HiSeq 2000	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5433	2015-12-16	21348	14392	2016-01-16	SRR3018032	SRS1187394	SRP063692	05115029-T-A-1_SI_5433	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115029-T-A-1_SI_5433				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115029		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997351	UM-MCTP	DS-CA-MDS	sra	SRX1459794	264	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5440	2015-12-16	22222	15255	2016-01-16	SRR3018033	SRS1187393	SRP063692	05115029-T-A-1_SI_5440	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115029-T-A-1_SI_5440				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115029		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997367	UM-MCTP	DS-CA-MDS	sra	SRX1459795	267	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5441	2015-12-16	16815	11541	2016-01-16	SRR3018034	SRS1187392	SRP063692	05115029-W-1_SI_5441	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115029-W-1_SI_5441				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115029		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997399	UM-MCTP	DS-CA-MDS	sra	SRX1459796	258	Illumina HiSeq 2000	PAIRED	PolyA	TRANSCRIPTOMIC	SI_5551	2015-12-16	12806	8337	2016-01-16	SRR3018035	SRS1187391	SRP063692	05115030-T-A-1_SI_5551	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115030-T-A-1_SI_5551				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115030		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997434	UM-MCTP	DS-CA-MDS	sra	SRX1459797	234	Illumina HiSeq 2000	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5555	2015-12-16	14508	9518	2016-01-16	SRR3018036	SRS1187390	SRP063692	05115030-T-A-1_SI_5555	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115030-T-A-1_SI_5555				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115030		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997371	UM-MCTP	DS-CA-MDS	sra	SRX1459798	229	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5565	2015-12-16	21722	14225	2016-01-16	SRR3018037	SRS1187388	SRP063692	05115030-T-A-1_SI_5565	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115030-T-A-1_SI_5565				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115030		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997494	UM-MCTP	DS-CA-MDS	sra	SRX1459799	224	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5566	2015-12-16	15100	9836	2016-01-16	SRR3018038	SRS1187386	SRP063692	05115030-W-1_SI_5566	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115030-W-1_SI_5566				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115030		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997496	UM-MCTP	DS-CA-MDS	sra	SRX1459800	261	Illumina HiSeq 2000	PAIRED	PolyA	TRANSCRIPTOMIC	SI_5594	2015-12-16	10547	6753	2016-01-16	SRR3018039	SRS1187387	SRP063692	05115031-T-C-1_SI_5594	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115031-T-C-1_SI_5594				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115031		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997429	UM-MCTP	DS-CA-MDS	sra	SRX1459801	225	Illumina HiSeq 2000	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5604	2015-12-16	11500	7398	2016-01-16	SRR3018040	SRS1187385	SRP063692	05115031-T-C-1_SI_5604	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115031-T-C-1_SI_5604				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115031		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997460	UM-MCTP	DS-CA-MDS	sra	SRX1459802	220	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5624	2015-12-16	21118	13457	2016-01-16	SRR3018041	SRS1187398	SRP063692	05115031-T-C-1_SI_5624	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115031-T-C-1_SI_5624				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115031		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997362	UM-MCTP	DS-CA-MDS	sra	SRX1459803	232	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5625	2015-12-16	12563	8067	2016-01-16	SRR3018042	SRS1187384	SRP063692	05115031-W-1_SI_5625	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115031-W-1_SI_5625				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115031		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997324	UM-MCTP	DS-CA-MDS	sra	SRX1459804	234	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5671	2015-12-16	21786	14204	2016-01-16	SRR3018043	SRS1187382	SRP063692	05115032-T-A-1_SI_5671	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115032-T-A-1_SI_5671				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115032		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997435	UM-MCTP	DS-CA-MDS	sra	SRX1459805	242	Illumina HiSeq 2000	PAIRED	PolyA	TRANSCRIPTOMIC	SI_5665	2015-12-16	15733	10571	2016-01-16	SRR3018044	SRS1187389	SRP063692	05115032-T-A-2_SI_5665	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115032-T-A-2_SI_5665				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115032		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997299	UM-MCTP	DS-CA-MDS	sra	SRX1459806	245	Illumina HiSeq 2000	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5684	2015-12-16	9932	6526	2016-01-16	SRR3018045	SRS1187380	SRP063692	05115032-T-A-2_SI_5684	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115032-T-A-2_SI_5684				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115032		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997383	UM-MCTP	DS-CA-MDS	sra	SRX1459807	240	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5672	2015-12-16	15046	9773	2016-01-16	SRR3018046	SRS1187395	SRP063692	05115032-W-1_SI_5672	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115032-W-1_SI_5672				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115032		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997491	UM-MCTP	DS-CA-MDS	sra	SRX1459808	271	Illumina HiSeq 2000	PAIRED	PolyA	TRANSCRIPTOMIC	SI_5668	2015-12-16	14595	9729	2016-01-16	SRR3018047	SRS1187381	SRP063692	05115033-T-A-1_SI_5668	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115033-T-A-1_SI_5668				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115033		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997454	UM-MCTP	DS-CA-MDS	sra	SRX1459809	261	Illumina HiSeq 2000	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5688	2015-12-16	13786	9216	2016-01-16	SRR3018048	SRS1187379	SRP063692	05115033-T-A-1_SI_5688	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115033-T-A-1_SI_5688				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115033		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997296	UM-MCTP	DS-CA-MDS	sra	SRX1459810	241	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5679	2015-12-16	27071	18166	2016-01-16	SRR3018049	SRS1187376	SRP063692	05115033-T-A-2_SI_5679	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115033-T-A-2_SI_5679				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115033		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997455	UM-MCTP	DS-CA-MDS	sra	SRX1459811	244	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5680	2015-12-16	15375	10320	2016-01-16	SRR3018050	SRS1187375	SRP063692	05115033-W-1_SI_5680	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115033-W-1_SI_5680				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115033		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997433	UM-MCTP	DS-CA-MDS	sra	SRX1459812	421	Illumina HiSeq 2000	PAIRED	PolyA	TRANSCRIPTOMIC	SI_5924	2015-12-16	8779	5904	2016-01-16	SRR3018051	SRS1187374	SRP063692	05115034-T-A-1_SI_5924	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115034-T-A-1_SI_5924				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115034		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997340	UM-MCTP	DS-CA-MDS	sra	SRX1459813	236	Illumina HiSeq 2000	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5939	2015-12-16	13801	9040	2016-01-16	SRR3018052	SRS1187373	SRP063692	05115034-T-A-1_SI_5939	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115034-T-A-1_SI_5939				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115034		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997374	UM-MCTP	DS-CA-MDS	sra	SRX1459814	216	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5954	2015-12-16	25645	17043	2016-01-16	SRR3018053	SRS1210193	SRP063692	05115034_T-A-2_SI_5954	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115034_T-A-2_SI_5954				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115034		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997344	UM-MCTP	DS-CA-MDS	sra	SRX1459815	217	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5955	2015-12-16	15632	10416	2016-01-16	SRR3018054	SRS1187378	SRP063692	05115034-W-1_SI_5955	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115034-W-1_SI_5955				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115034		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997368	UM-MCTP	DS-CA-MDS	sra	SRX1459816	210	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5888	2015-12-16	22963	15135	2016-01-16	SRR3018055	SRS1187377	SRP063692	05115057-T-A-1_SI_5888	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115057-T-A-1_SI_5888				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115057		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997357	UM-MCTP	DS-CA-MDS	sra	SRX1459817	245	Illumina HiSeq 2000	PAIRED	PolyA	TRANSCRIPTOMIC	SI_5873	2015-12-16	12567	8344	2016-01-16	SRR3018056	SRS1187369	SRP063692	05115057-T-A-2_SI_5873	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115057-T-A-2_SI_5873				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115057		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997462	UM-MCTP	DS-CA-MDS	sra	SRX1459818	233	Illumina HiSeq 2000	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5900	2015-12-16	12608	8204	2016-01-16	SRR3018057	SRS1187371	SRP063692	05115057-T-A-2_SI_5900	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115057-T-A-2_SI_5900				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115057		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997500	UM-MCTP	DS-CA-MDS	sra	SRX1459819	217	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5889	2015-12-16	15062	9934	2016-01-16	SRR3018058	SRS1187372	SRP063692	05115057-W-1_SI_5889	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115057-W-1_SI_5889				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115057		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997390	UM-MCTP	DS-CA-MDS	sra	SRX1459820	244	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_6173	2015-12-16	15381	9843	2016-01-16	SRR3018059	SRS1187368	SRP063692	05115058-T-A-1_SI_6173	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115058-T-A-1_SI_6173				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115058		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997348	UM-MCTP	DS-CA-MDS	sra	SRX1459821	239	Illumina HiSeq 2000	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6218	2015-12-16	12039	7562	2016-01-16	SRR3018060	SRS1187367	SRP063692	05115058-T-A-1_SI_6218	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115058-T-A-1_SI_6218				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115058		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997450	UM-MCTP	DS-CA-MDS	sra	SRX1459822	254	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_6271	2015-12-16	12037	7566	2016-01-16	SRR3018061	SRS1187366	SRP063692	05115058-T-A-1_SI_6271	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115058-T-A-1_SI_6271				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115058		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997459	UM-MCTP	DS-CA-MDS	sra	SRX1459823	234	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_6174	2015-12-16	9224	5875	2016-01-16	SRR3018062	SRS1187365	SRP063692	05115058-W-1_SI_6174	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115058-W-1_SI_6174				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115058		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997305	UM-MCTP	DS-CA-MDS	sra	SRX1459824	282	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_6059	2015-12-16	12411	7798	2016-01-16	SRR3018063	SRS1187364	SRP063692	05115073-T-C-1_SI_6059	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115073-T-C-1_SI_6059				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115073		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997315	UM-MCTP	DS-CA-MDS	sra	SRX1459825	270	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6072	2015-12-16	13589	8588	2016-01-16	SRR3018064	SRS1187363	SRP063692	05115073-T-C-1_SI_6072	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115073-T-C-1_SI_6072				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115073		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997303	UM-MCTP	DS-CA-MDS	sra	SRX1459826	235	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6086	2015-12-16	24042	15153	2016-01-16	SRR3018065	SRS1187362	SRP063692	05115073-T-C-1_SI_6086	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115073-T-C-1_SI_6086				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115073		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997439	UM-MCTP	DS-CA-MDS	sra	SRX1459827	213	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6048	2015-12-16	16442	10306	2016-01-16	SRR3018066	SRS1187361	SRP063692	05115073-W-1_SI_6048	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115073-W-1_SI_6048				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115073		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997326	UM-MCTP	DS-CA-MDS	sra	SRX1459828	215	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_6189	2015-12-16	22884	14690	2016-01-16	SRR3018067	SRS1187359	SRP063692	05115075-T-A-1_SI_6189	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115075-T-A-1_SI_6189				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115075		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997378	UM-MCTP	DS-CA-MDS	sra	SRX1459829	261	Illumina HiSeq 2000	PAIRED	PolyA	TRANSCRIPTOMIC	SI_6209	2015-12-16	12380	8262	2016-01-16	SRR3018068	SRS1187360	SRP063692	05115075-T-A-1_SI_6209	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115075-T-A-1_SI_6209				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115075		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997436	UM-MCTP	DS-CA-MDS	sra	SRX1459830	250	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_6190	2015-12-16	15161	9766	2016-01-16	SRR3018069	SRS1187370	SRP063692	05115075-W-1_SI_6190	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115075-W-1_SI_6190				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115075		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997475	UM-MCTP	DS-CA-MDS	sra	SRX1459831	238	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_6193	2015-12-16	20994	13334	2016-01-16	SRR3018070	SRS1187356	SRP063692	05115076-T-C-2_SI_6193	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115076-T-C-2_SI_6193				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115076		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997380	UM-MCTP	DS-CA-MDS	sra	SRX1459832	249	Illumina HiSeq 2000	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6223	2015-12-16	17158	11429	2016-01-16	SRR3018071	SRS1187357	SRP063692	05115076-T-C-2_SI_6223	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115076-T-C-2_SI_6223				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115076		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997304	UM-MCTP	DS-CA-MDS	sra	SRX1459833	223	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_6194	2015-12-16	14835	9434	2016-01-16	SRR3018072	SRS1187353	SRP063692	05115076-W-1_SI_6194	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115076-W-1_SI_6194				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115076		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997388	UM-MCTP	DS-CA-MDS	sra	SRX1459834	258	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_6325	2015-12-16	16158	9736	2016-01-16	SRR3018073	SRS1187358	SRP063692	05115078-T-C-1_SI_6325	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115078-T-C-1_SI_6325				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115078		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997406	UM-MCTP	DS-CA-MDS	sra	SRX1459835	273	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6351	2015-12-16	12217	7538	2016-01-16	SRR3018074	SRS1187354	SRP063692	05115078-T-C-1_SI_6351	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115078-T-C-1_SI_6351				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115078		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997372	UM-MCTP	DS-CA-MDS	sra	SRX1459836	232	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6371	2015-12-16	23575	14418	2016-01-16	SRR3018075	SRS1187351	SRP063692	05115078-T-C-1_SI_6371	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115078-T-C-1_SI_6371				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115078		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997339	UM-MCTP	DS-CA-MDS	sra	SRX1459837	237	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6372	2015-12-16	16741	10246	2016-01-16	SRR3018076	SRS1187352	SRP063692	05115078-W-1_SI_6372	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115078-W-1_SI_6372				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115078		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997431	UM-MCTP	DS-CA-MDS	sra	SRX1459838	225	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5673	2015-12-16	21386	14042	2016-01-16	SRR3018077	SRS1187348	SRP063692	05115098-T-A-1_SI_5673	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115098-T-A-1_SI_5673				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115098		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997334	UM-MCTP	DS-CA-MDS	sra	SRX1459839	251	Illumina HiSeq 2000	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_5685	2015-12-16	12674	8551	2016-01-16	SRR3018078	SRS1187349	SRP063692	05115098-T-A-1_SI_5685	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115098-T-A-1_SI_5685				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115098		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997408	UM-MCTP	DS-CA-MDS	sra	SRX1459840	230	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5674	2015-12-16	17326	11421	2016-01-16	SRR3018079	SRS1187355	SRP063692	05115098-W-1_SI_5674	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115098-W-1_SI_5674				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115098		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997401	UM-MCTP	DS-CA-MDS	sra	SRX1459841	267	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_6321	2015-12-16	10976	6575	2016-01-16	SRR3018080	SRS1187346	SRP063692	05115127-T-A-1_SI_6321	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115127-T-A-1_SI_6321				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115127		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997411	UM-MCTP	DS-CA-MDS	sra	SRX1459842	244	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6344	2015-12-16	12202	7555	2016-01-16	SRR3018081	SRS1187347	SRP063692	05115127-T-A-1_SI_6344	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115127-T-A-1_SI_6344				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115127		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997331	UM-MCTP	DS-CA-MDS	sra	SRX1459843	245	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_6443	2015-12-16	20452	13112	2016-01-16	SRR3018082	SRS1187344	SRP063692	05115127-T-A-1_SI_6443	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115127-T-A-1_SI_6443				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115127		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997385	UM-MCTP	DS-CA-MDS	sra	SRX1459844	231	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_5993	2015-12-16	14422	9621	2016-01-16	SRR3018083	SRS1187343	SRP063692	05115127-W-1_SI_5993	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115127-W-1_SI_5993				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115127		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		220	PRJNA283923	SAMN03997386	UM-MCTP	DS-CA-MDS	sra	SRX1459845	256	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_6851	2015-12-16	12033	7452	2016-01-16	SRR3018084	SRS1187342	SRP063692	05115128-T-A-1_SI_6851	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115128-T-A-1_SI_6851				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115128		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		220	PRJNA283923	SAMN03997352	UM-MCTP	DS-CA-MDS	sra	SRX1459846	222	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6860	2015-12-16	8820	5464	2016-01-16	SRR3018085	SRS1187341	SRP063692	05115128-T-A-1_SI_6860	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115128-T-A-1_SI_6860				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115128		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		220	PRJNA283923	SAMN03997347	UM-MCTP	DS-CA-MDS	sra	SRX1459847	226	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6875	2015-12-16	21383	13275	2016-01-16	SRR3018086	SRS1187345	SRP063692	05115128-T-A-1_SI_6875	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115128-T-A-1_SI_6875				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115128		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		220	PRJNA283923	SAMN03997440	UM-MCTP	DS-CA-MDS	sra	SRX1459848	221	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6876	2015-12-16	14304	8896	2016-01-16	SRR3018087	SRS1187340	SRP063692	05115128-W-1_SI_6876	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115128-W-1_SI_6876				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115128		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997384	UM-MCTP	DS-CA-MDS	sra	SRX1459849	209	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_6673	2015-12-16	21224	13520	2016-01-16	SRR3018088	SRS1187339	SRP063692	05115129-T-A-1_SI_6673	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115129-T-A-1_SI_6673				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115129		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		220	PRJNA283923	SAMN03997320	UM-MCTP	DS-CA-MDS	sra	SRX1459850	275	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_6690	2015-12-16	9132	5754	2016-01-16	SRR3018089	SRS1187337	SRP063692	05115129-T-A-1_SI_6690	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115129-T-A-1_SI_6690				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115129		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		220	PRJNA283923	SAMN03997404	UM-MCTP	DS-CA-MDS	sra	SRX1459851	234	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6701	2015-12-16	9508	5923	2016-01-16	SRR3018090	SRS1187336	SRP063692	05115129-T-A-1_SI_6701	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115129-T-A-1_SI_6701				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115129		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997323	UM-MCTP	DS-CA-MDS	sra	SRX1459852	234	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_6674	2015-12-16	16082	10288	2016-01-16	SRR3018091	SRS1187335	SRP063692	05115129-W-1_SI_6674	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115129-W-1_SI_6674				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115129		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		220	PRJNA283923	SAMN03997316	UM-MCTP	DS-CA-MDS	sra	SRX1459853	248	Illumina HiSeq 2000	PAIRED	PolyA	TRANSCRIPTOMIC	SI_6695	2015-12-16	10616	6415	2016-01-16	SRR3018092	SRS1187334	SRP063692	05115130-T-A-1_SI_6695	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115130-T-A-1_SI_6695				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115130		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		220	PRJNA283923	SAMN03997498	UM-MCTP	DS-CA-MDS	sra	SRX1459854	231	Illumina HiSeq 2000	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6706	2015-12-16	9197	5577	2016-01-16	SRR3018093	SRS1187333	SRP063692	05115130-T-A-1_SI_6706	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115130-T-A-1_SI_6706				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115130		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		220	PRJNA283923	SAMN03997417	UM-MCTP	DS-CA-MDS	sra	SRX1459855	234	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_6711	2015-12-16	19113	11643	2016-01-16	SRR3018094	SRS1187332	SRP063692	05115130-T-A-1_SI_6711	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115130-T-A-1_SI_6711				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115130		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		220	PRJNA283923	SAMN03997394	UM-MCTP	DS-CA-MDS	sra	SRX1459856	230	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_6712	2015-12-16	14966	9044	2016-01-16	SRR3018095	SRS1187338	SRP063692	05115130-W-1_SI_6712	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115130-W-1_SI_6712				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115130		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997487	UM-MCTP	DS-CA-MDS	sra	SRX1459857	232	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6522	2015-12-16	22822	13632	2016-01-16	SRR3018096	SRS1187330	SRP063692	05115152-T-A-1_SI_6522	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115152-T-A-1_SI_6522				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115152		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997453	UM-MCTP	DS-CA-MDS	sra	SRX1459858	240	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6567	2015-12-16	15916	9625	2016-01-16	SRR3018097	SRS1187331	SRP063692	05115152-T-A-1_SI_6567	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115152-T-A-1_SI_6567				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115152		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997410	UM-MCTP	DS-CA-MDS	sra	SRX1459859	235	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6523	2015-12-16	15682	9367	2016-01-16	SRR3018098	SRS1187328	SRP063692	05115152-W-1_SI_6523	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115152-W-1_SI_6523				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115152		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997444	UM-MCTP	DS-CA-MDS	sra	SRX1459860	253	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_7010	2015-12-16	10226	6160	2016-01-16	SRR3018099	SRS1187327	SRP063692	05115158-T-B-1_SI_7010	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115158-T-B-1_SI_7010				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115158		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997392	UM-MCTP	DS-CA-MDS	sra	SRX1459861	202	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7018	2015-12-16	9589	5763	2016-01-16	SRR3018100	SRS1187329	SRP063692	05115158-T-B-1_SI_7018	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115158-T-B-1_SI_7018				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115158		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997501	UM-MCTP	DS-CA-MDS	sra	SRX1459862	221	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7028	2015-12-16	20649	12174	2016-01-16	SRR3018101	SRS1187326	SRP063692	05115158-T-B-1_SI_7028	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115158-T-B-1_SI_7028				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115158		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997502	UM-MCTP	DS-CA-MDS	sra	SRX1459863	208	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7029	2015-12-16	14173	8341	2016-01-16	SRR3018102	SRS1187325	SRP063692	05115158-W-1_SI_7029	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115158-W-1_SI_7029				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115158		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997332	UM-MCTP	DS-CA-MDS	sra	SRX1459864	241	Illumina HiSeq 2000	PAIRED	PolyA	TRANSCRIPTOMIC	SI_7203	2015-12-16	11508	7279	2016-01-16	SRR3018103	SRS1187323	SRP063692	05115160-T-A-1_SI_7203	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115160-T-A-1_SI_7203				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115160		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997389	UM-MCTP	DS-CA-MDS	sra	SRX1459865	231	Illumina HiSeq 2000	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7212	2015-12-16	9558	6062	2016-01-16	SRR3018104	SRS1187324	SRP063692	05115160-T-A-1_SI_7212	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115160-T-A-1_SI_7212				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115160		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997359	UM-MCTP	DS-CA-MDS	sra	SRX1459866	229	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_7225	2015-12-16	20505	12953	2016-01-16	SRR3018105	SRS1187321	SRP063692	05115160-T-A-1_SI_7225	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115160-T-A-1_SI_7225				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115160		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997461	UM-MCTP	DS-CA-MDS	sra	SRX1459867	191	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_7226	2015-12-16	14294	9015	2016-01-16	SRR3018106	SRS1187322	SRP063692	05115160-W-1_SI_7226	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115160-W-1_SI_7226				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115160		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997469	UM-MCTP	DS-CA-MDS	sra	SRX1459868	219	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_6667	2015-12-16	22508	14423	2016-01-16	SRR3018107	SRS1187319	SRP063692	05115186-T-A-1_SI_6667	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115186-T-A-1_SI_6667				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115186		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		220	PRJNA283923	SAMN03997310	UM-MCTP	DS-CA-MDS	sra	SRX1459869	249	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6698	2015-12-16	8537	5344	2016-01-16	SRR3018108	SRS1187320	SRP063692	05115186-T-A-1_SI_6698	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115186-T-A-1_SI_6698				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115186		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		220	PRJNA283923	SAMN03997325	UM-MCTP	DS-CA-MDS	sra	SRX1459870	273	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_6848	2015-12-16	14729	9199	2016-01-16	SRR3018109	SRS1187318	SRP063692	05115186-T-A-2_SI_6848	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115186-T-A-2_SI_6848				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115186		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997311	UM-MCTP	DS-CA-MDS	sra	SRX1459871	230	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_6668	2015-12-16	16121	10301	2016-01-16	SRR3018110	SRS1187316	SRP063692	05115186-W-1_SI_6668	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115186-W-1_SI_6668				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115186		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997337	UM-MCTP	DS-CA-MDS	sra	SRX1459872	253	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_7398	2015-12-16	12708	7773	2016-01-16	SRR3018111	SRS1187315	SRP063692	05115187-T-A-1_SI_7398	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115187-T-A-1_SI_7398				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115187		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997364	UM-MCTP	DS-CA-MDS	sra	SRX1459873	249	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7404	2015-12-16	11919	7363	2016-01-16	SRR3018112	SRS1187314	SRP063692	05115187-T-A-1_SI_7404	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115187-T-A-1_SI_7404				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115187		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997412	UM-MCTP	DS-CA-MDS	sra	SRX1459874	214	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7416	2015-12-16	24839	15405	2016-01-16	SRR3018113	SRS1187317	SRP063692	05115187-T-A-1_SI_7416	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115187-T-A-1_SI_7416				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115187		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997409	UM-MCTP	DS-CA-MDS	sra	SRX1459875	221	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7417	2015-12-16	15268	9521	2016-01-16	SRR3018114	SRS1187313	SRP063692	05115187-W-1_SI_7417	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115187-W-1_SI_7417				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115187		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997432	UM-MCTP	DS-CA-MDS	sra	SRX1459876	262	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_7585	2015-12-16	14292	8848	2016-01-16	SRR3018115	SRS1187311	SRP063692	05115193-T-A-1_SI_7585	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115193-T-A-1_SI_7585				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115193		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997349	UM-MCTP	DS-CA-MDS	sra	SRX1459877	231	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7596	2015-12-16	12720	7914	2016-01-16	SRR3018116	SRS1187309	SRP063692	05115193-T-A-1_SI_7596	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115193-T-A-1_SI_7596				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115193		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997416	UM-MCTP	DS-CA-MDS	sra	SRX1459878	237	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7609	2015-12-16	23641	14672	2016-01-16	SRR3018117	SRS1187312	SRP063692	05115193-T-A-1_SI_7609	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115193-T-A-1_SI_7609				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115193		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997373	UM-MCTP	DS-CA-MDS	sra	SRX1459879	219	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7610	2015-12-16	15388	9575	2016-01-16	SRR3018118	SRS1187308	SRP063692	05115193-W-1_SI_7610	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115193-W-1_SI_7610				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115193		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997360	UM-MCTP	DS-CA-MDS	sra	SRX1459880	221	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_7070	2015-12-16	11215	6615	2016-01-16	SRR3018119	SRS1187307	SRP063692	05115194-T-A-1_SI_7070	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115194-T-A-1_SI_7070				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115194		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997457	UM-MCTP	DS-CA-MDS	sra	SRX1459881	210	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7075	2015-12-16	8532	5229	2016-01-16	SRR3018120	SRS1187310	SRP063692	05115194-T-A-1_SI_7075	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115194-T-A-1_SI_7075				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115194		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997422	UM-MCTP	DS-CA-MDS	sra	SRX1459882	232	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7083	2015-12-16	26389	16263	2016-01-16	SRR3018121	SRS1187350	SRP063692	05115194-T-A-1_SI_7083	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115194-T-A-1_SI_7083				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115194		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997370	UM-MCTP	DS-CA-MDS	sra	SRX1459883	247	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7084	2015-12-16	12707	7873	2016-01-16	SRR3018122	SRS1187305	SRP063692	05115194-W-1_SI_7084	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115194-W-1_SI_7084				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115194		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997425	UM-MCTP	DS-CA-MDS	sra	SRX1459884	265	Illumina HiSeq 2000	PAIRED	PolyA	TRANSCRIPTOMIC	SI_7118	2015-12-16	9375	5839	2016-01-16	SRR3018123	SRS1187304	SRP063692	05115195-T-A-1_SI_7118	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115195-T-A-1_SI_7118				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115195		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997472	UM-MCTP	DS-CA-MDS	sra	SRX1459885	253	Illumina HiSeq 2000	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7134	2015-12-16	9399	5868	2016-01-16	SRR3018124	SRS1187301	SRP063692	05115195-T-A-1_SI_7134	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115195-T-A-1_SI_7134				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115195		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997478	UM-MCTP	DS-CA-MDS	sra	SRX1459886	255	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_7150	2015-12-16	21420	13259	2016-01-16	SRR3018125	SRS1187303	SRP063692	05115195-T-A-1_SI_7150	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115195-T-A-1_SI_7150				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115195		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997377	UM-MCTP	DS-CA-MDS	sra	SRX1459887	259	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_7151	2015-12-16	15070	9307	2016-01-16	SRR3018126	SRS1187302	SRP063692	05115195-W-1_SI_7151	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115195-W-1_SI_7151				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115195		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997306	UM-MCTP	DS-CA-MDS	sra	SRX1459888	268	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_7233	2015-12-16	12323	7519	2016-01-16	SRR3018127	SRS1187298	SRP063692	05115196-T-A-1_SI_7233	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115196-T-A-1_SI_7233				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115196		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997379	UM-MCTP	DS-CA-MDS	sra	SRX1459889	223	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7263	2015-12-16	12742	7709	2016-01-16	SRR3018128	SRS1187299	SRP063692	05115196-T-A-1_SI_7263	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115196-T-A-1_SI_7263				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115196		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997341	UM-MCTP	DS-CA-MDS	sra	SRX1459890	215	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7269	2015-12-16	19868	11698	2016-01-16	SRR3018129	SRS1187306	SRP063692	05115196-T-A-1_SI_7269	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115196-T-A-1_SI_7269				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115196		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997451	UM-MCTP	DS-CA-MDS	sra	SRX1459891	240	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7270	2015-12-16	12738	7545	2016-01-16	SRR3018130	SRS1187297	SRP063692	05115196-W-1_SI_7270	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115196-W-1_SI_7270				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115196		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997375	UM-MCTP	DS-CA-MDS	sra	SRX1459892	248	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_7237	2015-12-16	12762	7891	2016-01-16	SRR3018131	SRS1187296	SRP063692	05115197-T-A-1_SI_7237	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115197-T-A-1_SI_7237				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115197		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997346	UM-MCTP	DS-CA-MDS	sra	SRX1459893	251	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7267	2015-12-16	12223	7505	2016-01-16	SRR3018132	SRS1187300	SRP063692	05115197-T-A-1_SI_7267	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115197-T-A-1_SI_7267				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115197		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997405	UM-MCTP	DS-CA-MDS	sra	SRX1459894	233	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7277	2015-12-16	23050	13794	2016-01-16	SRR3018133	SRS1187293	SRP063692	05115197-T-A-1_SI_7277	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115197-T-A-1_SI_7277				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115197		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997468	UM-MCTP	DS-CA-MDS	sra	SRX1459895	235	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7278	2015-12-16	13913	8335	2016-01-16	SRR3018134	SRS1187292	SRP063692	05115197-W-1_SI_7278	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115197-W-1_SI_7278				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115197		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997479	UM-MCTP	DS-CA-MDS	sra	SRX1459896	247	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7405	2015-12-16	13272	8478	2016-01-16	SRR3018135	SRS1187290	SRP063692	05115198-T-A-1_SI_7405	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115198-T-A-1_SI_7405				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115198		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997397	UM-MCTP	DS-CA-MDS	sra	SRX1459897	204	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7418	2015-12-16	22168	13512	2016-01-16	SRR3018136	SRS1187295	SRP063692	05115198-T-A-1_SI_7418	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115198-T-A-1_SI_7418				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115198		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997483	UM-MCTP	DS-CA-MDS	sra	SRX1459898	240	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7419	2015-12-16	16841	10288	2016-01-16	SRR3018137	SRS1187289	SRP063692	05115198-W-1_SI_7419	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115198-W-1_SI_7419				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115198		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997333	UM-MCTP	DS-CA-MDS	sra	SRX1459899	218	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6535	2015-12-16	17162	10422	2016-01-16	SRR3018138	SRS1187291	SRP063692	05115199-T-A-1_SI_6535	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115199-T-A-1_SI_6535				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115199		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997465	UM-MCTP	DS-CA-MDS	sra	SRX1459900	228	Illumina HiSeq 2000	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6573	2015-12-16	9964	6308	2016-01-16	SRR3018139	SRS1187288	SRP063692	05115199-T-A-1_SI_6573	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115199-T-A-1_SI_6573				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115199		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997447	UM-MCTP	DS-CA-MDS	sra	SRX1459901	217	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6537	2015-12-16	15550	9398	2016-01-16	SRR3018140	SRS1187287	SRP063692	05115199-W-1_SI_6537	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115199-W-1_SI_6537				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115199		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997342	UM-MCTP	DS-CA-MDS	sra	SRX1459902	221	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_7068	2015-12-16	11378	6759	2016-01-16	SRR3018141	SRS1187285	SRP063692	05115203-T-A-1_SI_7068	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115203-T-A-1_SI_7068				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115203		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997419	UM-MCTP	DS-CA-MDS	sra	SRX1459903	195	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7073	2015-12-16	8774	5464	2016-01-16	SRR3018142	SRS1187284	SRP063692	05115203-T-A-1_SI_7073	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115203-T-A-1_SI_7073				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115203		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997313	UM-MCTP	DS-CA-MDS	sra	SRX1459904	243	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7079	2015-12-16	37922	23634	2016-01-16	SRR3018143	SRS1187283	SRP063692	05115203-T-A-1_SI_7079	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115203-T-A-1_SI_7079				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115203		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997307	UM-MCTP	DS-CA-MDS	sra	SRX1459905	241	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7080	2015-12-16	27513	17083	2016-01-16	SRR3018144	SRS1187282	SRP063692	05115203-W-1_SI_7080	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115203-W-1_SI_7080				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115203		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997414	UM-MCTP	DS-CA-MDS	sra	SRX1459906	271	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_7821	2015-12-16	11404	7022	2016-01-16	SRR3018145	SRS1187280	SRP063692	05115254-T-A-1_SI_7821	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115254-T-A-1_SI_7821				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115254		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997345	UM-MCTP	DS-CA-MDS	sra	SRX1459907	258	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_7828	2015-12-16	22990	14262	2016-01-16	SRR3018146	SRS1187294	SRP063692	05115254-T-A-1_SI_7828	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115254-T-A-1_SI_7828				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115254		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997413	UM-MCTP	DS-CA-MDS	sra	SRX1459908	263	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7848	2015-12-16	13834	8539	2016-01-16	SRR3018147	SRS1187278	SRP063692	05115254-T-A-1_SI_7848	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115254-T-A-1_SI_7848				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115254		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997381	UM-MCTP	DS-CA-MDS	sra	SRX1459909	246	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_7829	2015-12-16	13629	8484	2016-01-16	SRR3018148	SRS1187279	SRP063692	05115254-W-1_SI_7829	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115254-W-1_SI_7829				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115254		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN03997329	UM-MCTP	DS-CA-MDS	sra	SRX1459910	278	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_8294	2015-12-16	12502	6094	2016-01-16	SRR3018149	SRS1187286	SRP063692	05115255-T-A-2_SI_8294	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115255-T-A-2_SI_8294				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115255		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN03997301	UM-MCTP	DS-CA-MDS	sra	SRX1459911	286	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_8318	2015-12-16	13435	6436	2016-01-16	SRR3018150	SRS1187276	SRP063692	05115255-T-A-2_SI_8318	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115255-T-A-2_SI_8318				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115255		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN03997438	UM-MCTP	DS-CA-MDS	sra	SRX1459912	274	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_8331	2015-12-16	23189	11226	2016-01-16	SRR3018151	SRS1187277	SRP063692	05115255-T-A-2_SI_8331	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115255-T-A-2_SI_8331				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115255		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN03997402	UM-MCTP	DS-CA-MDS	sra	SRX1459913	256	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_8332	2015-12-16	16995	8068	2016-01-16	SRR3018152	SRS1187281	SRP063692	05115255-W-1_SI_8332	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115255-W-1_SI_8332				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115255		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997443	UM-MCTP	DS-CA-MDS	sra	SRX1459914	280	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_7956	2015-12-16	13097	8115	2016-01-16	SRR3018153	SRS1187275	SRP063692	05115256-T-C-2_SI_7956	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115256-T-C-2_SI_7956				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115256		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997298	UM-MCTP	DS-CA-MDS	sra	SRX1459915	268	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7976	2015-12-16	12148	7526	2016-01-16	SRR3018154	SRS1187274	SRP063692	05115256-T-C-2_SI_7976	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115256-T-C-2_SI_7976				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115256		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN03997421	UM-MCTP	DS-CA-MDS	sra	SRX1459916	265	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7993	2015-12-16	16264	7997	2016-01-16	SRR3018155	SRS1187273	SRP063692	05115256-T-C-2_SI_7993	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115256-T-C-2_SI_7993				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115256		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997464	UM-MCTP	DS-CA-MDS	sra	SRX1459917	258	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7977	2015-12-16	15260	9400	2016-01-16	SRR3018156	SRS1187271	SRP063692	05115256-W-1_SI_7977	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115256-W-1_SI_7977				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115256		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997415	UM-MCTP	DS-CA-MDS	sra	SRX1459918	269	Illumina HiSeq 2000	PAIRED	PolyA	TRANSCRIPTOMIC	SI_6061	2015-12-16	12848	8494	2016-01-16	SRR3018157	SRS1187272	SRP063692	05115258-T-A-4_SI_6061	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115258-T-A-4_SI_6061				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115258		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997350	UM-MCTP	DS-CA-MDS	sra	SRX1459919	265	Illumina HiSeq 2000	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6074	2015-12-16	11958	7899	2016-01-16	SRR3018158	SRS1187270	SRP063692	05115258-T-A-4_SI_6074	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115258-T-A-4_SI_6074				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115258		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997424	UM-MCTP	DS-CA-MDS	sra	SRX1459920	235	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_6088	2015-12-16	24841	16373	2016-01-16	SRR3018159	SRS1187269	SRP063692	05115258-T-A-4_SI_6088	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115258-T-A-4_SI_6088				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115258		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997327	UM-MCTP	DS-CA-MDS	sra	SRX1459921	222	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_6144	2015-12-16	15583	10217	2016-01-16	SRR3018160	SRS1187267	SRP063692	05115258-W-1_SI_6144	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115258-W-1_SI_6144				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115258		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997448	UM-MCTP	DS-CA-MDS	sra	SRX1459922	239	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6520	2015-12-16	22839	14141	2016-01-16	SRR3018161	SRS1187266	SRP063692	05115259-T-C-2_SI_6520	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115259-T-C-2_SI_6520				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115259		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997458	UM-MCTP	DS-CA-MDS	sra	SRX1459923	279	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_6554	2015-12-16	13199	8050	2016-01-16	SRR3018162	SRS1187268	SRP063692	05115259-T-C-2_SI_6554	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115259-T-C-2_SI_6554				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115259		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997343	UM-MCTP	DS-CA-MDS	sra	SRX1459924	224	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_6566	2015-12-16	11764	7096	2016-01-16	SRR3018163	SRS1187264	SRP063692	05115259-T-C-2_SI_6566	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115259-T-C-2_SI_6566				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115259		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997318	UM-MCTP	DS-CA-MDS	sra	SRX1459925	231	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_6521	2015-12-16	17992	11158	2016-01-16	SRR3018164	SRS1187265	SRP063692	05115259-W-1_SI_6521	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115259-W-1_SI_6521				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115259		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN03997300	UM-MCTP	DS-CA-MDS	sra	SRX1459926	284	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_8246	2015-12-16	12785	6532	2016-01-16	SRR3018165	SRS1187263	SRP063692	05115260-T-A-1_SI_8246	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115260-T-A-1_SI_8246				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115260		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN03997361	UM-MCTP	DS-CA-MDS	sra	SRX1459927	265	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_8256	2015-12-16	11104	5255	2016-01-16	SRR3018166	SRS1187262	SRP063692	05115260-T-A-1_SI_8256	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115260-T-A-1_SI_8256				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115260		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN03997437	UM-MCTP	DS-CA-MDS	sra	SRX1459928	244	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_8270	2015-12-16	19062	8742	2016-01-16	SRR3018167	SRS1187261	SRP063692	05115260-T-A-1_SI_8270	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115260-T-A-1_SI_8270				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115260		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN03997428	UM-MCTP	DS-CA-MDS	sra	SRX1459929	223	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_8271	2015-12-16	14103	6251	2016-01-16	SRR3018168	SRS1187260	SRP063692	05115260-W-1_SI_8271	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115260-W-1_SI_8271				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115260		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997430	UM-MCTP	DS-CA-MDS	sra	SRX1459930	262	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_7590	2015-12-16	11848	7176	2016-01-16	SRR3018169	SRS1187259	SRP063692	05115261-T-A-2_SI_7590	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115261-T-A-2_SI_7590				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115261		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997484	UM-MCTP	DS-CA-MDS	sra	SRX1459931	246	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_7602	2015-12-16	12533	7627	2016-01-16	SRR3018170	SRS1187258	SRP063692	05115261-T-A-2_SI_7602	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115261-T-A-2_SI_7602				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115261		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997471	UM-MCTP	DS-CA-MDS	sra	SRX1459932	247	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7642	2015-12-16	20798	12535	2016-01-16	SRR3018171	SRS1187257	SRP063692	05115261-T-A-2_SI_7642	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115261-T-A-2_SI_7642				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115261		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997382	UM-MCTP	DS-CA-MDS	sra	SRX1459933	256	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_7643	2015-12-16	14009	8474	2016-01-16	SRR3018172	SRS1187256	SRP063692	05115261-W-1_SI_7643	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115261-W-1_SI_7643				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115261		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997400	UM-MCTP	DS-CA-MDS	sra	SRX1459934	286	Illumina HiSeq 2000	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_8398	2015-12-16	11166	7154	2016-01-16	SRR3018173	SRS1187255	SRP063692	05115276-T-A-1_SI_8398	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115276-T-A-1_SI_8398				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115276		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997490	UM-MCTP	DS-CA-MDS	sra	SRX1459935	266	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_8407	2015-12-16	13464	8372	2016-01-16	SRR3018174	SRS1187254	SRP063692	05115276-T-A-1_SI_8407	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115276-T-A-1_SI_8407				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115276		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997426	UM-MCTP	DS-CA-MDS	sra	SRX1459936	305	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_8420	2015-12-16	22547	14337	2016-01-16	SRR3018175	SRS1187253	SRP063692	05115276-T-A-1_SI_8420	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115276-T-A-1_SI_8420				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115276		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997499	UM-MCTP	DS-CA-MDS	sra	SRX1459937	292	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_8421	2015-12-16	15485	9855	2016-01-16	SRR3018176	SRS1187252	SRP063692	05115276-W-1_SI_8421	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115276-W-1_SI_8421				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115276		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN03997309	UM-MCTP	DS-CA-MDS	sra	SRX1459938	271	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_8296	2015-12-16	12788	6317	2016-01-16	SRR3018177	SRS1187251	SRP063692	05115290-T-A-1_SI_8296	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115290-T-A-1_SI_8296				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115290		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN03997493	UM-MCTP	DS-CA-MDS	sra	SRX1459939	286	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_8320	2015-12-16	11822	5748	2016-01-16	SRR3018178	SRS1187250	SRP063692	05115290-T-A-1_SI_8320	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115290-T-A-1_SI_8320				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115290		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN03997396	UM-MCTP	DS-CA-MDS	sra	SRX1459940	267	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_8335	2015-12-16	24750	12005	2016-01-16	SRR3018179	SRS1187249	SRP063692	05115290-T-A-1_SI_8335	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115290-T-A-1_SI_8335				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115290		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN03997354	UM-MCTP	DS-CA-MDS	sra	SRX1459941	254	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_8336	2015-12-16	17847	8621	2016-01-16	SRR3018180	SRS1187248	SRP063692	05115290-W-1_SI_8336	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115290-W-1_SI_8336				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115290		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		220	PRJNA283923	SAMN03997403	UM-MCTP	DS-CA-MDS	sra	SRX1459942	278	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_8399	2015-12-16	15202	9327	2016-01-16	SRR3018181	SRS1187247	SRP063692	05115291-T-C-1_SI_8399	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115291-T-C-1_SI_8399				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115291		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		220	PRJNA283923	SAMN03997481	UM-MCTP	DS-CA-MDS	sra	SRX1459943	266	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_8408	2015-12-16	13911	8482	2016-01-16	SRR3018182	SRS1187246	SRP063692	05115291-T-C-1_SI_8408	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115291-T-C-1_SI_8408				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115291		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		220	PRJNA283923	SAMN03997427	UM-MCTP	DS-CA-MDS	sra	SRX1459944	294	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_8422	2015-12-16	23357	14528	2016-01-16	SRR3018183	SRS1187245	SRP063692	05115291-T-C-1_SI_8422	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115291-T-C-1_SI_8422				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115291		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		220	PRJNA283923	SAMN03997407	UM-MCTP	DS-CA-MDS	sra	SRX1459945	307	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_8423	2015-12-16	16495	10193	2016-01-16	SRR3018184	SRS1187244	SRP063692	05115291-W-1_SI_8423	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115291-W-1_SI_8423				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115291		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997476	UM-MCTP	DS-CA-MDS	sra	SRX1459946	309	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_8527	2015-12-16	11517	7244	2016-01-16	SRR3018185	SRS1187243	SRP063692	05115327-T-A-1_SI_8527	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115327-T-A-1_SI_8527				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115327		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997495	UM-MCTP	DS-CA-MDS	sra	SRX1459947	273	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_8540	2015-12-16	20803	13052	2016-01-16	SRR3018186	SRS1187242	SRP063692	05115327-T-A-1_SI_8540	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115327-T-A-1_SI_8540				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115327		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		200	PRJNA283923	SAMN03997338	UM-MCTP	DS-CA-MDS	sra	SRX1459948	263	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_8556	2015-12-16	12886	7932	2016-01-16	SRR3018187	SRS1187241	SRP063692	05115327-T-A-1_SI_8556	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115327-T-A-1_SI_8556				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115327		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		200	PRJNA283923	SAMN03997308	UM-MCTP	DS-CA-MDS	sra	SRX1459949	282	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_8541	2015-12-16	15990	10028	2016-01-16	SRR3018188	SRS1187240	SRP063692	05115327-W-1_SI_8541	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115327-W-1_SI_8541				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115327		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN03997445	UM-MCTP	DS-CA-MDS	sra	SRX1459950	233	Illumina HiSeq 2500	PAIRED	PolyA	TRANSCRIPTOMIC	SI_9074	2015-12-16	18256	9298	2016-01-16	SRR3018189	SRS1187239	SRP063692	05115359-T-A-1_SI_9074	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115359-T-A-1_SI_9074				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115359		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN03997387	UM-MCTP	DS-CA-MDS	sra	SRX1459951	264	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_9102	2015-12-16	33185	17107	2016-01-16	SRR3018190	SRS1187238	SRP063692	05115359-T-A-1_SI_9102	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115359-T-A-1_SI_9102				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115359		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN03997488	UM-MCTP	DS-CA-MDS	sra	SRX1459952	279	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_9124	2015-12-16	13036	6903	2016-01-16	SRR3018191	SRS1187237	SRP063692	05115359-T-A-1_SI_9124	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115359-T-A-1_SI_9124				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115359		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN03997330	UM-MCTP	DS-CA-MDS	sra	SRX1459953	244	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_9103	2015-12-16	20034	10135	2016-01-16	SRR3018192	SRS1187236	SRP063692	05115359-W-1_SI_9103	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115359-W-1_SI_9103				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115359		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997335	UM-MCTP	DS-CA-MDS	sra	SRX1459954	236	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_4439	2015-12-16	21529	14426	2016-01-16	SRR3018193	SRS1187235	SRP063692	06115012-T-B-4_SI_4439	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	06115012-T-B-4_SI_4439				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	06115012		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997302	UM-MCTP	DS-CA-MDS	sra	SRX1459955	230	Illumina HiSeq 2000	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_4882	2015-12-16	19965	13029	2016-01-16	SRR3018194	SRS1187233	SRP063692	06115012-T-C-5_SI_4882	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	06115012-T-C-5_SI_4882				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	06115012		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997398	UM-MCTP	DS-CA-MDS	sra	SRX1459956	249	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_4440	2015-12-16	13986	9402	2016-01-16	SRR3018195	SRS1187234	SRP063692	06115012-W-1_SI_4440	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	06115012-W-1_SI_4440				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	06115012		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997355	UM-MCTP	DS-CA-MDS	sra	SRX1459957	227	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_4552	2015-12-16	13429	8618	2016-01-16	SRR3018196	SRS1187232	SRP063692	06115013_SI_4552	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	06115013_SI_4552				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	06115013		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997456	UM-MCTP	DS-CA-MDS	sra	SRX1459958	255	Illumina HiSeq 2000	PAIRED	PolyA	TRANSCRIPTOMIC	SI_4538	2015-12-16	11459	7222	2016-01-16	SRR3018197	SRS1187231	SRP063692	06115013-T-C-2_SI_4538	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	06115013-T-C-2_SI_4538				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	06115013		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997442	UM-MCTP	DS-CA-MDS	sra	SRX1459959	225	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_4553	2015-12-16	22463	14270	2016-01-16	SRR3018198	SRS1187230	SRP063692	06115013-T-C-3_SI_4553	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	06115013-T-C-3_SI_4553				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	06115013		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997486	UM-MCTP	DS-CA-MDS	sra	SRX1459960	254	Illumina HiSeq 2000	PAIRED	PolyA	TRANSCRIPTOMIC	SI_4539	2015-12-16	10646	6693	2016-01-16	SRR3018199	SRS1187229	SRP063692	06115014-T-C-1_SI_4539	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	06115014-T-C-1_SI_4539				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	06115014		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997391	UM-MCTP	DS-CA-MDS	sra	SRX1459961	256	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_4555	2015-12-16	18819	12159	2016-01-16	SRR3018200	SRS1187228	SRP063692	06115014-T-C-2_SI_4555	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	06115014-T-C-2_SI_4555				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	06115014		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997497	UM-MCTP	DS-CA-MDS	sra	SRX1459962	243	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	SI_4554	2015-12-16	20911	13559	2016-01-16	SRR3018201	SRS1187227	SRP063692	06115014-W-1_SI_4554	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	06115014-W-1_SI_4554				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	06115014		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075849	BI	DS-PC-MDS	sra	SRX5119241	211	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0145544880_Illumina_P5-Yahih_P7-Zepon	2018-12-12	12050	6062	2019-02-15	SRR8304739	SRS4133113	SRP063692	01115081-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115081-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDM, SL-HDG, SL-HCB, SL-HDL, SL-HDH, SL-HCC, SL-HDK, SL-HBC	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115081	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075726	BI	DS-PC-MDS	sra	SRX5119242	176	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0145543206_Illumina_P5-Reboc_P7-Yeyey	2018-12-12	11816	5447	2019-02-15	SRR8304740	SRS4133114	SRP063692	01115086-T-A-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115086-T-A-1		Exome		phs000915		SL-HAC, SL-HDF, SL-HBU, SL-HAK, SL-HAE, SL-HBW, SL-HDD, SL-HAM, SL-HAA, SL-HDE, SL-HBT	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115086	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075793	BI	DS-PC-MDS	sra	SRX5119243	153	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0145543237_Illumina_P5-Zafec_P7-Defin	2018-12-12	10891	5175	2019-02-15	SRR8304741	SRS4133115	SRP063692	01115082-T-A-FFPE	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115082-T-A-FFPE		Exome		phs000915		SL-HAC, SL-HDF, SL-HBU, SL-HAK, SL-HAE, SL-HBW, SL-HDD, SL-HAM, SL-HAA, SL-HDE, SL-HBT	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115082	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076038	BI	DS-PC-MDS	sra	SRX5119244	164	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0145543258_Illumina_P5-Litaz_P7-Zafed	2018-12-12	9388	4471	2019-02-15	SRR8304742	SRS4133116	SRP063692	01115082-T-C-FFPE	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115082-T-C-FFPE		Exome		phs000915		SL-HAC, SL-HDF, SL-HBU, SL-HAK, SL-HAE, SL-HBW, SL-HDD, SL-HAM, SL-HAA, SL-HDE, SL-HBT	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115082	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076059	BI	DS-PC-MDS	sra	SRX5119245	162	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0145543202_Illumina_P5-Razac_P7-Folar	2018-12-12	13594	6271	2019-02-15	SRR8304743	SRS4133117	SRP063692	01115083-T-C-FFPE	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115083-T-C-FFPE		Exome		phs000915		SL-HAC, SL-HDF, SL-HBU, SL-HAK, SL-HAE, SL-HBW, SL-HDD, SL-HAM, SL-HAA, SL-HDE, SL-HBT	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115083	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076111	BI	DS-PC-MDS	sra	SRX5119246	161	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0145543262_Illumina_P5-Fefaj_P7-Narad	2018-12-12	11285	5321	2019-02-15	SRR8304744	SRS4133118	SRP063692	01115083-T-A-FFPE	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115083-T-A-FFPE		Exome		phs000915		SL-HAC, SL-HDF, SL-HBU, SL-HAK, SL-HAE, SL-HBW, SL-HDD, SL-HAM, SL-HAA, SL-HDE, SL-HBT	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115083	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076173	BI	DS-PC-MDS	sra	SRX5119247	195	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148908980_Illumina_P5-Boleh_P7-Nanat	2018-12-12	11909	5919	2019-02-15	SRR8304745	SRS4133119	SRP063692	01115084-P-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115084-P-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDM, SL-HDG, SL-HCB, SL-HDL, SL-HDH, SL-HCC, SL-HDK, SL-HBC	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115084	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076206	BI	DS-PC-MDS	sra	SRX5119248	188	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148908977_Illumina_P5-Jaxah_P7-Nehin	2018-12-12	10885	5472	2019-02-15	SRR8304746	SRS4133120	SRP063692	01115086-P-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115086-P-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDM, SL-HDG, SL-HCB, SL-HDL, SL-HDH, SL-HCC, SL-HDK, SL-HBC	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115086	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075747	BI	DS-PC-MDS	sra	SRX5119249	194	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148909031_Illumina_P5-Wexoj_P7-Pahol	2018-12-12	12180	6107	2019-02-15	SRR8304747	SRS4133121	SRP063692	01115082-P-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115082-P-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDM, SL-HDG, SL-HCB, SL-HDL, SL-HDH, SL-HCC, SL-HDK, SL-HBC	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115082	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075757	BI	DS-PC-MDS	sra	SRX5119250	180	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0145543205_Illumina_P5-Halif_P7-Janil	2018-12-12	11957	5412	2019-02-15	SRR8304748	SRS4133122	SRP063692	01115085-T-C-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115085-T-C-1		Exome		phs000915		SL-HAC, SL-HDF, SL-HBU, SL-HAK, SL-HAE, SL-HBW, SL-HDD, SL-HAM, SL-HAA, SL-HDE, SL-HBT	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115085	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075769	BI	DS-PC-MDS	sra	SRX5119251	198	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0145544850_Illumina_P5-Nawoh_P7-Najod	2018-12-12	9407	4713	2019-02-15	SRR8304749	SRS4133123	SRP063692	01115091-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115091-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDM, SL-HDG, SL-HCB, SL-HDL, SL-HDH, SL-HCC, SL-HDK, SL-HBC	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115091	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075811	BI	DS-PC-MDS	sra	SRX5119252	279	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148909033_Illumina_P5-Wihoy_P7-Hopow	2018-12-12	6534	3335	2019-02-15	SRR8304750	SRS4133124	SRP063692	01115089-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115089-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDM, SL-HDG, SL-HCB, SL-HDL, SL-HDH, SL-HCC, SL-HDK, SL-HBC	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115089	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075881	BI	DS-PC-MDS	sra	SRX5119253	198	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148909010_Illumina_P5-Boyij_P7-Jofij	2018-12-12	10468	5335	2019-02-15	SRR8304751	SRS4133125	SRP063692	01115088-P-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115088-P-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDM, SL-HDG, SL-HCB, SL-HDL, SL-HDH, SL-HCC, SL-HDK, SL-HBC	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115088	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075888	BI	DS-PC-MDS	sra	SRX5119254	186	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148909053_Illumina_P5-Belez_P7-Yoxen	2018-12-12	11191	5623	2019-02-15	SRR8304752	SRS4133126	SRP063692	01115090-P-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115090-P-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDM, SL-HDG, SL-HCB, SL-HDL, SL-HDH, SL-HCC, SL-HDK, SL-HBC	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115090	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075924	BI	DS-PC-MDS	sra	SRX5119255	181	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0145543234_Illumina_P5-Kenaw_P7-Liyik	2018-12-12	9296	4432	2019-02-15	SRR8304753	SRS4133127	SRP063692	01115081-T-C-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115081-T-C-1		Exome		phs000915		SL-HAC, SL-HDF, SL-HBU, SL-HAK, SL-HAE, SL-HBW, SL-HDD, SL-HAM, SL-HAA, SL-HDE, SL-HBT	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115081	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075942	BI	DS-PC-MDS	sra	SRX5119256	165	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148909041_Illumina_P5-Wexed_P7-Lacok	2018-12-12	10156	5237	2019-02-15	SRR8304754	SRS4133128	SRP063692	01115088-T-A-FFPE	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115088-T-A-FFPE		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDM, SL-HDG, SL-HCB, SL-HDL, SL-HDH, SL-HCC, SL-HDK, SL-HBC	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115088	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075965	BI	DS-PC-MDS	sra	SRX5119257	171	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148909037_Illumina_P5-Nalok_P7-Teyay	2018-12-12	10778	5396	2019-02-15	SRR8304755	SRS4133129	SRP063692	01115085-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115085-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDM, SL-HDG, SL-HCB, SL-HDL, SL-HDH, SL-HCC, SL-HDK, SL-HBC	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115085	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075972	BI	DS-PC-MDS	sra	SRX5119258	178	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148908989_Illumina_P5-Dobix_P7-Hihar	2018-12-12	9004	4630	2019-02-15	SRR8304756	SRS4133130	SRP063692	01115093-T-A-2	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115093-T-A-2		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDM, SL-HDG, SL-HCB, SL-HDL, SL-HDH, SL-HCC, SL-HDK, SL-HBC	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115093	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076007	BI	DS-PC-MDS	sra	SRX5119259	170	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148905098_Illumina_P5-Hohez_P7-Cebey	2018-12-12	10834	5564	2019-02-15	SRR8304757	SRS4133131	SRP063692	01115092-T-C-FFPE	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115092-T-C-FFPE		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDM, SL-HDG, SL-HCB, SL-HDL, SL-HDH, SL-HCC, SL-HDK, SL-HBC	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115092	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076138	BI	DS-PC-MDS	sra	SRX5119260	169	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148908975_Illumina_P5-Yewow_P7-Tehed	2018-12-12	10016	5056	2019-02-15	SRR8304758	SRS4133132	SRP063692	01115089-T-C-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115089-T-C-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDM, SL-HDG, SL-HCB, SL-HDL, SL-HDH, SL-HCC, SL-HDK, SL-HBC	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115089	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075822	BI	DS-PC-MDS	sra	SRX5119261	173	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148909043_Illumina_P5-Zezip_P7-Lajar	2018-12-12	9251	4825	2019-02-15	SRR8304759	SRS4133133	SRP063692	01115091-T-A-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115091-T-A-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDM, SL-HDG, SL-HCB, SL-HDL, SL-HDH, SL-HCC, SL-HDK, SL-HBC	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115091	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075827	BI	DS-PC-MDS	sra	SRX5119262	163	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0150675754_Illumina_P5-Paroy_P7-Debox	2018-12-12	22269	9905	2019-02-15	SRR8304760	SRS4133134	SRP063692	01115126-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115126-B-1		Exome	H7FMBADXX, H7HBEADXX, H7HBCADXX, H7H7DADXX, H7H6DADXX, H7H85ADXX, H7FPLADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HDH, SL-HDD, SL-HDE	No	HybridSelection		H7HBEADXX140225, H7H85ADXX140225, H7FPLADXX140225, H7FMBADXX140225, H7HBCADXX140225, H7H6DADXX140225, H7H7DADXX140225	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115126	PDO-3179	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076061	BI	DS-PC-MDS	sra	SRX5119263	177	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148909021_Illumina_P5-Nehol_P7-Nelac	2018-12-12	11993	6097	2019-02-15	SRR8304761	SRS4133135	SRP063692	01115093-T-A-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115093-T-A-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDM, SL-HDG, SL-HCB, SL-HDL, SL-HDH, SL-HCC, SL-HDK, SL-HBC	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115093	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076071	BI	DS-PC-MDS	sra	SRX5119264	185	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0145544906_Illumina_P5-Lahoy_P7-Difew	2018-12-12	11971	6013	2019-02-15	SRR8304762	SRS4133136	SRP063692	01115092-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115092-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDM, SL-HDG, SL-HCB, SL-HDL, SL-HDH, SL-HCC, SL-HDK, SL-HBC	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115092	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076161	BI	DS-PC-MDS	sra	SRX5119265	177	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0154850248_Illumina_P5-Wexoj_P7-Pahol	2018-12-12	38010	16680	2019-02-15	SRR8304763	SRS4133137	SRP063692	01115126-TA5	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115126-TA5		Exome	H9GVWADXX, H9GT6ADXX, H7FMBADXX, H7HBEADXX, H7HBCADXX, H7H7DADXX, H9G9JADXX, H7H6DADXX, H7H85ADXX, H7FPLADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HBW, SL-HDH, SL-HDD, SL-HDE	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115126	PDO-3180	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075825	BI	DS-PC-MDS	sra	SRX5119324	194	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0175880597_Illumina_P5-Faxen_P7-Zibod	2018-12-12	10981	5298	2019-02-15	SRR8304822	SRS4133182	SRP063692	01115245-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115245-B-1		Exome	HB6EFADXX, HB684ADXX, HB68PADXX, HB6CLADXX, HB6DYADXX, HB687ADXX, HBAM5ADXX, HB68BADXX, HB68WADXX, HB68VADXX, HBAHVADXX	phs000915		SL-HBU, SL-HDM, SL-HAE, SL-HDD, SL-HAN	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115245	PDO-5117	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076157	BI	DS-PC-MDS	sra	SRX5119325	192	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0167755437_Illumina_P5-Boyez_P7-Yokif	2018-12-12	9624	4179	2019-02-15	SRR8304823	SRS4133183	SRP063692	01115200-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115200-B-1		Exome	H7U9LADXX, H9GV8ADXX, H9G9NADXX	phs000915		SL-HBV, SL-HBW	No	HybridSelection		H7U9LADXX140625, H9GV8ADXX140625, H9G9NADXX140625	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115200	PDO-3985	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075797	BI	DS-PC-MDS	sra	SRX5119326	181	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0167755416_Illumina_P5-Zehil_P7-Hefel	2018-12-12	32218	14176	2019-02-15	SRR8304824	SRS4133184	SRP063692	01115150-TA4	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115150-TA4		Exome	H9GVWADXX, H9GT6ADXX, H7FMBADXX, H7HBEADXX, H7HBCADXX, H7H7DADXX, H9G9JADXX, H7H6DADXX, H7H85ADXX, H7FPLADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HBW, SL-HDH, SL-HDD, SL-HDE	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115150	PDO-3985	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076063	BI	DS-PC-MDS	sra	SRX5119327	168	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0155694637_Illumina_P5-Tehax_P7-Nedob	2018-12-12	23912	10452	2019-02-15	SRR8304825	SRS4133185	SRP063692	01115150-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115150-B-1		Exome	H7FMBADXX, H7HBEADXX, H7HBCADXX, H7H7DADXX, H7H6DADXX, H7H85ADXX, H7FPLADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HDH, SL-HDD, SL-HDE	No	HybridSelection		H7HBEADXX140225, H7H85ADXX140225, H7FPLADXX140225, H7FMBADXX140225, H7HBCADXX140225, H7H6DADXX140225, H7H7DADXX140225	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115150	PDO-3179	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076117	BI	DS-PC-MDS	sra	SRX5119328	182	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	Pond-403879	2018-12-12	15168	3772	2019-02-15	SRR8304826	SRS4133186	SRP063692	01115200-TA3	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115200-TA3		Exome	C5L9LANXX, HM2YVADXX, HLWL3ADXX, C5L91ANXX	phs000915		SL-HAN, SL-HDJ, SL-HDG, SL-HAK	Yes	HybridSelection		C5L9LANXX150528, HM2YVADXX150604, HLWL3ADXX150606, C5L91ANXX150528	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115200	PDO-5953	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076006	BI	DS-PC-MDS	sra	SRX5119329	185	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0175880627_Illumina_P5-Wexoj_P7-Pahol	2018-12-12	12017	5775	2019-02-15	SRR8304827	SRS4133187	SRP063692	01115249-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115249-B-1		Exome	HB6EFADXX, HB684ADXX, HB68PADXX, HB6CLADXX, HB6DYADXX, HB687ADXX, HBAM5ADXX, HB68BADXX, HB68WADXX, HB68VADXX, HBAHVADXX	phs000915		SL-HBU, SL-HDM, SL-HAE, SL-HDD, SL-HAN	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115249	PDO-5117	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076210	BI	DS-PC-MDS	sra	SRX5119330	180	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0167755441_Illumina_P5-Zecan_P7-Yexic	2018-12-12	11305	4884	2019-02-15	SRR8304828	SRS4133188	SRP063692	01115200-TA4	DNA; RNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115200-TA4		Exome	H9GT6ADXX, H9GVWADXX, H9G9JADXX	phs000915		SL-HDD, SL-HBW	Yes	HybridSelection		H9GT6ADXX140625, H9GVWADXX140625, H9G9JADXX140625	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115200	PDO-3985	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076090	BI	DS-PC-MDS	sra	SRX5119331	86	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0176456222_Illumina_P5-Wizap_P7-Jatod	2018-12-12	12552	6093	2019-02-15	SRR8304829	SRS4133189	SRP063692	01115257-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115257-B-1		Exome	HB6EFADXX, HB684ADXX, HB68PADXX, HB6CLADXX, HB6DYADXX, HB687ADXX, HBAM5ADXX, HB68BADXX, HB68WADXX, HB68VADXX, HBAHVADXX	phs000915		SL-HBU, SL-HDM, SL-HAE, SL-HDD, SL-HAN	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115257	PDO-5117	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076205	BI	DS-PC-MDS	sra	SRX5119332	177	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0175880463_Illumina_P5-Yewow_P7-Tehed	2018-12-12	12235	5869	2019-02-15	SRR8304830	SRS4133190	SRP063692	01115245-TA1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115245-TA1		Exome	HCJLKADXX, HCHK5ADXX, HCHJTADXX, HCHJ7ADXX, HCKC2ADXX, HCHJYADXX, HCK3JADXX, HBG3BADXX, HCJ5GADXX, HCHMJADXX, HCHK2ADXX, HCHLWADXX	phs000915		SL-HDJ, SL-HDB, SL-HDH, SL-HDD, SL-HDE, SL-HCD	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115245	PDO-5117	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075918	BI	DS-PC-MDS	sra	SRX5119333	178	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0175880555_Illumina_P5-Boyij_P7-Jofij	2018-12-12	13499	6578	2019-02-15	SRR8304831	SRS4133191	SRP063692	01115284-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115284-B-1		Exome	HB6EFADXX, HB684ADXX, HB68PADXX, HB6CLADXX, HB6DYADXX, HB687ADXX, HBAM5ADXX, HB68BADXX, HB68WADXX, HB68VADXX, HBAHVADXX	phs000915		SL-HBU, SL-HDM, SL-HAE, SL-HDD, SL-HAN	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115284	PDO-5117	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075974	BI	DS-PC-MDS	sra	SRX5119334	188	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0175880548_Illumina_P5-Worox_P7-Xinay	2018-12-12	11232	5469	2019-02-15	SRR8304832	SRS4133192	SRP063692	01115257-TA2	DNA; RNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115257-TA2		Exome	HB6EFADXX, HB684ADXX, HB68PADXX, HB6CLADXX, HB6DYADXX, HB687ADXX, HBAM5ADXX, HB68BADXX, HB68WADXX, HB68VADXX, HBAHVADXX	phs000915		SL-HBU, SL-HDM, SL-HAE, SL-HDD, SL-HAN	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115257	PDO-5117	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076165	BI	DS-PC-MDS	sra	SRX5119335	177	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0139029875_Illumina_P5-Zehil_P7-Hefel	2018-12-13	12559	6145	2019-02-15	SRR8304833	SRS4133193	SRP063692	01115263-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115263-B-1		Exome	HB6EFADXX, HB684ADXX, HB68PADXX, HB6CLADXX, HB6DYADXX, HB687ADXX, HBAM5ADXX, HB68BADXX, HB68WADXX, HB68VADXX, HBAHVADXX	phs000915		SL-HBU, SL-HDM, SL-HAE, SL-HDD, SL-HAN	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115263	PDO-5117	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076204	BI	DS-PC-MDS	sra	SRX5119336	200	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0176456223_Illumina_P5-Boleh_P7-Nanat	2018-12-13	13885	6567	2019-02-15	SRR8304834	SRS4133194	SRP063692	01115284-TA2	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115284-TA2		Exome	HB6EFADXX, HB684ADXX, HB68PADXX, HB6CLADXX, HB6DYADXX, HB687ADXX, HBAM5ADXX, HB68BADXX, HB68WADXX, HB68VADXX, HBAHVADXX	phs000915		SL-HBU, SL-HDM, SL-HAE, SL-HDD, SL-HAN	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115284	PDO-5117	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075866	BI	DS-PC-MDS	sra	SRX5119337	182	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0175880563_Illumina_P5-Boxac_P7-Tawah	2018-12-13	13360	6418	2019-02-15	SRR8304835	SRS4133195	SRP063692	01115349-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115349-B-1		Exome	HB6EFADXX, HB684ADXX, HB68PADXX, HB6CLADXX, HB6DYADXX, HB687ADXX, HBAM5ADXX, HB68BADXX, HB68WADXX, HB68VADXX, HBAHVADXX	phs000915		SL-HBU, SL-HDM, SL-HAE, SL-HDD, SL-HAN	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115349	PDO-5117	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076095	BI	DS-PC-MDS	sra	SRX5119338	191	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0176456220_Illumina_P5-Paroy_P7-Debox	2018-12-13	11600	5670	2019-02-15	SRR8304836	SRS4133197	SRP063692	01115264-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115264-B-1		Exome	HB6EFADXX, HB684ADXX, HB68PADXX, HB6CLADXX, HB6DYADXX, HB687ADXX, HBAM5ADXX, HB68BADXX, HB68WADXX, HB68VADXX, HBAHVADXX	phs000915		SL-HBU, SL-HDM, SL-HAE, SL-HDD, SL-HAN	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115264	PDO-5117	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075729	BI	DS-PC-MDS	sra	SRX5119339	212	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0176456219_Illumina_P5-Teyec_P7-Wezap	2018-12-13	10883	5396	2019-02-15	SRR8304837	SRS4133196	SRP063692	01115343-TA1	DNA; RNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115343-TA1		Exome	HB6EFADXX, HB684ADXX, HB68PADXX, HB6CLADXX, HB6DYADXX, HB687ADXX, HBAM5ADXX, HB68BADXX, HB68WADXX, HB68VADXX, HBAHVADXX	phs000915		SL-HBU, SL-HDM, SL-HAE, SL-HDD, SL-HAN	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115343	PDO-5117	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076218	BI	DS-PC-MDS	sra	SRX5119340	204	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0175880456_Illumina_P5-Lolip_P7-Xopad	2018-12-13	10195	4972	2019-02-15	SRR8304838	SRS4133198	SRP063692	01115265-TA1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115265-TA1		Exome	HCJLKADXX, HCHK5ADXX, HCHJTADXX, HCHJ7ADXX, HCKC2ADXX, HCHJYADXX, HCK3JADXX, HBG3BADXX, HCJ5GADXX, HCHMJADXX, HCHK2ADXX, HCHLWADXX	phs000915		SL-HDJ, SL-HDB, SL-HDH, SL-HDD, SL-HDE, SL-HCD	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115265	PDO-5117	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076219	BI	DS-PC-MDS	sra	SRX5119341	186	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0175880547_Illumina_P5-Naxic_P7-Joxih	2018-12-14	12391	6070	2019-02-15	SRR8304839	SRS4133199	SRP063692	01115264-TA3	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115264-TA3		Exome	HB6EFADXX, HB684ADXX, HB68PADXX, HB6CLADXX, HB6DYADXX, HB687ADXX, HBAM5ADXX, HB68BADXX, HB68WADXX, HB68VADXX, HBAHVADXX	phs000915		SL-HBU, SL-HDM, SL-HAE, SL-HDD, SL-HAN	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115264	PDO-5117	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075831	BI	DS-PC-MDS	sra	SRX5119342	231	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0176456240_Illumina_P5-Nalok_P7-Teyay	2018-12-13	9063	4373	2019-02-15	SRR8304840	SRS4133201	SRP063692	01115263-TA2	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115263-TA2		Exome	HB6EFADXX, HB684ADXX, HB68PADXX, HB6CLADXX, HB6DYADXX, HB687ADXX, HBAM5ADXX, HB68BADXX, HB68WADXX, HB68VADXX, HBAHVADXX	phs000915		SL-HBU, SL-HDM, SL-HAE, SL-HDD, SL-HAN	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115257	PDO-5117	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076175	BI	DS-PC-MDS	sra	SRX5119343	182	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0176456198_Illumina_P5-Yahih_P7-Zepon	2018-12-14	12798	6256	2019-02-15	SRR8304841	SRS4133200	SRP063692	01115265-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115265-B-1		Exome	HB6EFADXX, HB684ADXX, HB68PADXX, HB6CLADXX, HB6DYADXX, HB687ADXX, HBAM5ADXX, HB68BADXX, HB68WADXX, HB68VADXX, HBAHVADXX	phs000915		SL-HBU, SL-HDM, SL-HAE, SL-HDD, SL-HAN	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115265	PDO-5117	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075690	BI	DS-PC-MDS	sra	SRX5119344	182	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0176456192_Illumina_P5-Zecan_P7-Yexic	2018-12-14	10752	5282	2019-02-15	SRR8304842	SRS4133202	SRP063692	01115343-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115343-B-1		Exome	HB6EFADXX, HB684ADXX, HB68PADXX, HB6CLADXX, HB6DYADXX, HB687ADXX, HBAM5ADXX, HB68BADXX, HB68WADXX, HB68VADXX, HBAHVADXX	phs000915		SL-HBU, SL-HDM, SL-HAE, SL-HDD, SL-HAN	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115343	PDO-5117	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076153	BI	DS-PC-MDS	sra	SRX5119345	183	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0175880638_Illumina_P5-Zaped_P7-Dizax	2018-12-14	10724	5273	2019-02-15	SRR8304843	SRS4133203	SRP063692	01115349-TA1	DNA; RNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115349-TA1		Exome	HB6EFADXX, HB684ADXX, HB68PADXX, HB6CLADXX, HB6DYADXX, HB687ADXX, HBAM5ADXX, HB68BADXX, HB68WADXX, HB68VADXX, HBAHVADXX	phs000915		SL-HBU, SL-HDM, SL-HAE, SL-HDD, SL-HAN	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115349	PDO-5117	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075803	BI	DS-PC-MDS	sra	SRX5119346	181	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0185495702_Illumina_P5-Fibow_P7-Bebor	2018-12-13	18096	2921	2019-02-15	SRR8304844	SRS4133204	SRP063692	01115360-TA6	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115360-TA6		Exome	C7N7BANXX	phs000915		SL-HAA	Yes	HybridSelection		C7N7BANXX151102	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115360	PDO-7223	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075928	BI	DS-PC-MDS	sra	SRX5119347	187	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	Pond-403873	2018-12-14	15193	3744	2019-02-15	SRR8304845	SRS4133205	SRP063692	01115372-TA7	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115372-TA7		Exome	C5L91ANXX, C5L9LANXX, HM2YVADXX, HLWL3ADXX	phs000915		SL-HAK, SL-HAN, SL-HDJ, SL-HDG	Yes	HybridSelection		C5L91ANXX150528, C5L9LANXX150528, HM2YVADXX150604, HLWL3ADXX150606	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115372	PDO-5953	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075732	BI	DS-PC-MDS	sra	SRX5119348	180	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0185495623_Illumina_P5-Jacob_P7-Wojar	2018-12-14	16297	2653	2019-02-15	SRR8304846	SRS4133206	SRP063692	01115362-TA2	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115362-TA2		Exome	C7N7BANXX	phs000915		SL-HAA	Yes	HybridSelection		C7N7BANXX151102	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115362	PDO-7223	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075781	BI	DS-PC-MDS	sra	SRX5119349	179	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	Pond-428366	2018-12-13	9608	2183	2019-02-15	SRR8304847	SRS4133207	SRP063692	01115378-TA4	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115378-TA4		Exome	C7G4VANXX, C6PMAANXX	phs000915		SL-HAE, SL-HAC	Yes	HybridSelection		C7G4VANXX150828, C6PMAANXX150729	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115378	PDO-5953	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075758	BI	DS-PC-MDS	sra	SRX5119350	172	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	Pond-403875	2018-12-13	11874	3011	2019-02-15	SRR8304848	SRS4133208	SRP063692	01115382-TA6	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115382-TA6		Exome	HLWL3ADXX, C5L91ANXX, C5L9LANXX, HM2YVADXX	phs000915		SL-HDG, SL-HAK, SL-HAN, SL-HDJ	Yes	HybridSelection		HLWL3ADXX150606, C5L91ANXX150528, C5L9LANXX150528, HM2YVADXX150604	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115504	PDO-5953	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076082	BI	DS-PC-MDS	sra	SRX5119351	194	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0187458271_Illumina_P5-Zaped_P7-Pewij	2018-12-14	22146	5434	2019-02-15	SRR8304849	SRS4133209	SRP063692	01115463-TA3	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115463-TA3		Exome	C7N8NANXX, C7N16ANXX	phs000915		SL-HAN	Yes	HybridSelection		C7N8NANXX151022, C7N16ANXX151022	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115463	PDO-7170	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076115	BI	DS-PC-MDS	sra	SRX5119352	189	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0187458328_Illumina_P5-Dohel_P7-Wapah	2018-12-14	28792	6928	2019-02-15	SRR8304850	SRS4133210	SRP063692	01115444-TA6	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115444-TA6		Exome	C7N8NANXX, C7N16ANXX	phs000915		SL-HAN	Yes	HybridSelection		C7N8NANXX151022, C7N16ANXX151022	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115444	PDO-7170	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075673	BI	DS-PC-MDS	sra	SRX5119353	204	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0187458285_Illumina_P5-Henox_P7-Peten	2018-12-14	27027	6566	2019-02-15	SRR8304851	SRS4133211	SRP063692	01115432-TA2-TA4	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115432-TA2-TA4		Exome	C7N16ANXX, C7N8NANXX	phs000915		SL-HAN	Yes	HybridSelection		C7N16ANXX151022, C7N8NANXX151022	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115442	PDO-7170	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075735	BI	DS-PC-MDS	sra	SRX5119354	188	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0187458292_Illumina_P5-Boyij_P7-Caton	2018-12-14	22026	5334	2019-02-15	SRR8304852	SRS4133213	SRP063692	01115466-TA6	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115466-TA6		Exome	C7N8NANXX, C7N16ANXX	phs000915		SL-HAN	Yes	HybridSelection		C7N8NANXX151022, C7N16ANXX151022	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115466	PDO-7170	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075964	BI	DS-PC-MDS	sra	SRX5119355	180	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	Pond-403874	2018-12-14	13278	3319	2019-02-15	SRR8304853	SRS4133212	SRP063692	01115374-TA2	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	01115374-TA2		Exome	HLWL3ADXX, C5L91ANXX, C5L9LANXX, HM2YVADXX	phs000915		SL-HDG, SL-HAK, SL-HAN, SL-HDJ	Yes	HybridSelection		HLWL3ADXX150606, C5L91ANXX150528, C5L9LANXX150528, HM2YVADXX150604	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115503	PDO-5953	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075715	BI	DS-PC-MDS	sra	SRX5119356	201	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0187458331_Illumina_P5-Belez_P7-Zixof	2018-12-14	22185	5319	2019-02-15	SRR8304854	SRS4133214	SRP063692	01115468-TA2	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115468-TA2		Exome	C7N8NANXX, C7N16ANXX	phs000915		SL-HAN	Yes	HybridSelection		C7N8NANXX151022, C7N16ANXX151022	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115468	PDO-7170	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076020	BI	DS-PC-MDS	sra	SRX5119357	198	Illumina HiSeq 4000	PAIRED	Hybrid Selection	GENOMIC	0188133400_Illumina_P5-Hezef_P7-Carof	2018-12-13	30378	6726	2019-02-15	SRR8304855	SRS4133215	SRP063692	01115528-TA1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115528-TA1		Exome	HC37KBBXX, H7N2FBBXX, H7MFVBBXX, H7GTCBBXX	phs000915		SL-HFB, SL-HFA	Yes	HybridSelection		HC37KBBXX160502, H7N2FBBXX160325, H7MFVBBXX160325, H7GTCBBXX160325	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115544	PDO-8269	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076114	BI	DS-PC-MDS	sra	SRX5119358	192	Illumina HiSeq 4000	PAIRED	Hybrid Selection	GENOMIC	0188133372_Illumina_P5-Hohez_P7-Cebey	2018-12-14	27749	6182	2019-02-15	SRR8304856	SRS4133216	SRP063692	01115527-TA4	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115527-TA4		Exome	H7GTCBBXX, H7MFVBBXX, HC37KBBXX, H7N2FBBXX	phs000915		SL-HFA, SL-HFB	Yes	HybridSelection		H7GTCBBXX160325, H7MFVBBXX160325, HC37KBBXX160502, H7N2FBBXX160325	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115527	PDO-8269	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076108	BI	DS-PC-MDS	sra	SRX5119359	195	Illumina HiSeq 4000	PAIRED	Hybrid Selection	GENOMIC	0188133319_Illumina_P5-Jacob_P7-Wojar	2018-12-14	22933	5227	2019-02-15	SRR8304857	SRS4133217	SRP063692	01115531-TA4	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115531-TA4		Exome	H7GTCBBXX, HC37KBBXX, H7MFVBBXX, H7N2FBBXX	phs000915		SL-HFA, SL-HFB	Yes	HybridSelection		H7GTCBBXX160325, HC37KBBXX160502, H7MFVBBXX160325, H7N2FBBXX160325	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115531	PDO-8269	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075857	BI	DS-PC-MDS	sra	SRX5119360	202	Illumina HiSeq 4000	PAIRED	Hybrid Selection	GENOMIC	0188133367_Illumina_P5-Xefac_P7-Wapah	2018-12-14	25782	5900	2019-02-15	SRR8304858	SRS4133219	SRP063692	01115526-TA5	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115526-TA5		Exome	H7MFVBBXX, H7N2FBBXX, H7GTCBBXX, HC37KBBXX	phs000915		SL-HFB, SL-HFA	Yes	HybridSelection		H7MFVBBXX160325, H7N2FBBXX160325, H7GTCBBXX160325, HC37KBBXX160502	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115526	PDO-8269	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075917	BI	DS-PC-MDS	sra	SRX5119361	195	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0187458327_Illumina_P5-Hewij_P7-Cotax	2018-12-14	23499	5760	2019-02-15	SRR8304859	SRS4133218	SRP063692	01115467-TA2	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115467-TA2		Exome	C7N8NANXX, C7N16ANXX	phs000915		SL-HAN	Yes	HybridSelection		C7N8NANXX151022, C7N16ANXX151022	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115467	PDO-7170	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075944	BI	DS-PC-MDS	sra	SRX5119362	203	Illumina HiSeq 4000	PAIRED	Hybrid Selection	GENOMIC	0188133323_Illumina_P5-Kahiz_P7-Yobex	2018-12-14	27815	6151	2019-02-15	SRR8304860	SRS4133220	SRP063692	01115549-TA2	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115549-TA2		Exome	HC37KBBXX, H7GTCBBXX, H7N2FBBXX, H7MFVBBXX	phs000915		SL-HFB, SL-HFA	Yes	HybridSelection		HC37KBBXX160502, H7GTCBBXX160325, H7N2FBBXX160325, H7MFVBBXX160325	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115549	PDO-8269	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076110	BI	DS-PC-MDS	sra	SRX5119363	203	Illumina HiSeq 4000	PAIRED	Hybrid Selection	GENOMIC	0188133322_Illumina_P5-Xayol_P7-Zawol	2018-12-14	23858	5314	2019-02-15	SRR8304861	SRS4133221	SRP063692	01115525-TA5	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115525-TA5		Exome	H7N2FBBXX, H7MFVBBXX, HC37KBBXX, H7GTCBBXX	phs000915		SL-HFB, SL-HFA	Yes	HybridSelection		H7N2FBBXX160325, H7MFVBBXX160325, HC37KBBXX160502, H7GTCBBXX160325	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115525	PDO-8269	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076032	BI	DS-PC-MDS	sra	SRX5119364	199	Illumina HiSeq 4000	PAIRED	Hybrid Selection	GENOMIC	0188133371_Illumina_P5-Kacox_P7-Yebiw	2018-12-14	28744	6430	2019-02-15	SRR8304862	SRS4133222	SRP063692	01115550-TA5	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115550-TA5		Exome	HC37KBBXX, H7GTCBBXX, H7MFVBBXX, H7N2FBBXX	phs000915		SL-HFB, SL-HFA	Yes	HybridSelection		HC37KBBXX160502, H7GTCBBXX160325, H7MFVBBXX160325, H7N2FBBXX160325	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115550	PDO-8269	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076088	BI	DS-PC-MDS	sra	SRX5119365	190	Illumina HiSeq 4000	PAIRED	Hybrid Selection	GENOMIC	0188133374_Illumina_P5-Fefaj_P7-Narad	2018-12-14	24102	5363	2019-02-15	SRR8304863	SRS4133223	SRP063692	01115554-TA1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115554-TA1		Exome	H7MFVBBXX, H7N2FBBXX, H7GTCBBXX, HC37KBBXX	phs000915		SL-HFB, SL-HFA	Yes	HybridSelection		H7MFVBBXX160325, H7N2FBBXX160325, H7GTCBBXX160325, HC37KBBXX160502	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115554	PDO-8269	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075995	BI	DS-PC-MDS	sra	SRX5119366	196	Illumina HiSeq 4000	PAIRED	Hybrid Selection	GENOMIC	0188133351_Illumina_P5-Pecef_P7-Fofeb	2018-12-14	24436	5496	2019-02-15	SRR8304864	SRS4133224	SRP063692	01115569-TA5	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115569-TA5		Exome	H7N2FBBXX, HC37KBBXX, H7GTCBBXX, H7MFVBBXX	phs000915		SL-HFB, SL-HFA	Yes	HybridSelection		H7N2FBBXX160325, HC37KBBXX160502, H7GTCBBXX160325, H7MFVBBXX160325	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115569	PDO-8269	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076166	BI	DS-PC-MDS	sra	SRX5119367	195	Illumina HiSeq 4000	PAIRED	Hybrid Selection	GENOMIC	0188133369_Illumina_P5-Jolac_P7-Yoboh	2018-12-14	23098	5278	2019-02-15	SRR8304865	SRS4133225	SRP063692	01115556-TC3	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115556-TC3		Exome	H7N2FBBXX, H7GTCBBXX, H7MFVBBXX, HC37KBBXX	phs000915		SL-HFB, SL-HFA	Yes	HybridSelection		H7N2FBBXX160325, H7GTCBBXX160325, H7MFVBBXX160325, HC37KBBXX160502	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115556	PDO-8269	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075748	BI	DS-PC-MDS	sra	SRX5119368	191	Illumina HiSeq 4000	PAIRED	Hybrid Selection	GENOMIC	0188133368_Illumina_P5-Licax_P7-Xilan	2018-12-14	25168	5617	2019-02-15	SRR8304866	SRS4133226	SRP063692	01115578-TA2	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115578-TA2		Exome	H7N2FBBXX, H7MFVBBXX, H7GTCBBXX, HC37KBBXX	phs000915		SL-HFB, SL-HFA	Yes	HybridSelection		H7N2FBBXX160325, H7MFVBBXX160325, H7GTCBBXX160325, HC37KBBXX160502	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115578	PDO-8269	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076042	BI	DS-PC-MDS	sra	SRX5119369	194	Illumina HiSeq 4000	PAIRED	Hybrid Selection	GENOMIC	0188133324_Illumina_P5-Jafey_P7-Pepac	2018-12-14	31756	7081	2019-02-15	SRR8304867	SRS4133227	SRP063692	01115576-TB1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115576-TB1		Exome	H7N2FBBXX, H7GTCBBXX, HC37KBBXX, H7MFVBBXX	phs000915		SL-HFB, SL-HFA	Yes	HybridSelection		H7N2FBBXX160325, H7GTCBBXX160325, HC37KBBXX160502, H7MFVBBXX160325	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115576	PDO-8269	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076200	BI	DS-PC-MDS	sra	SRX5119370	195	Illumina HiSeq 4000	PAIRED	Hybrid Selection	GENOMIC	0188133350_Illumina_P5-Fezex_P7-Caton	2018-12-14	25364	5647	2019-02-15	SRR8304868	SRS4133228	SRP063692	01115577-TC2	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115577-TC2		Exome	H7GTCBBXX, H7MFVBBXX, H7N2FBBXX, HC37KBBXX	phs000915		SL-HFA, SL-HFB	Yes	HybridSelection		H7GTCBBXX160325, H7MFVBBXX160325, H7N2FBBXX160325, HC37KBBXX160502	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115577	PDO-8269	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075768	BI	DS-PC-MDS	sra	SRX5119371	196	Illumina HiSeq 4000	PAIRED	Hybrid Selection	GENOMIC	0188133342_Illumina_P5-Hikaz_P7-Keloj	2018-12-14	24126	5525	2019-02-15	SRR8304869	SRS4133229	SRP063692	01115581-TA4	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115581-TA4		Exome	H7GTCBBXX, HC37KBBXX, H7MFVBBXX, H7N2FBBXX	phs000915		SL-HFA, SL-HFB	Yes	HybridSelection		H7GTCBBXX160325, HC37KBBXX160502, H7MFVBBXX160325, H7N2FBBXX160325	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115581	PDO-8269	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076119	BI	DS-PC-MDS	sra	SRX5119372	202	Illumina HiSeq 4000	PAIRED	Hybrid Selection	GENOMIC	0188133398_Illumina_P5-Fibow_P7-Bebor	2018-12-14	22226	5095	2019-02-15	SRR8304870	SRS4133230	SRP063692	01115574-TC2	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	01115574-TC2		Exome	HC37KBBXX, H7GTCBBXX, H7N2FBBXX, H7MFVBBXX	phs000915		SL-HFB, SL-HFA	Yes	HybridSelection		HC37KBBXX160502, H7GTCBBXX160325, H7N2FBBXX160325, H7MFVBBXX160325	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115574	PDO-8269	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076220	BI	DS-CA-MDS	sra	SRX5119373	200	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0154845182_Illumina_P5-Lahoy_P7-Difew	2018-12-14	29405	13613	2019-02-15	SRR8304871	SRS4133231	SRP063692	06115116-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115116-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HDC, SL-HBW, SL-HDH, SL-HCC, SL-HDD, SL-HDE	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115116	PDO-2351	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075680	BI	DS-CA-MDS	sra	SRX5121603	219	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0154845206_Illumina_P5-Xazen_P7-Xoren	2018-12-13	22888	10926	2019-02-15	SRR8307101	SRS4134842	SRP063692	06115116-T	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115116-T		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HDC, SL-HBW, SL-HDH, SL-HCC, SL-HDD, SL-HDE	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115116	PDO-2351	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075728	BI	DS-CA-MDS	sra	SRX5121604	183	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0164095180_tagged_800	2018-12-13	11555	5730	2019-02-15	SRR8307102	SRS4134843	SRP063692	06115295-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115295-B-1		Exome	HABDCADXX, HAAFBADXX, HABJ1ADXX, HABHVADXX, HAAL2ADXX, HA5U2ADXX, HAB16ADXX	phs000915		SL-HDH, SL-HDD, SL-HDF, SL-HDG	No	HybridSelection		HABJ1ADXX140917, HAAFBADXX140917, HABHVADXX140917, HABDCADXX140917, HAAL2ADXX140917, HAB16ADXX140917, HA5U2ADXX140917	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115295	PDO-4605	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075761	BI	DS-CA-MDS	sra	SRX5121605	207	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0150675799_Illumina_P5-Henox_P7-Fotey	2018-12-13	24493	11264	2019-02-15	SRR8307103	SRS4134844	SRP063692	06115119-T	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115119-T		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HDC, SL-HBW, SL-HDH, SL-HCC, SL-HDD, SL-HDE	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115119	PDO-2351	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075771	BI	DS-CA-MDS	sra	SRX5121606	178	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0164095146_tagged_861	2018-12-13	10428	5161	2019-02-15	SRR8307104	SRS4134845	SRP063692	06115285-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115285-B-1		Exome	HABDCADXX, HAAFBADXX, HABJ1ADXX, HABHVADXX, HAAL2ADXX, HA5U2ADXX, HAB16ADXX	phs000915		SL-HDG, SL-HDH, SL-HDD, SL-HDF	No	HybridSelection		HABJ1ADXX140917, HAAFBADXX140917, HABHVADXX140917, HABDCADXX140917, HAAL2ADXX140917, HAB16ADXX140917, HA5U2ADXX140917	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115285	PDO-4605	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075773	BI	DS-CA-MDS	sra	SRX5121607	174	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0164095168_tagged_214	2018-12-13	16937	8696	2019-02-15	SRR8307105	SRS4134846	SRP063692	06115295-T-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115295-T-B-1		Exome	HAB3KADXX, HAB5LADXX, HAB62ADXX, HAB5JADXX	phs000915		SL-HDC, SL-HDB	Yes	HybridSelection		HAB3KADXX140917, HAB5LADXX140917, HAB62ADXX140917, HAB5JADXX140917	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115295	PDO-4605	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075817	BI	DS-CA-MDS	sra	SRX5121608	178	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911951_tagged_379	2018-12-13	22557	11352	2019-02-15	SRR8307106	SRS4134847	SRP063692	06115236-T-C-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115236-T-C-1		Exome	HAHU3ADXX, HAHWGADXX	phs000915		SL-HDH	Yes	HybridSelection		HAHU3ADXX141006, HAHWGADXX141006	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115236	PDO-4605	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075860	BI	DS-CA-MDS	sra	SRX5121609	175	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911974_tagged_438	2018-12-13	12365	6025	2019-02-15	SRR8307107	SRS4134848	SRP063692	06115319-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115319-B-1		Exome	HABDCADXX, HAAFBADXX, HABJ1ADXX, HABHVADXX, HAAL2ADXX, HA5U2ADXX, HAB16ADXX	phs000915		SL-HDD, SL-HDH, SL-HDG, SL-HDF	No	HybridSelection		HABJ1ADXX140917, HAAFBADXX140917, HABHVADXX140917, HABDCADXX140917, HAAL2ADXX140917, HAB16ADXX140917, HA5U2ADXX140917	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115319	PDO-4605	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075885	BI	DS-CA-MDS	sra	SRX5121610	173	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0180656478_Illumina_P5-Hikaz_P7-Keloj	2018-12-13	23178	10613	2019-02-15	SRR8307108	SRS4134849	SRP063692	06115124-T-B-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115124-T-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HDC, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115124	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075889	BI	DS-CA-MDS	sra	SRX5121611	233	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0154845205_Illumina_P5-Teyec_P7-Wezap	2018-12-13	21710	10324	2019-02-15	SRR8307109	SRS4134850	SRP063692	06115120-T	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115120-T		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HDC, SL-HBW, SL-HDH, SL-HCC, SL-HDD, SL-HDE	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115120	PDO-2351	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075900	BI	DS-CA-MDS	sra	SRX5121612	196	Illumina HiSeq 4000	PAIRED	Hybrid Selection	GENOMIC	0191736102_Illumina_P5-Zaped_P7-Dizax	2018-12-13	21014	4395	2019-02-15	SRR8307110	SRS4134851	SRP063692	06115250-T-B2-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115250-T-B2-1		Exome	HC3CGBBXX, HC3GJBBXX	phs000915		SL-HFC	Yes	HybridSelection		HC3CGBBXX160425, HC3GJBBXX160425	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115250	PDO-8519	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075912	BI	DS-CA-MDS	sra	SRX5121613	201	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0154861404_Illumina_P5-Naxic_P7-Joxih	2018-12-13	31694	14824	2019-02-15	SRR8307111	SRS4134852	SRP063692	06115120-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115120-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HDC, SL-HBW, SL-HDH, SL-HCC, SL-HDD, SL-HDE	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115120	PDO-2351	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075940	BI	DS-CA-MDS	sra	SRX5121614	194	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0164095197_tagged_579	2018-12-13	15497	8001	2019-02-15	SRR8307112	SRS4134853	SRP063692	06115285-T-C-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115285-T-C-1		Exome	HAB62ADXX, HAB5JADXX, HAB5LADXX, HAB3KADXX	phs000915		SL-HDC, SL-HDB	Yes	HybridSelection		HAB62ADXX140917, HAB5JADXX140917, HAB5LADXX140917, HAB3KADXX140917	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115285	PDO-4605	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075953	BI	DS-CA-MDS	sra	SRX5121615	173	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911973_tagged_357	2018-12-13	18969	9898	2019-02-15	SRR8307113	SRS4134854	SRP063692	06115286-T-C-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115286-T-C-1		Exome	HAB5LADXX, HAB62ADXX, HAB3KADXX, HAB5JADXX	phs000915		SL-HDB, SL-HDC	Yes	HybridSelection		HAB5LADXX140917, HAB62ADXX140917, HAB3KADXX140917, HAB5JADXX140917	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115286	PDO-4605	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075983	BI	DS-CA-MDS	sra	SRX5121616	173	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0154850274_tagged_754	2018-12-13	10476	5009	2019-02-15	SRR8307114	SRS4134855	SRP063692	06115236-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115236-B-1		Exome	HABDCADXX, HAAFBADXX, HABJ1ADXX, HABHVADXX, HAAL2ADXX, HA5U2ADXX, HAB16ADXX	phs000915		SL-HDF, SL-HDH, SL-HDD, SL-HDG	No	HybridSelection		HABJ1ADXX140917, HAAFBADXX140917, HABHVADXX140917, HABDCADXX140917, HAAL2ADXX140917, HAB16ADXX140917, HA5U2ADXX140917	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115236	PDO-4605	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076097	BI	DS-CA-MDS	sra	SRX5121617	173	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911945_tagged_298	2018-12-13	12622	6052	2019-02-15	SRR8307115	SRS4134856	SRP063692	06115288-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115288-B-1		Exome	HABDCADXX, HAAFBADXX, HABJ1ADXX, HABHVADXX, HAAL2ADXX, HA5U2ADXX, HAB16ADXX	phs000915		SL-HDG, SL-HDD, SL-HDH, SL-HDF	No	HybridSelection		HABJ1ADXX140917, HAAFBADXX140917, HABHVADXX140917, HABDCADXX140917, HAAL2ADXX140917, HAB16ADXX140917, HA5U2ADXX140917	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115288	PDO-4605	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076199	BI	DS-CA-MDS	sra	SRX5121618	216	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0154845186_Illumina_P5-Faxen_P7-Zibod	2018-12-13	21738	10160	2019-02-15	SRR8307116	SRS4134857	SRP063692	06115119-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115119-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HDC, SL-HBW, SL-HDH, SL-HCC, SL-HDD, SL-HDE	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115119	PDO-2351	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075834	BI	DS-CA-MDS	sra	SRX5121619	198	Illumina HiSeq 4000	PAIRED	Hybrid Selection	GENOMIC	0191736144_Illumina_P5-Lilel_P7-Koweh	2018-12-13	17984	3795	2019-02-15	SRR8307117	SRS4134858	SRP063692	06115296-T-A1-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115296-T-A1-1		Exome	HC3GJBBXX, HC3CGBBXX	phs000915		SL-HFC	Yes	HybridSelection		HC3GJBBXX160425, HC3CGBBXX160425	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115296	PDO-8519	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076040	BI	DS-CA-MDS	sra	SRX5121620	173	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911999_tagged_745	2018-12-13	11285	5523	2019-02-15	SRR8307118	SRS4134859	SRP063692	06115286-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115286-B-1		Exome	HABDCADXX, HAAFBADXX, HABJ1ADXX, HABHVADXX, HAAL2ADXX, HA5U2ADXX, HAB16ADXX	phs000915		SL-HDG, SL-HDD, SL-HDH, SL-HDF	No	HybridSelection		HABJ1ADXX140917, HAAFBADXX140917, HABHVADXX140917, HABDCADXX140917, HAAL2ADXX140917, HAB16ADXX140917, HA5U2ADXX140917	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115286	PDO-4605	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076109	BI	DS-CA-MDS	sra	SRX5121621	178	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0154850247_tagged_332	2018-12-13	17679	9137	2019-02-15	SRR8307119	SRS4134860	SRP063692	06115288-T-A-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115288-T-A-1		Exome	HAB3KADXX, HAB62ADXX, HAB5LADXX, HAB5JADXX	phs000915		SL-HDC, SL-HDB	Yes	HybridSelection		HAB3KADXX140917, HAB62ADXX140917, HAB5LADXX140917, HAB5JADXX140917	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115288	PDO-4605	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075764	BI	DS-PC-MDS	sra	SRX5121622	174	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0148912004_Illumina_P5-Tehax_P7-Nedob	2018-12-13	12909	5977	2019-02-15	SRR8307120	SRS4134861	SRP063692	10-448.P30.blood	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	10-448.P30.blood		Exome	H7J59ADXX, H7J32ADXX, H7J36ADXX, H7GKKADXX, H7TPUADXX	phs000915		SL-HBW, SL-HDD, SL-HBV	No	HybridSelection		H7J36ADXX140422, H7J59ADXX140422, H7TPUADXX140422, H7GKKADXX140422, H7J32ADXX140422	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115313	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075824	BI	DS-PC-MDS	sra	SRX5121623	191	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0148911982_Illumina_P5-Polez_P7-Bezic	2018-12-13	11027	5119	2019-02-15	SRR8307121	SRS4134862	SRP063692	10-448.P20.blood	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	10-448.P20.blood		Exome	H7J59ADXX, H7J32ADXX, H7J36ADXX, H7GKKADXX, H7TPUADXX	phs000915		SL-HBW, SL-HBV, SL-HDD	No	HybridSelection		H7J36ADXX140422, H7J59ADXX140422, H7TPUADXX140422, H7GKKADXX140422, H7J32ADXX140422	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115306	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076050	BI	DS-CA-MDS	sra	SRX5121626	193	Illumina HiSeq 4000	PAIRED	Hybrid Selection	GENOMIC	0191736099_Illumina_P5-Teyec_P7-Wezap	2018-12-13	20454	4501	2019-02-15	SRR8307124	SRS4134941	SRP063692	06115590-T-A-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115590-T-A-1		Exome	HC3CGBBXX, HC3GJBBXX	phs000915		SL-HFC	Yes	HybridSelection		HC3CGBBXX160425, HC3GJBBXX160425	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115590	PDO-8519	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076084	BI	DS-PC-MDS	sra	SRX5121627	183	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0148911985_Illumina_P5-Zecan_P7-Yexic	2018-12-13	9819	4573	2019-02-15	SRR8307125	SRS4134942	SRP063692	10-448.P40.blood	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	10-448.P40.blood		Exome	H7J59ADXX, H7J32ADXX, H7J36ADXX, H7GKKADXX, H7TPUADXX	phs000915		SL-HBV, SL-HDD, SL-HBW	No	HybridSelection		H7J36ADXX140422, H7J59ADXX140422, H7TPUADXX140422, H7GKKADXX140422, H7J32ADXX140422	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115190	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076214	BI	DS-CA-MDS	sra	SRX5121628	134	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656452_Illumina_P5-Pahaz_P7-Wayac	2018-12-13	24035	10976	2019-02-15	SRR8307126	SRS4134943	SRP063692	06115400-T-B-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115400-T-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HDC, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115400	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076010	BI	DS-PC-MDS	sra	SRX5121629	179	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0148912030_Illumina_P5-Kizez_P7-Cakax	2018-12-13	10985	5123	2019-02-15	SRR8307127	SRS4134944	SRP063692	10-448.P27.blood	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	10-448.P27.blood		Exome	H7J59ADXX, H7J32ADXX, H7J36ADXX, H7GKKADXX, H7TPUADXX	phs000915		SL-HBV, SL-HDD, SL-HBW	No	HybridSelection		H7J36ADXX140422, H7J59ADXX140422, H7TPUADXX140422, H7GKKADXX140422, H7J32ADXX140422	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115307	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075980	BI	DS-CA-MDS	sra	SRX5121630	180	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656454_Illumina_P5-Reboc_P7-Yeyey	2018-12-13	25898	11877	2019-02-15	SRR8307128	SRS4134945	SRP063692	06115402-T-C-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115402-T-C-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HDC, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115402	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075968	BI	DS-PC-MDS	sra	SRX5121631	187	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911983_Illumina_P5-Paroy_P7-Debox	2018-12-13	9777	4555	2019-02-15	SRR8307129	SRS4134946	SRP063692	10-448.P42.blood	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	10-448.P42.blood		Exome	H7J59ADXX, H7J32ADXX, H7J36ADXX, H7GKKADXX, H7TPUADXX	phs000915		SL-HDD, SL-HBW, SL-HBV	No	HybridSelection		H7J36ADXX140422, H7J59ADXX140422, H7TPUADXX140422, H7GKKADXX140422, H7J32ADXX140422	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115312	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075809	BI	DS-CA-MDS	sra	SRX5121632	147	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656483_Illumina_P5-Zecez_P7-Kewot	2018-12-13	19108	8855	2019-02-15	SRR8307130	SRS4134947	SRP063692	6115124-B-2	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	6115124-B-2		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HDC, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115124	PDO-5957	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075675	BI	DS-CA-MDS	sra	SRX5121633	197	Illumina HiSeq 4000	PAIRED	Hybrid Selection	GENOMIC	0191736179_Illumina_P5-Zitey_P7-Fapix	2018-12-13	23133	4878	2019-02-15	SRR8307131	SRS4134948	SRP063692	06115593-T-C-2	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115593-T-C-2		Exome	HC3CGBBXX, HC3GJBBXX	phs000915		SL-HFC	Yes	HybridSelection		HC3CGBBXX160425, HC3GJBBXX160425	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115593	PDO-8519	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075696	BI	DS-PC-MDS	sra	SRX5121634	179	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0148908966_Illumina_P5-Reboc_P7-Yeyey	2018-12-13	10120	5281	2019-02-15	SRR8307132	SRS4134949	SRP063692	1115090-T-C-2	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	1115090-T-C-2		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDM, SL-HDG, SL-HCB, SL-HDL, SL-HDH, SL-HCC, SL-HDK, SL-HBC	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115090	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075863	BI	DS-CA-MDS	sra	SRX5121635	199	Illumina HiSeq 4000	PAIRED	Hybrid Selection	GENOMIC	0191736158_Illumina_P5-Kizez_P7-Cakax	2018-12-13	23219	4887	2019-02-15	SRR8307133	SRS4134950	SRP063692	06115592-T-C-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115592-T-C-1		Exome	HC3CGBBXX, HC3GJBBXX	phs000915		SL-HFC	Yes	HybridSelection		HC3CGBBXX160425, HC3GJBBXX160425	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115592	PDO-8519	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076121	BI	DS-PC-MDS	sra	SRX5121636	191	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0148912010_Illumina_P5-Lahoy_P7-Difew	2018-12-13	10581	4854	2019-02-15	SRR8307134	SRS4134951	SRP063692	10-448.P38.blood	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	10-448.P38.blood		Exome	H7J59ADXX, H7J32ADXX, H7J36ADXX, H7GKKADXX, H7TPUADXX	phs000915		SL-HBW, SL-HBV, SL-HDD	No	HybridSelection		H7J36ADXX140422, H7J59ADXX140422, H7TPUADXX140422, H7GKKADXX140422, H7J32ADXX140422	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115311	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075948	BI	DS-CA-MDS	sra	SRX5121637	208	Illumina HiSeq 4000	PAIRED	Hybrid Selection	GENOMIC	0191736159_Illumina_P5-Wihoy_P7-Hopow	2018-12-13	22171	4717	2019-02-15	SRR8307135	SRS4134952	SRP063692	06115427-T-C-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115427-T-C-1		Exome	HC3GJBBXX, HC3CGBBXX	phs000915		SL-HFC	Yes	HybridSelection		HC3GJBBXX160425, HC3CGBBXX160425	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115427	PDO-8519	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075882	BI	DS-CA-MDS	sra	SRX5121638	186	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0180656453_Illumina_P5-Halif_P7-Janil	2018-12-13	28055	12567	2019-02-15	SRR8307136	SRS4134953	SRP063692	06115401-T-A-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115401-T-A-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HDC, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115401	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075887	BI	DS-PC-MDS	sra	SRX5121755	176	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0148911955_Illumina_P5-Pojif_P7-Xedeb	2018-12-13	11419	5345	2019-02-15	SRR8307253	SRS4135070	SRP063692	10-448.P22.blood	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	10-448.P22.blood		Exome	H7J59ADXX, H7J32ADXX, H7J36ADXX, H7GKKADXX, H7TPUADXX	phs000915		SL-HBV, SL-HDD, SL-HBW	No	HybridSelection		H7J36ADXX140422, H7J59ADXX140422, H7TPUADXX140422, H7GKKADXX140422, H7J32ADXX140422	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115314	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076113	BI	DS-CA-MDS	sra	SRX5121756	175	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656507_Illumina_P5-Kacox_P7-Yebiw	2018-12-13	25334	11357	2019-02-15	SRR8307254	SRS4135071	SRP063692	06115400-T-A-1	DNA; RNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115400-T-A-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HDC, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115400	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075710	BI	DS-PC-MDS	sra	SRX5121757	184	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0148912002_Illumina_P5-Liwox_P7-Tefew	2018-12-13	10815	5036	2019-02-15	SRR8307255	SRS4135072	SRP063692	10-448.P34.blood	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	10-448.P34.blood		Exome	H7J59ADXX, H7J32ADXX, H7J36ADXX, H7GKKADXX, H7TPUADXX	phs000915		SL-HBV, SL-HDD, SL-HBW	No	HybridSelection		H7J36ADXX140422, H7J59ADXX140422, H7TPUADXX140422, H7GKKADXX140422, H7J32ADXX140422	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115310	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075779	BI	DS-PC-MDS	sra	SRX5121758	178	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0148912013_Illumina_P5-Nalok_P7-Teyay	2018-12-13	11384	5205	2019-02-15	SRR8307256	SRS4135073	SRP063692	10-448.P05.blood	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	10-448.P05.blood		Exome	H7J59ADXX, H7J32ADXX, H7J36ADXX, H7GKKADXX, H7TPUADXX	phs000915		SL-HBV, SL-HDD, SL-HBW	No	HybridSelection		H7J36ADXX140422, H7J59ADXX140422, H7TPUADXX140422, H7GKKADXX140422, H7J32ADXX140422	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115303	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075988	BI	DS-PC-MDS	sra	SRX5121759	168	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148909042_Illumina_P5-Poxew_P7-Likif	2018-12-13	7652	3994	2019-02-15	SRR8307257	SRS4135074	SRP063692	1115090-T-C-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	1115090-T-C-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDM, SL-HDG, SL-HCB, SL-HDL, SL-HDH, SL-HCC, SL-HDK, SL-HBC	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115090	PDO-1907	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075959	BI	DS-CA-MDS	sra	SRX5121760	174	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656455_Illumina_P5-Jacob_P7-Wojar	2018-12-13	21880	9952	2019-02-15	SRR8307258	SRS4135075	SRP063692	06115403-T-A-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	06115403-T-A-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HDC, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115403	PDO-5958	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075774	BI	DS-CA-MDS	sra	SRX5121761	178	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656538_Illumina_P5-Popal_P7-Xezit	2018-12-13	10585	5054	2019-02-15	SRR8307259	SRS4135076	SRP063692	6115386-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	6115386-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115386	PDO-5957	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075898	BI	DS-PC-MDS	sra	SRX5121762	180	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911938_Illumina_P5-Razac_P7-Folar	2018-12-13	10852	4988	2019-02-15	SRR8307260	SRS4135077	SRP063692	10-448.P29.blood	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	10-448.P29.blood		Exome	H7J59ADXX, H7J32ADXX, H7J36ADXX, H7GKKADXX, H7TPUADXX	phs000915		SL-HDD, SL-HBW, SL-HBV	No	HybridSelection		H7J36ADXX140422, H7J59ADXX140422, H7TPUADXX140422, H7GKKADXX140422, H7J32ADXX140422	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115308	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075921	BI	DS-CA-MDS	sra	SRX5121763	157	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0180656542_Illumina_P5-Kizez_P7-Cakax	2018-12-13	8147	3879	2019-02-15	SRR8307261	SRS4135078	SRP063692	6115381-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	6115381-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115381	PDO-5957	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075700	BI	DS-CA-MDS	sra	SRX5121764	174	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0164097433_Illumina_P5-Hewij_P7-Zidel	2018-12-13	12288	5375	2019-02-15	SRR8307262	SRS4135079	SRP063692	6115250-N-B1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	6115250-N-B1		Exome	H9FV9ADXX, H9FN4ADXX, H9FMUADXX, H9FWGADXX	phs000915		SL-HDB, SL-HDE, SL-HBW, SL-HBV	No	HybridSelection		H9FV9ADXX140616, H9FN4ADXX140616, H9FMUADXX140616, H9FWGADXX140616	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115250	PDO-3948	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075878	BI	DS-PC-MDS	sra	SRX5121765	180	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0148911979_Illumina_P5-Dohel_P7-Bical	2018-12-13	13654	6216	2019-02-15	SRR8307263	SRS4135080	SRP063692	10-448.P15.blood	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	10-448.P15.blood		Exome	H7J59ADXX, H7J32ADXX, H7J36ADXX, H7GKKADXX, H7TPUADXX	phs000915		SL-HBV, SL-HBW, SL-HDD	No	HybridSelection		H7J36ADXX140422, H7J59ADXX140422, H7TPUADXX140422, H7GKKADXX140422, H7J32ADXX140422	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115305	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076162	BI	DS-CA-MDS	sra	SRX5121795	178	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656539_Illumina_P5-Lilel_P7-Koweh	2018-12-13	10712	5102	2019-02-15	SRR8307293	SRS4135110	SRP063692	6115385-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	6115385-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115385	PDO-5957	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076024	BI	DS-PC-MDS	sra	SRX5121796	184	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911988_Illumina_P5-Naxic_P7-Joxih	2018-12-13	11868	5502	2019-02-15	SRR8307294	SRS4135111	SRP063692	10-448.P31.blood	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	10-448.P31.blood		Exome	H7J59ADXX, H7J32ADXX, H7J36ADXX, H7GKKADXX, H7TPUADXX	phs000915		SL-HDD, SL-HBV, SL-HBW	No	HybridSelection		H7J36ADXX140422, H7J59ADXX140422, H7TPUADXX140422, H7GKKADXX140422, H7J32ADXX140422	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115309	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075730	BI	DS-CA-MDS	sra	SRX5121797	182	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0164097473_Illumina_P5-Zecan_P7-Yexic	2018-12-13	9986	4479	2019-02-15	SRR8307295	SRS4135112	SRP063692	6115235-N-B1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	6115235-N-B1		Exome	H9FN4ADXX, H9FWGADXX, H9FV9ADXX, H9FMUADXX	phs000915		SL-HDE, SL-HBV, SL-HDB, SL-HBW	No	HybridSelection		H9FN4ADXX140616, H9FWGADXX140616, H9FV9ADXX140616, H9FMUADXX140616	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115235	PDO-3948	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075829	BI	DS-CA-MDS	sra	SRX5121798	176	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0164097628_Illumina_P5-Worox_P7-Xinay	2018-12-13	10628	4781	2019-02-15	SRR8307296	SRS4135113	SRP063692	6115247-N-B1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	6115247-N-B1		Exome	H9FMUADXX, H9FV9ADXX, H9FWGADXX, H9FN4ADXX	phs000915		SL-HBW, SL-HDB, SL-HBV, SL-HDE	No	HybridSelection		H9FMUADXX140616, H9FV9ADXX140616, H9FWGADXX140616, H9FN4ADXX140616	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115247	PDO-3948	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075873	BI	DS-CA-MDS	sra	SRX5121942	187	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0164097435_Illumina_P5-Yalor_P7-Doyez	2018-12-13	10564	4591	2019-02-15	SRR8307440	SRS4135258	SRP063692	6115242-N-B1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	6115242-N-B1		Exome	H9FV9ADXX, H9FMUADXX, H9FWGADXX, H9FN4ADXX	phs000915		SL-HDB, SL-HBW, SL-HBV, SL-HDE	No	HybridSelection		H9FV9ADXX140616, H9FMUADXX140616, H9FWGADXX140616, H9FN4ADXX140616	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115242	PDO-3948	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076172	BI	DS-PC-MDS	sra	SRX5121943	190	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148912008_Illumina_P5-Poded_P7-Rojan	2018-12-13	11483	5026	2019-02-15	SRR8307441	SRS4135259	SRP063692	DFCI.10-448.P05_base_OCT_A	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	DFCI.10-448.P05_base_OCT_A		Exome	H7J3HADXX, H7J0PADXX, H7J33ADXX, H7J0TADXX, H7J1HADXX, H7J0RADXX, H7HW1ADXX, H7GKUADXX, H7J0VADXX, H7HWGADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HDH, SL-HDD, SL-HDE	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115303	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075960	BI	DS-CA-MDS	sra	SRX5121944	140	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656540_Illumina_P5-Kefaz_P7-Honok	2018-12-13	9694	4541	2019-02-15	SRR8307442	SRS4135260	SRP063692	6115383-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	6115383-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115383	PDO-5957	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075977	BI	DS-PC-MDS	sra	SRX5121945	183	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148912009_Illumina_P5-Wihoy_P7-Hopow	2018-12-13	11501	4951	2019-02-15	SRR8307443	SRS4135261	SRP063692	DFCI.10-448.P05_base_OCT_C	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	DFCI.10-448.P05_base_OCT_C		Exome	H7J3HADXX, H7J0PADXX, H7J33ADXX, H7J0TADXX, H7J1HADXX, H7J0RADXX, H7HW1ADXX, H7GKUADXX, H7J0VADXX, H7HWGADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HDH, SL-HDD, SL-HDE	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115303	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076013	BI	DS-PC-MDS	sra	SRX5121946	176	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911963_Illumina_P5-Xecox_P7-Fofiz	2018-12-13	12852	5798	2019-02-15	SRR8307444	SRS4135262	SRP063692	DFCI.10-448.P27_base_PAX_1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	DFCI.10-448.P27_base_PAX_1		Exome	H7J3HADXX, H7J0PADXX, H7J33ADXX, H7J0TADXX, H7J1HADXX, H7J0RADXX, H7HW1ADXX, H7GKUADXX, H7J0VADXX, H7HWGADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HDH, SL-HDD, SL-HDE	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115307	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075841	BI	DS-PC-MDS	sra	SRX5121947	172	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911960_Illumina_P5-Zehil_P7-Hefel	2018-12-13	13006	5892	2019-02-15	SRR8307445	SRS4135263	SRP063692	DFCI.10-448.P05_post_formalin_2	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	DFCI.10-448.P05_post_formalin_2		Exome	H7J3HADXX, H7J0PADXX, H7J33ADXX, H7J0TADXX, H7J1HADXX, H7J0RADXX, H7HW1ADXX, H7GKUADXX, H7J0VADXX, H7HWGADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HDH, SL-HDD, SL-HDE	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115303	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075705	BI	DS-PC-MDS	sra	SRX5121948	168	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911980_Illumina_P5-Jacil_P7-Xijoy	2018-12-13	11044	5292	2019-02-15	SRR8307446	SRS4135264	SRP063692	DFCI.10-448.P22_base_PAX_1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	DFCI.10-448.P22_base_PAX_1		Exome	H7J3HADXX, H7J0PADXX, H7J33ADXX, H7J0TADXX, H7J1HADXX, H7J0RADXX, H7HW1ADXX, H7GKUADXX, H7J0VADXX, H7HWGADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HDH, SL-HDD, SL-HDE	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115314	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075861	BI	DS-CA-MDS	sra	SRX5121949	172	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656523_Illumina_P5-Xazen_P7-Xoren	2018-12-13	9690	4604	2019-02-15	SRR8307447	SRS4135265	SRP063692	6115396-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	6115396-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115396	PDO-5957	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075695	BI	DS-CA-MDS	sra	SRX5121950	171	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656474_Illumina_P5-Zitey_P7-Fapix	2018-12-13	8121	3902	2019-02-15	SRR8307448	SRS4135266	SRP063692	6115392-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	6115392-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115392	PDO-5957	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075999	BI	DS-CA-MDS	sra	SRX5121951	151	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0180656524_Illumina_P5-Zaped_P7-Dizax	2018-12-13	9048	4288	2019-02-15	SRR8307449	SRS4135267	SRP063692	6115397-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	6115397-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115397	PDO-5957	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076021	BI	DS-CA-MDS	sra	SRX5121952	173	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656520_Illumina_P5-Poded_P7-Rojan	2018-12-13	8853	4170	2019-02-15	SRR8307450	SRS4135268	SRP063692	6115393-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	6115393-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115393	PDO-5957	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076034	BI	DS-CA-MDS	sra	SRX5121953	188	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656526_Illumina_P5-Nerow_P7-Jacaz	2018-12-13	11462	5373	2019-02-15	SRR8307451	SRS4135269	SRP063692	6115399-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	6115399-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115399	PDO-5957	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075725	BI	DS-CA-MDS	sra	SRX5121954	199	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656535_Illumina_P5-Bocef_P7-Diwar	2018-12-13	10498	4868	2019-02-15	SRR8307452	SRS4135270	SRP063692	6115389-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	6115389-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115389	PDO-5957	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075987	BI	DS-CA-MDS	sra	SRX5121955	166	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	0180656528_Illumina_P5-Xarez_P7-Fojol	2018-12-13	9586	4507	2019-02-15	SRR8307453	SRS4135271	SRP063692	6115401-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	6115401-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115401	PDO-5957	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075792	BI	DS-PC-MDS	sra	SRX5121958	170	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148910000_Illumina_P5-Depob_P7-Binot	2018-12-13	13341	6212	2019-02-15	SRR8307456	SRS4135274	SRP063692	DFCI.10-448.P30_base_PAX_1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	DFCI.10-448.P30_base_PAX_1		Exome	H7J3HADXX, H7J0PADXX, H7J33ADXX, H7J0TADXX, H7J1HADXX, H7J0RADXX, H7HW1ADXX, H7GKUADXX, H7J0VADXX, H7HWGADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HDH, SL-HDD, SL-HDE	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115313	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075736	BI	DS-PC-MDS	sra	SRX5121959	180	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911989_Illumina_P5-Faxen_P7-Zibod	2018-12-13	12068	5291	2019-02-15	SRR8307457	SRS4135275	SRP063692	DFCI.10-448.P42_base_pull	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	DFCI.10-448.P42_base_pull		Exome	H7J3HADXX, H7J0PADXX, H7J33ADXX, H7J0TADXX, H7J1HADXX, H7J0RADXX, H7HW1ADXX, H7GKUADXX, H7J0VADXX, H7HWGADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HDH, SL-HDD, SL-HDE	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115312	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075851	BI	DS-PC-MDS	sra	SRX5122000	177	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911953_Illumina_P5-Jaxah_P7-Nehin	2018-12-13	12133	5230	2019-02-15	SRR8307498	SRS4135316	SRP063692	DFCI.10-448.P38_base_OCT_D	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	DFCI.10-448.P38_base_OCT_D		Exome	H7J3HADXX, H7J0PADXX, H7J33ADXX, H7J0TADXX, H7J1HADXX, H7J0RADXX, H7HW1ADXX, H7GKUADXX, H7J0VADXX, H7HWGADXX	phs000915		SL-HDF, SL-HDJ, SL-HDG, SL-HDH, SL-HDD, SL-HDE	Yes	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	1115311	PDO-3556	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076067	BI	DS-CA-MDS	sra	SRX5122001	180	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656521_Illumina_P5-Wihoy_P7-Hopow	2018-12-13	7198	3321	2019-02-15	SRR8307499	SRS4135317	SRP063692	6115394-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	6115394-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115394	PDO-5957	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076127	BI	DS-CA-MDS	sra	SRX5122002	168	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0164095130_tagged_38	2018-12-13	14396	6865	2019-02-15	SRR8307500	SRS4135318	SRP063692	06115317-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115317-B-1		Exome	HABDCADXX, HAAFBADXX, HABJ1ADXX, HABHVADXX, HAAL2ADXX, HA5U2ADXX, HAB16ADXX	phs000915		SL-HDF, SL-HDH, SL-HDG, SL-HDD	No	HybridSelection		HABJ1ADXX140917, HAAFBADXX140917, HABHVADXX140917, HABDCADXX140917, HAAL2ADXX140917, HAB16ADXX140917, HA5U2ADXX140917	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115317	PDO-4605	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075840	BI	DS-CA-MDS	sra	SRX5122003	178	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148912023_tagged_293	2018-12-13	17603	9046	2019-02-15	SRR8307501	SRS4135319	SRP063692	06115319-T-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115319-T-B-1		Exome	HAB5JADXX, HAB3KADXX, HAB62ADXX, HAB5LADXX	phs000915		SL-HDB, SL-HDC	Yes	HybridSelection		HAB5JADXX140917, HAB3KADXX140917, HAB62ADXX140917, HAB5LADXX140917	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115319	PDO-4605	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075874	BI	DS-CA-MDS	sra	SRX5122004	172	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0148911998_tagged_927	2018-12-14	16577	8521	2019-02-15	SRR8307502	SRS4135321	SRP063692	06115320-T-C-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115320-T-C-1		Exome	HAB5LADXX, HAB3KADXX, HAB62ADXX, HAB5JADXX	phs000915		SL-HDB, SL-HDC	Yes	HybridSelection		HAB5LADXX140917, HAB3KADXX140917, HAB62ADXX140917, HAB5JADXX140917	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115320	PDO-4605	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075933	BI	DS-CA-MDS	sra	SRX5122005	184	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0154844266_tagged_223	2018-12-13	9381	4622	2019-02-15	SRR8307503	SRS4135320	SRP063692	06115321-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115321-B-1		Exome	HABDCADXX, HAAFBADXX, HABJ1ADXX, HABHVADXX, HAAL2ADXX, HA5U2ADXX, HAB16ADXX	phs000915		SL-HDF, SL-HDG, SL-HDH, SL-HDD	No	HybridSelection		HABJ1ADXX140917, HAAFBADXX140917, HABHVADXX140917, HABDCADXX140917, HAAL2ADXX140917, HAB16ADXX140917, HA5U2ADXX140917	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115321	PDO-4605	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075958	BI	DS-CA-MDS	sra	SRX5122006	182	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0173433060_tagged_938	2018-12-13	10560	5204	2019-02-15	SRR8307504	SRS4135323	SRP063692	06115320-B-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115320-B-1		Exome	HABDCADXX, HAAFBADXX, HABJ1ADXX, HABHVADXX, HAAL2ADXX, HA5U2ADXX, HAB16ADXX	phs000915		SL-HDD, SL-HDH, SL-HDG, SL-HDF	No	HybridSelection		HABJ1ADXX140917, HAAFBADXX140917, HABHVADXX140917, HABDCADXX140917, HAAL2ADXX140917, HAB16ADXX140917, HA5U2ADXX140917	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115320	PDO-4605	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09076174	BI	DS-CA-MDS	sra	SRX5122007	178	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0164095115_tagged_373	2018-12-13	15452	7952	2019-02-15	SRR8307505	SRS4135322	SRP063692	06115317-T-C-1	DNA	whole_exome_agilent_1.1_refseq_plus_3_boosters	NCI_ProstateCancer_MetastaticCastrationResistant	06115317-T-C-1		Exome	HAB5JADXX, HAB62ADXX, HAB5LADXX, HAB3KADXX	phs000915		SL-HDB, SL-HDC	Yes	HybridSelection		HAB5JADXX140917, HAB62ADXX140917, HAB5LADXX140917, HAB3KADXX140917	Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115317	PDO-4605	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	152	PRJNA283923	SAMN09075745	BI	DS-CA-MDS	sra	SRX5122008	170	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	0180656536_Illumina_P5-Hezef_P7-Carof	2018-12-13	10793	4961	2019-02-15	SRR8307506	SRS4135324	SRP063692	6115388-B-1	DNA	whole_exome_illumina_coding_v1	NCI_ProstateCancer_MetastaticCastrationResistant	6115388-B-1		Exome		phs000915		SL-HDF, SL-HDJ, SL-HDB, SL-HDG, SL-HBV, SL-HBW, SL-HDH, SL-HDD, SL-HDE, SL-HCD	No	HybridSelection			Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	6115388	PDO-5957	ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076027	NCI-PHS000915	DS-CA-MDS	sra	SRX5125036	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_10018	2018-12-14	30890	14934	2019-02-15	SRR8311580	SRS4138350	SRP063692	05115501-T-A-1_SI_10018	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115501-T-A-1_SI_10018				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115501		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076011	NCI-PHS000915	DS-CA-MDS	sra	SRX5125037	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_10019	2018-12-14	16837	8147	2019-02-15	SRR8311581	SRS4138351	SRP063692	05115501-T-A-1_SI_10019	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115501-T-A-1_SI_10019				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115501		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09076124	NCI-PHS000915	DS-CA-MDS	sra	SRX5125038	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_10142	2018-12-14	17783	8936	2019-02-15	SRR8311582	SRS4138352	SRP063692	5115409_SI_10142	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115409_SI_10142				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115409		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09076196	NCI-PHS000915	DS-CA-MDS	sra	SRX5125039	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_10143	2018-12-14	13576	6751	2019-02-15	SRR8311583	SRS4138353	SRP063692	5115410_SI_10143	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115410_SI_10143				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115410		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09076016	NCI-PHS000915	DS-CA-MDS	sra	SRX5125044	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_10153	2018-12-14	15315	7271	2019-02-15	SRR8311588	SRS4138358	SRP063692	5115409_SI_10153	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115409_SI_10153				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115409		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09076156	NCI-PHS000915	DS-CA-MDS	sra	SRX5125045	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_10154	2018-12-14	17286	8018	2019-02-15	SRR8311589	SRS4138359	SRP063692	5115410_SI_10154	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115410_SI_10154				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115410		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076221	NCI-PHS000915	DS-CA-MDS	sra	SRX5125054	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_10172	2018-12-14	24911	11831	2019-02-15	SRR8311598	SRS4138368	SRP063692	5115409SI_10172	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115409SI_10172				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115409		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076049	NCI-PHS000915	DS-CA-MDS	sra	SRX5125055	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_10173	2018-12-14	18223	8593	2019-02-15	SRR8311599	SRS4138370	SRP063692	5115409_SI_10173	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115409_SI_10173				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115409		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076187	NCI-PHS000915	DS-CA-MDS	sra	SRX5125056	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_10174	2018-12-14	23427	10753	2019-02-15	SRR8311600	SRS4138369	SRP063692	5115410_SI_10174	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115410_SI_10174				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115410		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076083	NCI-PHS000915	DS-CA-MDS	sra	SRX5125057	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_10175	2018-12-14	15387	7150	2019-02-15	SRR8311601	SRS4138371	SRP063692	5115410_SI_10175	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115410_SI_10175				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115410		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09076092	NCI-PHS000915	DS-CA-MDS	sra	SRX5125074	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_10284	2018-12-14	16117	7295	2019-02-15	SRR8311618	SRS4138388	SRP063692	5115411_SI_10284	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115411_SI_10284				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115411		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075770	NCI-PHS000915	DS-CA-MDS	sra	SRX5125075	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_10290	2018-12-14	24257	11495	2019-02-15	SRR8311619	SRS4138389	SRP063692	5115411_SI_10290	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115411_SI_10290				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115411		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075778	NCI-PHS000915	DS-CA-MDS	sra	SRX5125076	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_10291	2018-12-14	17613	8182	2019-02-15	SRR8311620	SRS4138390	SRP063692	5115411_SI_10291	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115411_SI_10291				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115411		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09075850	NCI-PHS000915	DS-CA-MDS	sra	SRX5125077	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_10311	2018-12-14	16062	7818	2019-02-15	SRR8311621	SRS4138392	SRP063692	5115547_SI_10311	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115547_SI_10311				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115547		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09075767	NCI-PHS000915	DS-CA-MDS	sra	SRX5125078	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_10331	2018-12-14	14633	6551	2019-02-15	SRR8311622	SRS4138391	SRP063692	5115547_SI_10331	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115547_SI_10331				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115547		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075843	NCI-PHS000915	DS-CA-MDS	sra	SRX5125079	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_10341	2018-12-14	28077	12871	2019-02-15	SRR8311623	SRS4138393	SRP063692	5115547SI_10341	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115547SI_10341				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115547		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076033	NCI-PHS000915	DS-CA-MDS	sra	SRX5125080	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_10342	2018-12-14	16281	7645	2019-02-15	SRR8311624	SRS4138395	SRP063692	5115547SI_10342	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115547SI_10342				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115547		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09075688	NCI-PHS000915	DS-CA-MDS	sra	SRX5125081	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_10414	2018-12-14	13513	7084	2019-02-15	SRR8311625	SRS4138394	SRP063692	5115412_SI_10414	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115412_SI_10414				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115412		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09076143	NCI-PHS000915	DS-CA-MDS	sra	SRX5125082	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_10417	2018-12-14	17710	8689	2019-02-15	SRR8311626	SRS4138396	SRP063692	5115412_SI_10417	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115412_SI_10417				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115412		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075717	NCI-PHS000915	DS-CA-MDS	sra	SRX5125083	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_10427	2018-12-14	25585	12893	2019-02-15	SRR8311627	SRS4138399	SRP063692	5115412_SI_10427	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115412_SI_10427				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115412		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076141	NCI-PHS000915	DS-CA-MDS	sra	SRX5125084	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_10428	2018-12-14	17629	8959	2019-02-15	SRR8311628	SRS4138397	SRP063692	5115412_SI_10428	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115412_SI_10428				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115412		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09075904	NCI-PHS000915	DS-CA-MDS	sra	SRX5125099	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_10611	2018-12-14	17394	9219	2019-02-15	SRR8311643	SRS4138413	SRP063692	05115505-T-C-1_SI_10611	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115505-T-C-1_SI_10611				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115505		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076132	NCI-PHS000915	DS-CA-MDS	sra	SRX5125100	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_10613	2018-12-14	26443	14415	2019-02-15	SRR8311644	SRS4138414	SRP063692	05115505-T-C-1_SI_10613	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115505-T-C-1_SI_10613				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115505		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076091	NCI-PHS000915	DS-CA-MDS	sra	SRX5125101	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_10614	2018-12-14	16960	8994	2019-02-15	SRR8311645	SRS4138415	SRP063692	05115505-T-C-1_SI_10614	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115505-T-C-1_SI_10614				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115505		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09075821	NCI-PHS000915	DS-CA-MDS	sra	SRX5125106	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_10697	2018-12-14	12531	5912	2019-02-15	SRR8311650	SRS4138420	SRP063692	5115528_SI_10697	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115528_SI_10697				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115528		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09076078	NCI-PHS000915	DS-CA-MDS	sra	SRX5125107	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_10699	2018-12-14	15730	7343	2019-02-15	SRR8311651	SRS4138421	SRP063692	5115528_SI_10699	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115528_SI_10699				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115528		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076208	NCI-PHS000915	DS-CA-MDS	sra	SRX5125108	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_10712	2018-12-14	26988	12624	2019-02-15	SRR8311652	SRS4138422	SRP063692	5115528_SI_10712	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115528_SI_10712				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115528		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075971	NCI-PHS000915	DS-CA-MDS	sra	SRX5125109	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_10713	2018-12-14	17060	7993	2019-02-15	SRR8311653	SRS4138423	SRP063692	5115528_SI_10713	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115528_SI_10713				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115528		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09075890	NCI-PHS000915	DS-CA-MDS	sra	SRX5125110	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_10724	2018-12-14	16214	8221	2019-02-15	SRR8311654	SRS4138425	SRP063692	5115506_SI_10724	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115506_SI_10724				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115506		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09075930	NCI-PHS000915	DS-CA-MDS	sra	SRX5125116	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_10732	2018-12-14	16219	7647	2019-02-15	SRR8311660	SRS4138430	SRP063692	5115506_SI_10732	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115506_SI_10732				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115506		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075893	NCI-PHS000915	DS-CA-MDS	sra	SRX5125123	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_10747	2018-12-14	26815	12666	2019-02-15	SRR8311667	SRS4138436	SRP063692	5115506_SI_10747	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115506_SI_10747				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115506		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075709	NCI-PHS000915	DS-CA-MDS	sra	SRX5125124	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_10748	2018-12-14	17963	8321	2019-02-15	SRR8311668	SRS4138438	SRP063692	5115506_SI_10748	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115506_SI_10748				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115506		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		220	PRJNA283923	SAMN09076154	NCI-PHS000915	DS-CA-MDS	sra	SRX5125145	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_11081	2018-12-14	15019	10332	2019-02-15	SRR8311689	SRS4138459	SRP063692	5115608_SI_11081	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115608_SI_11081				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115608		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		220	PRJNA283923	SAMN09075802	NCI-PHS000915	DS-CA-MDS	sra	SRX5125146	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_11085	2018-12-14	13668	9429	2019-02-15	SRR8311690	SRS4138460	SRP063692	5115608_SI_11085	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115608_SI_11085				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115608		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09076116	NCI-PHS000915	DS-CA-MDS	sra	SRX5125147	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_11088	2018-12-14	15614	7331	2019-02-15	SRR8311691	SRS4138461	SRP063692	5115548_SI_11088	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115548_SI_11088				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115548		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076150	NCI-PHS000915	DS-CA-MDS	sra	SRX5125148	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_11090	2018-12-14	25106	12035	2019-02-15	SRR8311692	SRS4138462	SRP063692	5115548_SI_11090	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115548_SI_11090				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115548		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075979	NCI-PHS000915	DS-CA-MDS	sra	SRX5125149	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_11091	2018-12-14	18417	8618	2019-02-15	SRR8311693	SRS4138463	SRP063692	5115548_SI_11091	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115548_SI_11091				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115548		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		220	PRJNA283923	SAMN09076076	NCI-PHS000915	DS-CA-MDS	sra	SRX5125150	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_11094	2018-12-14	21937	15209	2019-02-15	SRR8311694	SRS4138464	SRP063692	5115608_SI_11094	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115608_SI_11094				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115608		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		220	PRJNA283923	SAMN09075908	NCI-PHS000915	DS-CA-MDS	sra	SRX5125151	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_11095	2018-12-14	17290	11995	2019-02-15	SRR8311695	SRS4138465	SRP063692	5115608_SI_11095	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115608_SI_11095				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115608		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09075894	NCI-PHS000915	DS-CA-MDS	sra	SRX5125152	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_11315	2018-12-14	17675	8675	2019-02-15	SRR8311696	SRS4138466	SRP063692	5115609_SI_11315	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115609_SI_11315				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115609		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076217	NCI-PHS000915	DS-CA-MDS	sra	SRX5125153	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_11321	2018-12-14	27135	13431	2019-02-15	SRR8311697	SRS4138467	SRP063692	5115609_SI_11321	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115609_SI_11321				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115609		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076142	NCI-PHS000915	DS-CA-MDS	sra	SRX5125154	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_11322	2018-12-14	21128	10297	2019-02-15	SRR8311698	SRS4138468	SRP063692	5115609_SI_11322	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115609_SI_11322				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115609		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09076128	NCI-PHS000915	DS-CA-MDS	sra	SRX5125157	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_11361	2018-12-14	14579	7496	2019-02-15	SRR8311701	SRS4138471	SRP063692	5115610_SI_11361	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115610_SI_11361				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115610		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09076077	NCI-PHS000915	DS-CA-MDS	sra	SRX5125158	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_11362	2018-12-14	15433	7992	2019-02-15	SRR8311702	SRS4138472	SRP063692	5115611_SI_11362	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115611_SI_11362				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115611		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09075676	NCI-PHS000915	DS-CA-MDS	sra	SRX5125159	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_11363	2018-12-14	17873	9231	2019-02-15	SRR8311703	SRS4138473	SRP063692	5115612_SI_11363	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115612_SI_11363				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115612		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09075910	NCI-PHS000915	DS-CA-MDS	sra	SRX5125160	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_11368	2018-12-14	13572	6405	2019-02-15	SRR8311704	SRS4138474	SRP063692	5115610_SI_11368	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115610_SI_11368				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115610		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09076104	NCI-PHS000915	DS-CA-MDS	sra	SRX5125161	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_11382	2018-12-14	14456	6813	2019-02-15	SRR8311705	SRS4138475	SRP063692	5115611_SI_11382	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115611_SI_11382				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115611		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09075765	NCI-PHS000915	DS-CA-MDS	sra	SRX5125162	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_11384	2018-12-14	15164	7167	2019-02-15	SRR8311706	SRS4138476	SRP063692	5115612_SI_11384	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115612_SI_11384				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115612		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09076074	NCI-PHS000915	DS-CA-MDS	sra	SRX5125165	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_11440	2018-12-14	15064	6986	2019-02-15	SRR8311709	SRS4138479	SRP063692	5115613_SI_11440	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115613_SI_11440				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115613		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076096	NCI-PHS000915	DS-CA-MDS	sra	SRX5125170	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_11446	2018-12-14	25509	11977	2019-02-15	SRR8311714	SRS4138484	SRP063692	5115610_SI_11446	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115610_SI_11446				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115610		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076075	NCI-PHS000915	DS-CA-MDS	sra	SRX5125171	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_11447	2018-12-14	15609	7196	2019-02-15	SRR8311715	SRS4138485	SRP063692	5115610_SI_11447	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115610_SI_11447				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115610		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076105	NCI-PHS000915	DS-CA-MDS	sra	SRX5125172	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_11448	2018-12-14	23090	10957	2019-02-15	SRR8311716	SRS4138486	SRP063692	5115611_SI_11448	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115611_SI_11448				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115611		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075883	NCI-PHS000915	DS-CA-MDS	sra	SRX5125173	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_11449	2018-12-14	19535	9270	2019-02-15	SRR8311717	SRS4138487	SRP063692	5115611_SI_11449	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115611_SI_11449				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115611		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075852	NCI-PHS000915	DS-CA-MDS	sra	SRX5125174	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_11450	2018-12-14	26850	12779	2019-02-15	SRR8311718	SRS4138488	SRP063692	5115612_SI_11450	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115612_SI_11450				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115612		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076140	NCI-PHS000915	DS-CA-MDS	sra	SRX5125175	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_11451	2018-12-14	17391	8372	2019-02-15	SRR8311719	SRS4138489	SRP063692	5115612_SI_11451	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115612_SI_11451				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115612		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075855	NCI-PHS000915	DS-CA-MDS	sra	SRX5125176	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_11452	2018-12-14	24082	11321	2019-02-15	SRR8311720	SRS4138490	SRP063692	5115613_SI_11452	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115613_SI_11452				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115613		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075871	NCI-PHS000915	DS-CA-MDS	sra	SRX5125177	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_11453	2018-12-14	17430	8206	2019-02-15	SRR8311721	SRS4138491	SRP063692	5115613_SI_11453	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115613_SI_11453				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115613		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09076089	NCI-PHS000915	DS-CA-MDS	sra	SRX5125199	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_11763	2018-12-14	11583	5932	2019-02-15	SRR8311743	SRS4138513	SRP063692	5115614_SI_11763	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115614_SI_11763				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115614		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09076098	NCI-PHS000915	DS-CA-MDS	sra	SRX5125200	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_11775	2018-12-14	17075	8296	2019-02-15	SRR8311744	SRS4138514	SRP063692	5115614_SI_11775	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115614_SI_11775				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115614		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075783	NCI-PHS000915	DS-CA-MDS	sra	SRX5125201	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_11789	2018-12-14	27689	13847	2019-02-15	SRR8311745	SRS4138515	SRP063692	5115614_SI_11789	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115614_SI_11789				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115614		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076045	NCI-PHS000915	DS-CA-MDS	sra	SRX5125202	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_11790	2018-12-14	20633	10181	2019-02-15	SRR8311746	SRS4138516	SRP063692	5115614_SI_11790	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115614_SI_11790				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115614		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		220	PRJNA283923	SAMN09075943	NCI-PHS000915	DS-CA-MDS	sra	SRX5125203	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_12052	2018-12-14	12356	8785	2019-02-15	SRR8311747	SRS4138517	SRP063692	5115615_SI_12052	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115615_SI_12052				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115615		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09076136	NCI-PHS000915	DS-CA-MDS	sra	SRX5125204	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_12054	2018-12-14	12099	6315	2019-02-15	SRR8311748	SRS4138518	SRP063692	5115648_SI_12054	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115648_SI_12054				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115648		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075901	NCI-PHS000915	DS-CA-MDS	sra	SRX5125205	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_12071	2018-12-14	26371	13346	2019-02-15	SRR8311749	SRS4138519	SRP063692	5115615_SI_12071	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115615_SI_12071				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115615		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075795	NCI-PHS000915	DS-CA-MDS	sra	SRX5125206	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_12072	2018-12-14	22733	11380	2019-02-15	SRR8311750	SRS4138520	SRP063692	5115615_SI_12072	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115615_SI_12072				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115615		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076180	NCI-PHS000915	DS-CA-MDS	sra	SRX5125207	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_12073	2018-12-14	29408	15300	2019-02-15	SRR8311751	SRS4138521	SRP063692	5115648_SI_12073	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115648_SI_12073				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115648		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075670	NCI-PHS000915	DS-CA-MDS	sra	SRX5125208	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_12074	2018-12-14	23341	12115	2019-02-15	SRR8311752	SRS4138522	SRP063692	5115648_SI_12074	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115648_SI_12074				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115648		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09075997	NCI-PHS000915	DS-CA-MDS	sra	SRX5125246	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_12340	2018-12-14	12916	6899	2019-02-15	SRR8311790	SRS4138560	SRP063692	5115650_SI_12340	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115650_SI_12340				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115650		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075704	NCI-PHS000915	DS-CA-MDS	sra	SRX5125247	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_12367	2018-12-14	34874	18413	2019-02-15	SRR8311791	SRS4138561	SRP063692	5115650_SI_12367	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115650_SI_12367				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115650		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09076224	NCI-PHS000915	DS-CA-MDS	sra	SRX5125248	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_12368	2018-12-14	20364	10776	2019-02-15	SRR8311792	SRS4138562	SRP063692	5115650_SI_12368	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115650_SI_12368				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115650		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09076155	NCI-PHS000915	DS-CA-MDS	sra	SRX5125249	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_12472	2018-12-14	14075	7058	2019-02-15	SRR8311793	SRS4138563	SRP063692	5115651_SI_12472	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115651_SI_12472				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115651		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		250	PRJNA283923	SAMN09076053	NCI-PHS000915	DS-CA-MDS	sra	SRX5125250	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_12473	2018-12-14	12211	6320	2019-02-15	SRR8311794	SRS4138564	SRP063692	5115651_SI_12473	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115651_SI_12473				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115651		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075742	NCI-PHS000915	DS-CA-MDS	sra	SRX5125251	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_12494	2018-12-14	33594	17592	2019-02-15	SRR8311795	SRS4138565	SRP063692	5115651_SI_12494	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115651_SI_12494				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115651		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		250	PRJNA283923	SAMN09075990	NCI-PHS000915	DS-CA-MDS	sra	SRX5125252	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_12495	2018-12-14	18628	9626	2019-02-15	SRR8311796	SRS4138566	SRP063692	5115651_SI_12495	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	5115651_SI_12495				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	5115651		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997335	NCI-PHS000915	DS-CA-MDS	sra	SRX5125281	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_4439	2018-12-14	21529	14588	2018-12-14	SRR8311825	SRS1187235	SRP063692	06115012-T-B-4_SI_4439	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	06115012-T-B-4_SI_4439				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	06115012		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997398	NCI-PHS000915	DS-CA-MDS	sra	SRX5125282	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_4440	2018-12-14	13986	9513	2018-12-14	SRR8311826	SRS1187234	SRP063692	06115012-W-1_SI_4440	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	06115012-W-1_SI_4440				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	06115012		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997456	NCI-PHS000915	DS-CA-MDS	sra	SRX5125283	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_4538	2018-12-14	11459	7316	2018-12-14	SRR8311827	SRS1187231	SRP063692	06115013-T-C-2_SI_4538	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	06115013-T-C-2_SI_4538				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	06115013		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997486	NCI-PHS000915	DS-CA-MDS	sra	SRX5125284	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_4539	2018-12-14	10646	6781	2018-12-14	SRR8311828	SRS1187229	SRP063692	06115014-T-C-1_SI_4539	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	06115014-T-C-1_SI_4539				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	06115014		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997355	NCI-PHS000915	DS-CA-MDS	sra	SRX5125285	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_4552	2018-12-14	13429	8727	2018-12-14	SRR8311829	SRS1187232	SRP063692	06115013_SI_4552	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	06115013_SI_4552				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	06115013		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997442	NCI-PHS000915	DS-CA-MDS	sra	SRX5125286	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_4553	2018-12-14	22463	14438	2018-12-14	SRR8311830	SRS1187230	SRP063692	06115013-T-C-3_SI_4553	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	06115013-T-C-3_SI_4553				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	06115013		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997497	NCI-PHS000915	DS-CA-MDS	sra	SRX5125287	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_4554	2018-12-14	20911	13715	2018-12-14	SRR8311831	SRS1187227	SRP063692	06115014-W-1_SI_4554	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	06115014-W-1_SI_4554				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	06115014		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997391	NCI-PHS000915	DS-CA-MDS	sra	SRX5125288	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_4555	2018-12-14	18819	12302	2018-12-14	SRR8311832	SRS1187228	SRP063692	06115014-T-C-2_SI_4555	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	06115014-T-C-2_SI_4555				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	06115014		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997363	NCI-PHS000915	DS-CA-MDS	sra	SRX5125289	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_4602	2018-12-14	14155	9182	2018-12-14	SRR8311833	SRS1187411	SRP063692	05115023-W-1_SI_4602	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115023-W-1_SI_4602				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115023		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997466	NCI-PHS000915	DS-CA-MDS	sra	SRX5125290	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_4603	2018-12-14	24154	15536	2018-12-14	SRR8311834	SRS1187413	SRP063692	05115023-T-A-1_SI_4603	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115023-T-A-1_SI_4603				phs000915			Yes		SNV (.MAF)		Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115023		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997365	NCI-PHS000915	DS-CA-MDS	sra	SRX5125291	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_4733	2018-12-14	10524	7105	2018-12-14	SRR8311835	SRS1187412	SRP063692	05115023-T-A-2_SI_4733	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115023-T-A-2_SI_4733				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115023		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA283923	SAMN03997366	NCI-PHS000915	DS-CA-MDS	sra	SRX5125292	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	TRANSCRIPTOMIC	SI_4737	2018-12-14	12180	8149	2018-12-14	SRR8311836	SRS1187416	SRP063692	05115024-T-A-1_SI_4737	RNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115024-T-A-1_SI_4737				phs000915			Yes				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115024		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		202	PRJNA283923	SAMN03997328	NCI-PHS000915	DS-CA-MDS	sra	SRX5125293	0	Illumina HiSeq 2500	PAIRED	Hybrid Selection	GENOMIC	SI_4741	2018-12-14	15456	10313	2018-12-14	SRR8311837	SRS1187410	SRP063692	05115024-W-1_SI_4741	DNA		NCI_ProstateCancer_MetastaticCastrationResistant	05115024-W-1_SI_4741				phs000915			No				Case Set	Prostatic Neoplasms	Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability	05115024		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292659	NCI-PHS001141	GRU	sra	SRX2034686	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S74_RNA_V1N	2016-10-20	31388	21938	2017-02-21	SRR4043781	SRS1628640	SRP082386	S74_RNA_V1N	RNA		NCI_PROMOTE	S74_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	74		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292660	NCI-PHS001141	GRU	sra	SRX2034687	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S56_DNA_V1B	2016-08-29	33114	14698	2017-02-21	SRR4043782	SRS1628639	SRP082386	S56_DNA_V1B	DNA		NCI_PROMOTE	S56_DNA_V1B	Blood			phs001141	56		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	56		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292661	NCI-PHS001141	GRU	sra	SRX2034688	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S31_RNA_V1N	2016-10-20	12756	7427	2017-02-21	SRR4043783	SRS1628642	SRP082386	S31_RNA_V1N	RNA		NCI_PROMOTE	S31_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	31		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292662	NCI-PHS001141	GRU	sra	SRX2034689	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S63_DNA_V1B	2016-08-30	28060	12933	2017-02-21	SRR4043784	SRS1628641	SRP082386	S63_DNA_V1B	DNA		NCI_PROMOTE	S63_DNA_V1B	Blood			phs001141	63		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	63		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292663	NCI-PHS001141	GRU	sra	SRX2034690	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S59_RNA_V1N	2016-10-20	19196	12923	2017-02-21	SRR4043785	SRS1628644	SRP082386	S59_RNA_V1N	RNA		NCI_PROMOTE	S59_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	59		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292664	NCI-PHS001141	GRU	sra	SRX2034691	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S58_RNA_V1T	2016-10-20	16517	10944	2017-02-21	SRR4043786	SRS1628645	SRP082386	S58_RNA_V1T	RNA		NCI_PROMOTE	S58_RNA_V1T	Soft Tissue			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	58		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292665	NCI-PHS001141	GRU	sra	SRX2034692	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S43_DNA_V1B	2016-08-29	33725	14247	2017-02-21	SRR4043787	SRS1628643	SRP082386	S43_DNA_V1B	DNA		NCI_PROMOTE	S43_DNA_V1B	Blood			phs001141	43		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	43		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292666	NCI-PHS001141	GRU	sra	SRX2034693	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S84_DNA_V1B	2016-09-01	26201	10246	2017-02-21	SRR4043788	SRS1628646	SRP082386	S84_DNA_V1B	DNA		NCI_PROMOTE	S84_DNA_V1B	Blood			phs001141	84		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	84		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292667	NCI-PHS001141	GRU	sra	SRX2034694	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S73_DNA_V1B	2016-08-30	28460	13116	2017-02-21	SRR4043789	SRS1628647	SRP082386	S73_DNA_V1B	DNA		NCI_PROMOTE	S73_DNA_V1B	Blood			phs001141	73		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	73		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292668	NCI-PHS001141	GRU	sra	SRX2034695	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S26_DNA_V1B	2016-08-27	28174	10796	2017-02-21	SRR4043790	SRS1628649	SRP082386	S26_DNA_V1B	DNA		NCI_PROMOTE	S26_DNA_V1B	Blood			phs001141	26		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	26		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292669	NCI-PHS001141	GRU	sra	SRX2034696	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S88_DNA_V1N	2016-09-01	38799	13888	2017-02-21	SRR4043791	SRS1628648	SRP082386	S88_DNA_V1N	DNA		NCI_PROMOTE	S88_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	88		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292670	NCI-PHS001141	GRU	sra	SRX2034697	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S62_DNA_V1B	2016-08-30	29454	11809	2017-02-21	SRR4043792	SRS1628650	SRP082386	S62_DNA_V1B	DNA		NCI_PROMOTE	S62_DNA_V1B	Blood			phs001141	62		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	62		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292671	NCI-PHS001141	GRU	sra	SRX2034698	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S46_DNA_V1T	2016-08-28	30977	14546	2017-02-21	SRR4043793	SRS1628653	SRP082386	S46_DNA_V1T	DNA		NCI_PROMOTE	S46_DNA_V1T	Prostate Bed			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	46		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292672	NCI-PHS001141	GRU	sra	SRX2034699	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S22_DNA_V1B	2016-08-27	22527	7806	2017-02-21	SRR4043794	SRS1628651	SRP082386	S22_DNA_V1B	DNA		NCI_PROMOTE	S22_DNA_V1B	Blood			phs001141	22		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	22		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292673	NCI-PHS001141	GRU	sra	SRX2034700	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S51_DNA_V1T	2016-08-29	34854	15327	2017-02-21	SRR4043795	SRS1628652	SRP082386	S51_DNA_V1T	DNA		NCI_PROMOTE	S51_DNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	51		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292674	NCI-PHS001141	GRU	sra	SRX2034701	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S12_DNA_V1B	2016-08-26	32316	13917	2017-02-21	SRR4043796	SRS1628654	SRP082386	S12_DNA_V1B	DNA		NCI_PROMOTE	S12_DNA_V1B	Blood			phs001141	12		No				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	12		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292675	NCI-PHS001141	GRU	sra	SRX2034702	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S14_RNA_V1T	2016-10-20	16804	11463	2017-02-21	SRR4043797	SRS1628655	SRP082386	S14_RNA_V1T	RNA		NCI_PROMOTE	S14_RNA_V1T	Soft Tissue			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	14		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292676	NCI-PHS001141	GRU	sra	SRX2034703	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S80_DNA_V1B	2016-08-31	25274	10380	2017-02-21	SRR4043798	SRS1628656	SRP082386	S80_DNA_V1B	DNA		NCI_PROMOTE	S80_DNA_V1B	Blood			phs001141	80		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	80		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292677	NCI-PHS001141	GRU	sra	SRX2034704	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S75_DNA_V1T	2016-08-31	31051	12255	2017-02-21	SRR4043799	SRS1628657	SRP082386	S75_DNA_V1T	DNA		NCI_PROMOTE	S75_DNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	75		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292678	NCI-PHS001141	GRU	sra	SRX2034705	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S72_DNA_V1N	2016-08-30	30754	12150	2017-02-21	SRR4043800	SRS1628660	SRP082386	S72_DNA_V1N	DNA		NCI_PROMOTE	S72_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	72		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292679	NCI-PHS001141	GRU	sra	SRX2034706	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S5_DNA_V1B	2016-08-29	31045	12461	2017-02-21	SRR4043801	SRS1628661	SRP082386	S5_DNA_V1B	DNA		NCI_PROMOTE	S5_DNA_V1B	Blood			phs001141	5		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	5		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292680	NCI-PHS001141	GRU	sra	SRX2034707	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S69_RNA_V1N	2016-10-20	16980	10169	2017-02-21	SRR4043802	SRS1628658	SRP082386	S69_RNA_V1N	RNA		NCI_PROMOTE	S69_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	69		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292681	NCI-PHS001141	GRU	sra	SRX2034708	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S43_RNA_V1T	2016-10-20	15097	9339	2017-02-21	SRR4043803	SRS1628659	SRP082386	S43_RNA_V1T	RNA		NCI_PROMOTE	S43_RNA_V1T	liver			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	43		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292682	NCI-PHS001141	GRU	sra	SRX2034709	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S39_RNA_V1N	2016-10-20	13971	8773	2017-02-21	SRR4043804	SRS1628664	SRP082386	S39_RNA_V1N	RNA		NCI_PROMOTE	S39_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	39		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292683	NCI-PHS001141	GRU	sra	SRX2034710	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S33_DNA_V1B	2016-08-28	24026	8551	2017-02-21	SRR4043805	SRS1628665	SRP082386	S33_DNA_V1B	DNA		NCI_PROMOTE	S33_DNA_V1B	Blood			phs001141	33		No				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	33		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292684	NCI-PHS001141	GRU	sra	SRX2034711	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S9_DNA_V1N	2016-09-01	29944	12145	2017-02-21	SRR4043806	SRS1628663	SRP082386	S9_DNA_V1N	DNA		NCI_PROMOTE	S9_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	9		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292685	NCI-PHS001141	GRU	sra	SRX2034712	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S68_RNA_V1N	2016-10-20	14785	8912	2017-02-21	SRR4043807	SRS1628662	SRP082386	S68_RNA_V1N	RNA		NCI_PROMOTE	S68_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	68		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292686	NCI-PHS001141	GRU	sra	SRX2034713	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S55_DNA_V1B	2016-08-29	29710	11824	2017-02-21	SRR4043808	SRS1628667	SRP082386	S55_DNA_V1B	DNA		NCI_PROMOTE	S55_DNA_V1B	Blood			phs001141	55		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	55		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292687	NCI-PHS001141	GRU	sra	SRX2034714	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S34_DNA_V1T	2016-08-28	27882	11024	2017-02-21	SRR4043809	SRS1628666	SRP082386	S34_DNA_V1T	DNA		NCI_PROMOTE	S34_DNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	34		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292688	NCI-PHS001141	GRU	sra	SRX2034715	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S35_DNA_V1T	2016-08-28	27875	11316	2017-02-21	SRR4043810	SRS1628669	SRP082386	S35_DNA_V1T	DNA		NCI_PROMOTE	S35_DNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	35		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292689	NCI-PHS001141	GRU	sra	SRX2034716	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S26_DNA_V1T	2016-08-27	22525	7593	2017-02-21	SRR4043811	SRS1628668	SRP082386	S26_DNA_V1T	DNA		NCI_PROMOTE	S26_DNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	26		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292690	NCI-PHS001141	GRU	sra	SRX2034717	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S54_RNA_V1N	2016-10-20	16014	10627	2017-02-21	SRR4043812	SRS1628670	SRP082386	S54_RNA_V1N	RNA		NCI_PROMOTE	S54_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	54		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292691	NCI-PHS001141	GRU	sra	SRX2034718	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S7_RNA_V1N	2016-10-20	17704	11028	2017-02-21	SRR4043813	SRS1628673	SRP082386	S7_RNA_V1N	RNA		NCI_PROMOTE	S7_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	7		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292692	NCI-PHS001141	GRU	sra	SRX2034719	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S20_DNA_V1T	2016-08-28	32079	13386	2017-02-21	SRR4043814	SRS1628672	SRP082386	S20_DNA_V1T	DNA		NCI_PROMOTE	S20_DNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	20		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292693	NCI-PHS001141	GRU	sra	SRX2034720	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S6_DNA_V1B	2016-08-30	38524	12918	2017-02-21	SRR4043815	SRS1628671	SRP082386	S6_DNA_V1B	DNA		NCI_PROMOTE	S6_DNA_V1B	Blood			phs001141	6		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	6		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292694	NCI-PHS001141	GRU	sra	SRX2034721	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S46_RNA_V1T	2016-10-20	18236	11648	2017-02-21	SRR4043816	SRS1628675	SRP082386	S46_RNA_V1T	RNA		NCI_PROMOTE	S46_RNA_V1T	Prostate Bed			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	46		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292695	NCI-PHS001141	GRU	sra	SRX2034722	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S10_DNA_V1B	2016-08-25	26854	11829	2017-02-21	SRR4043817	SRS1628674	SRP082386	S10_DNA_V1B	DNA		NCI_PROMOTE	S10_DNA_V1B	Blood			phs001141	10		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	10		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292696	NCI-PHS001141	GRU	sra	SRX2034723	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S53_DNA_V1B	2016-08-29	31324	13771	2017-02-21	SRR4043818	SRS1628676	SRP082386	S53_DNA_V1B	DNA		NCI_PROMOTE	S53_DNA_V1B	Blood			phs001141	53		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	53		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292697	NCI-PHS001141	GRU	sra	SRX2034724	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S41_DNA_V1B	2016-08-28	31226	12445	2017-02-21	SRR4043819	SRS1628677	SRP082386	S41_DNA_V1B	DNA		NCI_PROMOTE	S41_DNA_V1B	Blood			phs001141	41		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	41		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292698	NCI-PHS001141	GRU	sra	SRX2034725	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S41_DNA_V1N	2016-08-28	27786	12297	2017-02-21	SRR4043820	SRS1628680	SRP082386	S41_DNA_V1N	DNA		NCI_PROMOTE	S41_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	41		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292699	NCI-PHS001141	GRU	contigs sra	SRX2034726	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S18_RNA_V1N	2016-10-20	6597	3447	2017-02-21	SRR4043821	SRS1628678	SRP082386	S18_RNA_V1N	RNA		NCI_PROMOTE	S18_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	18		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292700	NCI-PHS001141	GRU	sra	SRX2034727	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S62_DNA_V1N	2016-08-30	31552	13098	2017-02-21	SRR4043822	SRS1628679	SRP082386	S62_DNA_V1N	DNA		NCI_PROMOTE	S62_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	62		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292701	NCI-PHS001141	GRU	sra	SRX2034728	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S38_DNA_V1B	2016-08-28	22636	7915	2017-02-21	SRR4043823	SRS1628681	SRP082386	S38_DNA_V1B	DNA		NCI_PROMOTE	S38_DNA_V1B	Blood			phs001141	38		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	38		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292702	NCI-PHS001141	GRU	sra	SRX2034729	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S32_DNA_V1B	2016-08-28	28390	11180	2017-02-21	SRR4043824	SRS1628683	SRP082386	S32_DNA_V1B	DNA		NCI_PROMOTE	S32_DNA_V1B	Blood			phs001141	32		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	32		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292703	NCI-PHS001141	GRU	sra	SRX2034730	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S68_DNA_V1N	2016-08-30	17805	6296	2017-02-21	SRR4043825	SRS1628682	SRP082386	S68_DNA_V1N	DNA		NCI_PROMOTE	S68_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	68		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292704	NCI-PHS001141	GRU	sra	SRX2034731	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S63_DNA_V1T	2016-08-30	31945	13894	2017-02-21	SRR4043826	SRS1628684	SRP082386	S63_DNA_V1T	DNA		NCI_PROMOTE	S63_DNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	63		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292705	NCI-PHS001141	GRU	sra	SRX2034732	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S10_RNA_V1N	2016-10-20	15718	8959	2017-02-21	SRR4043827	SRS1628685	SRP082386	S10_RNA_V1N	RNA		NCI_PROMOTE	S10_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	10		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292706	NCI-PHS001141	GRU	sra	SRX2034733	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S37_DNA_V1B	2016-08-29	31899	14954	2017-02-21	SRR4043828	SRS1628687	SRP082386	S37_DNA_V1B	DNA		NCI_PROMOTE	S37_DNA_V1B	Blood			phs001141	37		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	37		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292707	NCI-PHS001141	GRU	sra	SRX2034734	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S15_DNA_V1B	2016-08-27	26317	9688	2017-02-21	SRR4043829	SRS1628686	SRP082386	S15_DNA_V1B	DNA		NCI_PROMOTE	S15_DNA_V1B	Blood			phs001141	15		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	15		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292708	NCI-PHS001141	GRU	sra	SRX2034735	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S83_DNA_V1T	2016-09-01	41275	15215	2017-02-21	SRR4043830	SRS1628688	SRP082386	S83_DNA_V1T	DNA		NCI_PROMOTE	S83_DNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	83		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292709	NCI-PHS001141	GRU	sra	SRX2034736	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S78_RNA_V1N	2016-10-31	44420	31265	2017-02-21	SRR4043831	SRS1628689	SRP082386	S78_RNA_V1N	RNA		NCI_PROMOTE	S78_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	78		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292710	NCI-PHS001141	GRU	sra	SRX2034737	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S59_DNA_V1N	2016-08-29	25218	10662	2017-02-21	SRR4043832	SRS1628692	SRP082386	S59_DNA_V1N	DNA		NCI_PROMOTE	S59_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	59		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292711	NCI-PHS001141	GRU	sra	SRX2034738	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S57_DNA_V1N	2016-08-29	31704	12973	2017-02-21	SRR4043833	SRS1628690	SRP082386	S57_DNA_V1N	DNA		NCI_PROMOTE	S57_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	57		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292712	NCI-PHS001141	GRU	sra	SRX2034739	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S21_DNA_V1B	2016-08-27	30649	12079	2017-02-21	SRR4043834	SRS1628691	SRP082386	S21_DNA_V1B	DNA		NCI_PROMOTE	S21_DNA_V1B	Blood			phs001141	21		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	21		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292713	NCI-PHS001141	GRU	sra	SRX2034740	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S20_RNA_V1T	2016-10-20	19150	12532	2017-02-21	SRR4043835	SRS1628693	SRP082386	S20_RNA_V1T	RNA		NCI_PROMOTE	S20_RNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	20		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292714	NCI-PHS001141	GRU	sra	SRX2034741	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S56_RNA_V1T	2016-10-20	16237	10950	2017-02-21	SRR4043836	SRS1628694	SRP082386	S56_RNA_V1T	RNA		NCI_PROMOTE	S56_RNA_V1T	liver			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	56		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292715	NCI-PHS001141	GRU	sra	SRX2034742	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S43_DNA_V1T	2016-08-28	31428	12850	2017-02-21	SRR4043837	SRS1628696	SRP082386	S43_DNA_V1T	DNA		NCI_PROMOTE	S43_DNA_V1T	liver			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	43		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292716	NCI-PHS001141	GRU	sra	SRX2034743	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S39_DNA_V1B	2016-08-28	28253	10953	2017-02-21	SRR4043838	SRS1628695	SRP082386	S39_DNA_V1B	DNA		NCI_PROMOTE	S39_DNA_V1B	Blood			phs001141	39		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	39		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292717	NCI-PHS001141	GRU	sra	SRX2034744	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S1_RNA_V1N	2016-10-20	18460	11371	2017-02-21	SRR4043839	SRS1628697	SRP082386	S1_RNA_V1N	RNA		NCI_PROMOTE	S1_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	1		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292718	NCI-PHS001141	GRU	sra	SRX2034745	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S7_DNA_V1N	2016-08-31	31922	14127	2017-02-21	SRR4043840	SRS1628698	SRP082386	S7_DNA_V1N	DNA		NCI_PROMOTE	S7_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	7		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292719	NCI-PHS001141	GRU	sra	SRX2034746	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S72_RNA_V1N	2016-10-20	15826	10305	2017-02-21	SRR4043841	SRS1628699	SRP082386	S72_RNA_V1N	RNA		NCI_PROMOTE	S72_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	72		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292720	NCI-PHS001141	GRU	sra	SRX2034747	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S52_RNA_V1N	2016-10-20	11042	6975	2017-02-21	SRR4043842	SRS1628700	SRP082386	S52_RNA_V1N	RNA		NCI_PROMOTE	S52_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	52		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292721	NCI-PHS001141	GRU	sra	SRX2034748	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S5_RNA_V1T	2016-10-20	14628	9291	2017-02-21	SRR4043843	SRS1628701	SRP082386	S5_RNA_V1T	RNA		NCI_PROMOTE	S5_RNA_V1T	Soft Tissue			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	5		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292722	NCI-PHS001141	GRU	sra	SRX2034749	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S24_DNA_V1B	2016-08-27	31070	12432	2017-02-21	SRR4043844	SRS1628702	SRP082386	S24_DNA_V1B	DNA		NCI_PROMOTE	S24_DNA_V1B	Blood			phs001141	24		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	24		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292723	NCI-PHS001141	GRU	sra	SRX2034750	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S80_DNA_V1T	2016-08-31	21425	8501	2017-02-21	SRR4043845	SRS1628703	SRP082386	S80_DNA_V1T	DNA		NCI_PROMOTE	S80_DNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	80		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292724	NCI-PHS001141	GRU	sra	SRX2034751	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S27_DNA_V1B	2016-08-29	33283	13381	2017-02-21	SRR4043846	SRS1628704	SRP082386	S27_DNA_V1B	DNA		NCI_PROMOTE	S27_DNA_V1B	Blood			phs001141	27		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	27		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292725	NCI-PHS001141	GRU	sra	SRX2034752	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S35_DNA_V1B	2016-08-28	24273	8791	2017-02-21	SRR4043847	SRS1628705	SRP082386	S35_DNA_V1B	DNA		NCI_PROMOTE	S35_DNA_V1B	Blood			phs001141	35		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	35		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292726	NCI-PHS001141	GRU	sra	SRX2034753	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S66_DNA_V1T	2016-08-30	28042	12490	2017-02-21	SRR4043848	SRS1628706	SRP082386	S66_DNA_V1T	DNA		NCI_PROMOTE	S66_DNA_V1T	lung			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	66		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292727	NCI-PHS001141	GRU	contigs sra	SRX2034754	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S73_RNA_V1N	2016-10-20	3601	2045	2017-02-21	SRR4043849	SRS1628707	SRP082386	S73_RNA_V1N	RNA		NCI_PROMOTE	S73_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	73		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292728	NCI-PHS001141	GRU	sra	SRX2034755	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S3_RNA_V1N	2016-10-20	15448	9770	2017-02-21	SRR4043850	SRS1628708	SRP082386	S3_RNA_V1N	RNA		NCI_PROMOTE	S3_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	3		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292729	NCI-PHS001141	GRU	sra	SRX2034756	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S26_RNA_V1T	2016-10-20	15746	8706	2017-02-21	SRR4043851	SRS1628709	SRP082386	S26_RNA_V1T	RNA		NCI_PROMOTE	S26_RNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	26		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292730	NCI-PHS001141	GRU	sra	SRX2034757	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S76_DNA_V1N	2016-08-31	28140	10658	2017-02-21	SRR4043852	SRS1628710	SRP082386	S76_DNA_V1N	DNA		NCI_PROMOTE	S76_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	76		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292731	NCI-PHS001141	GRU	sra	SRX2034758	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S71_RNA_V1N	2016-10-20	18443	10749	2017-02-21	SRR4043853	SRS1628711	SRP082386	S71_RNA_V1N	RNA		NCI_PROMOTE	S71_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	71		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292732	NCI-PHS001141	GRU	sra	SRX2034759	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S48_DNA_V1B	2016-08-29	32191	13074	2017-02-21	SRR4043854	SRS1628712	SRP082386	S48_DNA_V1B	DNA		NCI_PROMOTE	S48_DNA_V1B	Blood			phs001141	48		No				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	48		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292733	NCI-PHS001141	GRU	sra	SRX2034760	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S47_RNA_V1N	2016-10-20	9672	5996	2017-02-21	SRR4043855	SRS1628713	SRP082386	S47_RNA_V1N	RNA		NCI_PROMOTE	S47_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	47		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292734	NCI-PHS001141	GRU	sra	SRX2034761	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S21_DNA_V1N	2016-08-27	30534	12203	2017-02-21	SRR4043856	SRS1628714	SRP082386	S21_DNA_V1N	DNA		NCI_PROMOTE	S21_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	21		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292735	NCI-PHS001141	GRU	sra	SRX2034762	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S79_RNA_V1N	2016-10-20	19991	13109	2017-02-21	SRR4043857	SRS1628715	SRP082386	S79_RNA_V1N	RNA		NCI_PROMOTE	S79_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	79		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292736	NCI-PHS001141	GRU	sra	SRX2034763	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S27_DNA_V1T	2016-08-29	33141	13241	2017-02-21	SRR4043858	SRS1628716	SRP082386	S27_DNA_V1T	DNA		NCI_PROMOTE	S27_DNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	27		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292737	NCI-PHS001141	GRU	sra	SRX2034764	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S60_DNA_V1B	2016-08-29	32133	14062	2017-02-21	SRR4043859	SRS1628717	SRP082386	S60_DNA_V1B	DNA		NCI_PROMOTE	S60_DNA_V1B	Blood			phs001141	60		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	60		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292738	NCI-PHS001141	GRU	sra	SRX2034765	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S85_RNA_V1N	2016-10-20	15414	10170	2017-02-21	SRR4043860	SRS1628718	SRP082386	S85_RNA_V1N	RNA		NCI_PROMOTE	S85_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	85		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292739	NCI-PHS001141	GRU	sra	SRX2034766	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S58_DNA_V1B	2016-10-24	31776	13207	2017-02-21	SRR4043861	SRS1628719	SRP082386	S58_DNA_V1B	DNA		NCI_PROMOTE	S58_DNA_V1B	Blood			phs001141	58		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	58		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292740	NCI-PHS001141	GRU	sra	SRX2034767	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S22_RNA_V1N	2016-10-20	18359	12380	2017-02-21	SRR4043862	SRS1628720	SRP082386	S22_RNA_V1N	RNA		NCI_PROMOTE	S22_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	22		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292741	NCI-PHS001141	GRU	sra	SRX2034768	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S8_DNA_V1B	2016-09-01	35509	11593	2017-02-21	SRR4043863	SRS1628721	SRP082386	S8_DNA_V1B	DNA		NCI_PROMOTE	S8_DNA_V1B	Blood			phs001141	8		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	8		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292742	NCI-PHS001141	GRU	sra	SRX2034769	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S75_RNA_V1T	2016-10-20	28108	19736	2017-02-21	SRR4043864	SRS1628722	SRP082386	S75_RNA_V1T	RNA		NCI_PROMOTE	S75_RNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	75		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292743	NCI-PHS001141	GRU	sra	SRX2034770	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S54_DNA_V1B	2016-08-29	32708	13878	2017-02-21	SRR4043865	SRS1628723	SRP082386	S54_DNA_V1B	DNA		NCI_PROMOTE	S54_DNA_V1B	Blood			phs001141	54		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	54		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292744	NCI-PHS001141	GRU	sra	SRX2034771	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S69_DNA_V1N	2016-08-30	28219	10599	2017-02-21	SRR4043866	SRS1628724	SRP082386	S69_DNA_V1N	DNA		NCI_PROMOTE	S69_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	69		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292745	NCI-PHS001141	GRU	sra	SRX2034772	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S79_DNA_V1B	2016-10-21	33296	15229	2017-02-21	SRR4043867	SRS1628725	SRP082386	S79_DNA_V1B	DNA		NCI_PROMOTE	S79_DNA_V1B	Blood			phs001141	79		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	79		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292746	NCI-PHS001141	GRU	sra	SRX2034773	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S56_DNA_V1T	2016-08-29	21420	7716	2017-02-21	SRR4043868	SRS1628726	SRP082386	S56_DNA_V1T	DNA		NCI_PROMOTE	S56_DNA_V1T	liver			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	56		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292747	NCI-PHS001141	GRU	sra	SRX2034774	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S17_DNA_V1B	2016-08-27	29652	11700	2017-02-21	SRR4043869	SRS1628727	SRP082386	S17_DNA_V1B	DNA		NCI_PROMOTE	S17_DNA_V1B	Blood			phs001141	17		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	17		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292748	NCI-PHS001141	GRU	sra	SRX2034775	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S75_DNA_V1B	2016-08-31	31658	12376	2017-02-21	SRR4043870	SRS1628728	SRP082386	S75_DNA_V1B	DNA		NCI_PROMOTE	S75_DNA_V1B	Blood			phs001141	75		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	75		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292749	NCI-PHS001141	GRU	sra	SRX2034776	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S66_DNA_V1B	2016-08-30	27278	12402	2017-02-21	SRR4043871	SRS1628729	SRP082386	S66_DNA_V1B	DNA		NCI_PROMOTE	S66_DNA_V1B	Blood			phs001141	66		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	66		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292750	NCI-PHS001141	GRU	sra	SRX2034777	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S61_DNA_V1B	2016-08-30	30425	12833	2017-02-21	SRR4043872	SRS1628730	SRP082386	S61_DNA_V1B	DNA		NCI_PROMOTE	S61_DNA_V1B	Blood			phs001141	61		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	61		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292751	NCI-PHS001141	GRU	sra	SRX2034778	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S70_DNA_V1B	2016-08-30	32251	12446	2017-02-21	SRR4043873	SRS1628731	SRP082386	S70_DNA_V1B	DNA		NCI_PROMOTE	S70_DNA_V1B	Blood			phs001141	70		No				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	70		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292752	NCI-PHS001141	GRU	sra	SRX2034779	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S17_DNA_V1N	2016-08-27	30468	12303	2017-02-21	SRR4043874	SRS1628732	SRP082386	S17_DNA_V1N	DNA		NCI_PROMOTE	S17_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	17		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292753	NCI-PHS001141	GRU	sra	SRX2034780	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S28_DNA_V1N	2016-08-27	33837	15029	2017-02-21	SRR4043875	SRS1628733	SRP082386	S28_DNA_V1N	DNA		NCI_PROMOTE	S28_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	28		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292754	NCI-PHS001141	GRU	sra	SRX2034781	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S5_DNA_V1T	2016-08-29	35680	16065	2017-02-21	SRR4043876	SRS1628734	SRP082386	S5_DNA_V1T	DNA		NCI_PROMOTE	S5_DNA_V1T	Soft Tissue			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	5		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292755	NCI-PHS001141	GRU	sra	SRX2034782	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S2_DNA_V1N	2016-08-27	28341	10520	2017-02-21	SRR4043877	SRS1628735	SRP082386	S2_DNA_V1N	DNA		NCI_PROMOTE	S2_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	2		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292756	NCI-PHS001141	GRU	sra	SRX2034783	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S19_DNA_V1N	2016-08-27	38091	13199	2017-02-21	SRR4043878	SRS1628736	SRP082386	S19_DNA_V1N	DNA		NCI_PROMOTE	S19_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	19		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292757	NCI-PHS001141	GRU	sra	SRX2034784	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S13_RNA_V1N	2016-10-20	16999	11682	2017-02-21	SRR4043879	SRS1628737	SRP082386	S13_RNA_V1N	RNA		NCI_PROMOTE	S13_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	13		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292758	NCI-PHS001141	GRU	sra	SRX2034785	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S25_DNA_V1B	2016-08-27	27026	9884	2017-02-21	SRR4043880	SRS1628739	SRP082386	S25_DNA_V1B	DNA		NCI_PROMOTE	S25_DNA_V1B	Blood			phs001141	25		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	25		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292759	NCI-PHS001141	GRU	sra	SRX2034786	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S65_RNA_V1N	2016-10-20	21565	13738	2017-02-21	SRR4043881	SRS1628738	SRP082386	S65_RNA_V1N	RNA		NCI_PROMOTE	S65_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	65		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292760	NCI-PHS001141	GRU	sra	SRX2034787	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S57_DNA_V1B	2016-08-29	31336	13335	2017-02-21	SRR4043882	SRS1628740	SRP082386	S57_DNA_V1B	DNA		NCI_PROMOTE	S57_DNA_V1B	Blood			phs001141	57		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	57		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292761	NCI-PHS001141	GRU	sra	SRX2034788	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S74_DNA_V1B	2016-08-31	34747	14348	2017-02-21	SRR4043883	SRS1628741	SRP082386	S74_DNA_V1B	DNA		NCI_PROMOTE	S74_DNA_V1B	Blood			phs001141	74		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	74		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292762	NCI-PHS001141	GRU	sra	SRX2034789	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S72_DNA_V1B	2016-08-30	28018	12977	2017-02-21	SRR4043884	SRS1628742	SRP082386	S72_DNA_V1B	DNA		NCI_PROMOTE	S72_DNA_V1B	Blood			phs001141	72		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	72		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292763	NCI-PHS001141	GRU	sra	SRX2034790	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S59_DNA_V1B	2016-08-29	31452	12816	2017-02-21	SRR4043885	SRS1628743	SRP082386	S59_DNA_V1B	DNA		NCI_PROMOTE	S59_DNA_V1B	Blood			phs001141	59		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	59		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292764	NCI-PHS001141	GRU	sra	SRX2034791	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S16_DNA_V1B	2016-08-27	32832	13877	2017-02-21	SRR4043886	SRS1628745	SRP082386	S16_DNA_V1B	DNA		NCI_PROMOTE	S16_DNA_V1B	Blood			phs001141	16		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	16		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292765	NCI-PHS001141	GRU	sra	SRX2034792	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S82_DNA_V1B	2016-12-01	25746	10066	2017-02-21	SRR4043887	SRS1628744	SRP082386	S82_DNA_V1B	DNA		NCI_PROMOTE	S82_DNA_V1B	Blood			phs001141	82		No				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	82		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292766	NCI-PHS001141	GRU	sra	SRX2034793	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S52_DNA_V1B	2016-08-29	31544	13405	2017-02-21	SRR4043888	SRS1628746	SRP082386	S52_DNA_V1B	DNA		NCI_PROMOTE	S52_DNA_V1B	Blood			phs001141	52		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	52		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292767	NCI-PHS001141	GRU	sra	SRX2034794	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S34_RNA_V1T	2016-10-20	17473	11536	2017-02-21	SRR4043889	SRS1628747	SRP082386	S34_RNA_V1T	RNA		NCI_PROMOTE	S34_RNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	34		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292768	NCI-PHS001141	GRU	sra	SRX2034795	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S81_DNA_V1N	2016-08-31	21156	7975	2017-02-21	SRR4043890	SRS1628748	SRP082386	S81_DNA_V1N	DNA		NCI_PROMOTE	S81_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	81		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292769	NCI-PHS001141	GRU	sra	SRX2034796	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S67_DNA_V1B	2016-08-30	34311	13791	2017-02-21	SRR4043891	SRS1628749	SRP082386	S67_DNA_V1B	DNA		NCI_PROMOTE	S67_DNA_V1B	Blood			phs001141	67		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	67		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292770	NCI-PHS001141	GRU	sra	SRX2034797	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S58_DNA_V1T	2016-10-21	23643	8542	2017-02-21	SRR4043892	SRS1628750	SRP082386	S58_DNA_V1T	DNA		NCI_PROMOTE	S58_DNA_V1T	Soft Tissue			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	58		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292525	NCI-PHS001141	GRU	sra	SRX2034798	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S55_RNA_V1N	2016-10-20	10920	6432	2017-02-21	SRR4043893	SRS1628751	SRP082386	S55_RNA_V1N	RNA		NCI_PROMOTE	S55_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	55		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292526	NCI-PHS001141	GRU	sra	SRX2034799	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S24_RNA_V1N	2016-10-20	14937	9406	2017-02-21	SRR4043894	SRS1628753	SRP082386	S24_RNA_V1N	RNA		NCI_PROMOTE	S24_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	24		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292527	NCI-PHS001141	GRU	sra	SRX2034800	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S23_DNA_V1N	2016-08-27	32966	13680	2017-02-21	SRR4043895	SRS1628752	SRP082386	S23_DNA_V1N	DNA		NCI_PROMOTE	S23_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	23		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292528	NCI-PHS001141	GRU	sra	SRX2034801	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S71_DNA_V1B	2016-08-30	33487	13369	2017-02-21	SRR4043896	SRS1628754	SRP082386	S71_DNA_V1B	DNA		NCI_PROMOTE	S71_DNA_V1B	Blood			phs001141	71		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	71		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292529	NCI-PHS001141	GRU	sra	SRX2034802	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S19_RNA_V1N	2016-10-20	18285	12150	2017-02-21	SRR4043897	SRS1628755	SRP082386	S19_RNA_V1N	RNA		NCI_PROMOTE	S19_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	19		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292530	NCI-PHS001141	GRU	sra	SRX2034803	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S21_RNA_V1N	2016-10-20	18702	12451	2017-02-21	SRR4043898	SRS1628756	SRP082386	S21_RNA_V1N	RNA		NCI_PROMOTE	S21_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	21		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292531	NCI-PHS001141	GRU	sra	SRX2034804	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S57_RNA_V1N	2016-10-20	16622	11341	2017-02-21	SRR4043899	SRS1628757	SRP082386	S57_RNA_V1N	RNA		NCI_PROMOTE	S57_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	57		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292532	NCI-PHS001141	GRU	sra	SRX2034805	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S45_DNA_V1B	2016-08-28	33013	13583	2017-02-21	SRR4043900	SRS1628758	SRP082386	S45_DNA_V1B	DNA		NCI_PROMOTE	S45_DNA_V1B	Blood			phs001141	45		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	45		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292533	NCI-PHS001141	GRU	sra	SRX2034806	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S19_DNA_V1B	2016-08-27	32426	13255	2017-02-21	SRR4043901	SRS1628759	SRP082386	S19_DNA_V1B	DNA		NCI_PROMOTE	S19_DNA_V1B	Blood			phs001141	19		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	19		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292534	NCI-PHS001141	GRU	sra	SRX2034807	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S73_DNA_V1N	2016-08-30	29869	11472	2017-02-21	SRR4043902	SRS1628761	SRP082386	S73_DNA_V1N	DNA		NCI_PROMOTE	S73_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	73		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292535	NCI-PHS001141	GRU	sra	SRX2034808	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S36_DNA_V1B	2016-08-28	17940	6103	2017-02-21	SRR4043903	SRS1628760	SRP082386	S36_DNA_V1B	DNA		NCI_PROMOTE	S36_DNA_V1B	Blood			phs001141	36		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	36		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292536	NCI-PHS001141	GRU	sra	SRX2034809	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S22_DNA_V1N	2016-08-27	30475	11825	2017-02-21	SRR4043904	SRS1628762	SRP082386	S22_DNA_V1N	DNA		NCI_PROMOTE	S22_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	22		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292537	NCI-PHS001141	GRU	sra	SRX2034810	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S32_DNA_V1N	2016-08-28	31121	12219	2017-02-21	SRR4043905	SRS1628763	SRP082386	S32_DNA_V1N	DNA		NCI_PROMOTE	S32_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	32		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292538	NCI-PHS001141	GRU	sra	SRX2034811	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S35_RNA_V1T	2016-10-20	17407	11723	2017-02-21	SRR4043906	SRS1628764	SRP082386	S35_RNA_V1T	RNA		NCI_PROMOTE	S35_RNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	35		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292539	NCI-PHS001141	GRU	sra	SRX2034812	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S49_DNA_V1T	2016-08-29	30449	13398	2017-02-21	SRR4043907	SRS1628765	SRP082386	S49_DNA_V1T	DNA		NCI_PROMOTE	S49_DNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	49		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292540	NCI-PHS001141	GRU	sra	SRX2034813	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S41_RNA_V1N	2016-10-20	21559	13912	2017-02-21	SRR4043908	SRS1628766	SRP082386	S41_RNA_V1N	RNA		NCI_PROMOTE	S41_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	41		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292541	NCI-PHS001141	GRU	sra	SRX2034814	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S45_DNA_V1N	2016-08-28	29594	12582	2017-02-21	SRR4043909	SRS1628767	SRP082386	S45_DNA_V1N	DNA		NCI_PROMOTE	S45_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	45		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292542	NCI-PHS001141	GRU	sra	SRX2034815	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S65_DNA_V1N	2016-08-30	27054	11889	2017-02-21	SRR4043910	SRS1628768	SRP082386	S65_DNA_V1N	DNA		NCI_PROMOTE	S65_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	65		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292543	NCI-PHS001141	GRU	sra	SRX2034816	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S27_RNA_V1T	2016-10-20	14081	8207	2017-02-21	SRR4043911	SRS1628769	SRP082386	S27_RNA_V1T	RNA		NCI_PROMOTE	S27_RNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	27		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292544	NCI-PHS001141	GRU	sra	SRX2034817	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S16_RNA_V1N	2016-10-20	19283	11653	2017-02-21	SRR4043912	SRS1628770	SRP082386	S16_RNA_V1N	RNA		NCI_PROMOTE	S16_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	16		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292545	NCI-PHS001141	GRU	sra	SRX2034818	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S87_DNA_V1B	2016-09-01	32481	15320	2017-02-21	SRR4043913	SRS1628772	SRP082386	S87_DNA_V1B	DNA		NCI_PROMOTE	S87_DNA_V1B	Blood			phs001141	87		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	87		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292546	NCI-PHS001141	GRU	sra	SRX2034819	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S48_RNA_V1N	2016-10-20	18214	10744	2017-02-21	SRR4043914	SRS1628771	SRP082386	S48_RNA_V1N	RNA		NCI_PROMOTE	S48_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	48		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292547	NCI-PHS001141	GRU	sra	SRX2034820	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S17_RNA_V1N	2016-10-20	12389	6988	2017-02-21	SRR4043915	SRS1628773	SRP082386	S17_RNA_V1N	RNA		NCI_PROMOTE	S17_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	17		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292548	NCI-PHS001141	GRU	sra	SRX2034821	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S76_DNA_V1B	2016-08-31	31196	12414	2017-02-21	SRR4043916	SRS1628774	SRP082386	S76_DNA_V1B	DNA		NCI_PROMOTE	S76_DNA_V1B	Blood			phs001141	76		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	76		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292549	NCI-PHS001141	GRU	sra	SRX2034822	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S42_DNA_V1B	2016-08-28	31928	12765	2017-02-21	SRR4043917	SRS1628775	SRP082386	S42_DNA_V1B	DNA		NCI_PROMOTE	S42_DNA_V1B	Blood			phs001141	42		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	42		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292550	NCI-PHS001141	GRU	sra	SRX2034823	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S87_DNA_V1T	2016-12-01	35699	17313	2017-02-21	SRR4043918	SRS1628776	SRP082386	S87_DNA_V1T	DNA		NCI_PROMOTE	S87_DNA_V1T	supraclavicular aden			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	87		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292551	NCI-PHS001141	GRU	sra	SRX2034824	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S15_DNA_V1N	2016-08-27	33467	14624	2017-02-21	SRR4043919	SRS1628777	SRP082386	S15_DNA_V1N	DNA		NCI_PROMOTE	S15_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	15		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292552	NCI-PHS001141	GRU	sra	SRX2034825	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S25_DNA_V1N	2016-08-27	29804	11843	2017-02-21	SRR4043920	SRS1628778	SRP082386	S25_DNA_V1N	DNA		NCI_PROMOTE	S25_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	25		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292553	NCI-PHS001141	GRU	sra	SRX2034826	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S2_RNA_V1N	2016-10-20	10814	6092	2017-02-21	SRR4043921	SRS1628779	SRP082386	S2_RNA_V1N	RNA		NCI_PROMOTE	S2_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	2		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292554	NCI-PHS001141	GRU	sra	SRX2034827	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S77_DNA_V1B	2016-08-31	25231	10854	2017-02-21	SRR4043922	SRS1628780	SRP082386	S77_DNA_V1B	DNA		NCI_PROMOTE	S77_DNA_V1B	Blood			phs001141	77		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	77		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292555	NCI-PHS001141	GRU	sra	SRX2034828	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S13_DNA_V1N	2016-08-27	32861	13442	2017-02-21	SRR4043923	SRS1628781	SRP082386	S13_DNA_V1N	DNA		NCI_PROMOTE	S13_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	13		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292556	NCI-PHS001141	GRU	sra	SRX2034829	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S81_DNA_V1B	2016-08-31	33088	15157	2017-02-21	SRR4043924	SRS1628782	SRP082386	S81_DNA_V1B	DNA		NCI_PROMOTE	S81_DNA_V1B	Blood			phs001141	81		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	81		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292557	NCI-PHS001141	GRU	sra	SRX2034830	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S23_RNA_V1N	2016-10-20	17770	11902	2017-02-21	SRR4043925	SRS1628783	SRP082386	S23_RNA_V1N	RNA		NCI_PROMOTE	S23_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	23		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292558	NCI-PHS001141	GRU	sra	SRX2034831	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S36_RNA_V1T	2016-10-20	11960	7545	2017-02-21	SRR4043926	SRS1628784	SRP082386	S36_RNA_V1T	RNA		NCI_PROMOTE	S36_RNA_V1T	Prostate Bed			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	36		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292559	NCI-PHS001141	GRU	sra	SRX2034832	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S80_RNA_V1T	2016-10-20	15357	10539	2017-02-21	SRR4043927	SRS1628785	SRP082386	S80_RNA_V1T	RNA		NCI_PROMOTE	S80_RNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	80		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292560	NCI-PHS001141	GRU	sra	SRX2034833	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S30_DNA_V1B	2016-08-27	31387	12877	2017-02-21	SRR4043928	SRS1628786	SRP082386	S30_DNA_V1B	DNA		NCI_PROMOTE	S30_DNA_V1B	Blood			phs001141	30		No				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	30		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292561	NCI-PHS001141	GRU	sra	SRX2034834	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S16_DNA_V1N	2016-08-27	31341	12624	2017-02-21	SRR4043929	SRS1628787	SRP082386	S16_DNA_V1N	DNA		NCI_PROMOTE	S16_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	16		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292562	NCI-PHS001141	GRU	sra	SRX2034835	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S13_DNA_V1B	2016-08-26	26834	9978	2017-02-21	SRR4043930	SRS1628788	SRP082386	S13_DNA_V1B	DNA		NCI_PROMOTE	S13_DNA_V1B	Blood			phs001141	13		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	13		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292563	NCI-PHS001141	GRU	sra	SRX2034836	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S64_DNA_V1N	2016-08-30	28418	12712	2017-02-21	SRR4043931	SRS1628789	SRP082386	S64_DNA_V1N	DNA		NCI_PROMOTE	S64_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	64		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292564	NCI-PHS001141	GRU	sra	SRX2034837	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S62_RNA_V1N	2016-10-20	14599	9716	2017-02-21	SRR4043932	SRS1628790	SRP082386	S62_RNA_V1N	RNA		NCI_PROMOTE	S62_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	62		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292565	NCI-PHS001141	GRU	sra	SRX2034838	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S55_DNA_V1N	2016-08-29	29909	11624	2017-02-21	SRR4043933	SRS1628791	SRP082386	S55_DNA_V1N	DNA		NCI_PROMOTE	S55_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	55		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292566	NCI-PHS001141	GRU	sra	SRX2034839	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S61_DNA_V1T	2016-08-30	29015	12408	2017-02-21	SRR4043934	SRS1628792	SRP082386	S61_DNA_V1T	DNA		NCI_PROMOTE	S61_DNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	61		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292567	NCI-PHS001141	GRU	sra	SRX2034840	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S3_DNA_V1B	2016-08-28	34410	13933	2017-02-21	SRR4043935	SRS1628793	SRP082386	S3_DNA_V1B	DNA		NCI_PROMOTE	S3_DNA_V1B	Blood			phs001141	3		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	3		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292568	NCI-PHS001141	GRU	sra	SRX2034841	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S64_RNA_V1N	2016-10-20	17819	11275	2017-02-21	SRR4043936	SRS1628794	SRP082386	S64_RNA_V1N	RNA		NCI_PROMOTE	S64_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	64		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292569	NCI-PHS001141	GRU	sra	SRX2034842	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S63_RNA_V1T	2016-10-20	13649	8767	2017-02-21	SRR4043937	SRS1628795	SRP082386	S63_RNA_V1T	RNA		NCI_PROMOTE	S63_RNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	63		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292570	NCI-PHS001141	GRU	sra	SRX2034843	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S76_RNA_V1N	2016-10-20	15057	10092	2017-02-21	SRR4043938	SRS1628796	SRP082386	S76_RNA_V1N	RNA		NCI_PROMOTE	S76_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	76		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292571	NCI-PHS001141	GRU	sra	SRX2034844	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S52_DNA_V1N	2016-12-01	25775	10535	2017-02-21	SRR4043939	SRS1628797	SRP082386	S52_DNA_V1N	DNA		NCI_PROMOTE	S52_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	52		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292572	NCI-PHS001141	GRU	sra	SRX2034845	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S40_RNA_V1N	2016-10-20	15857	9608	2017-02-21	SRR4043940	SRS1628798	SRP082386	S40_RNA_V1N	RNA		NCI_PROMOTE	S40_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	40		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292573	NCI-PHS001141	GRU	sra	SRX2034846	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S77_DNA_V1N	2016-08-31	25174	10712	2017-02-21	SRR4043941	SRS1628799	SRP082386	S77_DNA_V1N	DNA		NCI_PROMOTE	S77_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	77		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292574	NCI-PHS001141	GRU	sra	SRX2034847	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S11_DNA_V1B	2016-08-26	33211	13722	2017-02-21	SRR4043942	SRS1628800	SRP082386	S11_DNA_V1B	DNA		NCI_PROMOTE	S11_DNA_V1B	Blood			phs001141	11		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	11		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292575	NCI-PHS001141	GRU	sra	SRX2034848	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S40_DNA_V1B	2016-08-28	31112	13963	2017-02-21	SRR4043943	SRS1628801	SRP082386	S40_DNA_V1B	DNA		NCI_PROMOTE	S40_DNA_V1B	Blood			phs001141	40		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	40		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292576	NCI-PHS001141	GRU	sra	SRX2034849	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S7_DNA_V1B	2016-08-31	28467	11075	2017-02-21	SRR4043944	SRS1628802	SRP082386	S7_DNA_V1B	DNA		NCI_PROMOTE	S7_DNA_V1B	Blood			phs001141	7		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	7		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292577	NCI-PHS001141	GRU	sra	SRX2034850	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S12_RNA_V1N	2016-10-20	18395	12072	2017-02-21	SRR4043945	SRS1628803	SRP082386	S12_RNA_V1N	RNA		NCI_PROMOTE	S12_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	12		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292578	NCI-PHS001141	GRU	sra	SRX2034851	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S86_DNA_V1B	2016-12-01	38990	13347	2017-02-21	SRR4043946	SRS1628805	SRP082386	S86_DNA_V1B	DNA		NCI_PROMOTE	S86_DNA_V1B	Blood			phs001141	86		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	86		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292579	NCI-PHS001141	GRU	sra	SRX2034852	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S18_DNA_V1B	2016-08-27	29218	11156	2017-02-21	SRR4043947	SRS1628804	SRP082386	S18_DNA_V1B	DNA		NCI_PROMOTE	S18_DNA_V1B	Blood			phs001141	18		No				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	18		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292580	NCI-PHS001141	GRU	sra	SRX2034853	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S4_DNA_V1T	2016-08-29	40129	13097	2017-02-21	SRR4043948	SRS1628806	SRP082386	S4_DNA_V1T	DNA		NCI_PROMOTE	S4_DNA_V1T	lung			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	4		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292581	NCI-PHS001141	GRU	sra	SRX2034854	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S74_DNA_V1N	2016-08-31	26070	11985	2017-02-21	SRR4043949	SRS1628807	SRP082386	S74_DNA_V1N	DNA		NCI_PROMOTE	S74_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	74		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292582	NCI-PHS001141	GRU	sra	SRX2034855	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S1_DNA_V1B	2016-08-27	40574	14042	2017-02-21	SRR4043950	SRS1628809	SRP082386	S1_DNA_V1B	DNA		NCI_PROMOTE	S1_DNA_V1B	Blood			phs001141	1		No				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	1		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292583	NCI-PHS001141	GRU	sra	SRX2034856	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S2_DNA_V1B	2016-08-28	34203	14233	2017-02-21	SRR4043951	SRS1628810	SRP082386	S2_DNA_V1B	DNA		NCI_PROMOTE	S2_DNA_V1B	Blood			phs001141	2		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	2		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292584	NCI-PHS001141	GRU	sra	SRX2034857	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S49_DNA_V1B	2016-08-29	29678	11566	2017-02-21	SRR4043952	SRS1628808	SRP082386	S49_DNA_V1B	DNA		NCI_PROMOTE	S49_DNA_V1B	Blood			phs001141	49		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	49		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292585	NCI-PHS001141	GRU	sra	SRX2034858	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S60_DNA_V1N	2016-08-29	32388	13953	2017-02-21	SRR4043953	SRS1628819	SRP082386	S60_DNA_V1N	DNA		NCI_PROMOTE	S60_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	60		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292586	NCI-PHS001141	GRU	sra	SRX2034859	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S30_RNA_V1N	2016-10-20	12316	7000	2017-02-21	SRR4043954	SRS1628813	SRP082386	S30_RNA_V1N	RNA		NCI_PROMOTE	S30_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	30		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292587	NCI-PHS001141	GRU	sra	SRX2034860	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S61_RNA_V1T	2016-10-20	28683	19487	2017-02-21	SRR4043955	SRS1628811	SRP082386	S61_RNA_V1T	RNA		NCI_PROMOTE	S61_RNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	61		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292588	NCI-PHS001141	GRU	sra	SRX2034861	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S6_DNA_V1N	2016-08-30	39820	14521	2017-02-21	SRR4043956	SRS1628812	SRP082386	S6_DNA_V1N	DNA		NCI_PROMOTE	S6_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	6		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292589	NCI-PHS001141	GRU	sra	SRX2034862	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S40_DNA_V1N	2016-08-28	35385	15598	2017-02-21	SRR4043957	SRS1628814	SRP082386	S40_DNA_V1N	DNA		NCI_PROMOTE	S40_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	40		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292590	NCI-PHS001141	GRU	sra	SRX2034863	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S38_RNA_V1N	2016-10-20	14654	9411	2017-02-21	SRR4043958	SRS1628815	SRP082386	S38_RNA_V1N	RNA		NCI_PROMOTE	S38_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	38		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292591	NCI-PHS001141	GRU	sra	SRX2034864	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S14_DNA_V1T	2016-08-25	30817	13277	2017-02-21	SRR4043959	SRS1628817	SRP082386	S14_DNA_V1T	DNA		NCI_PROMOTE	S14_DNA_V1T	Soft Tissue			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	14		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292592	NCI-PHS001141	GRU	sra	SRX2034865	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S54_DNA_V1N	2016-08-29	27267	11793	2017-02-21	SRR4043960	SRS1628818	SRP082386	S54_DNA_V1N	DNA		NCI_PROMOTE	S54_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	54		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292593	NCI-PHS001141	GRU	sra	SRX2034866	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S53_RNA_V1N	2016-10-20	15526	10222	2017-02-21	SRR4043961	SRS1628816	SRP082386	S53_RNA_V1N	RNA		NCI_PROMOTE	S53_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	53		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292594	NCI-PHS001141	GRU	sra	SRX2034867	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S39_DNA_V1N	2016-08-28	32157	12539	2017-02-21	SRR4043962	SRS1628820	SRP082386	S39_DNA_V1N	DNA		NCI_PROMOTE	S39_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	39		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292595	NCI-PHS001141	GRU	sra	SRX2034868	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S84_RNA_V1T	2016-10-20	14684	9622	2017-02-21	SRR4043963	SRS1628821	SRP082386	S84_RNA_V1T	RNA		NCI_PROMOTE	S84_RNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	84		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292596	NCI-PHS001141	GRU	sra	SRX2034869	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S38_DNA_V1N	2016-08-28	32840	13397	2017-02-21	SRR4043964	SRS1628823	SRP082386	S38_DNA_V1N	DNA		NCI_PROMOTE	S38_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	38		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292597	NCI-PHS001141	GRU	sra	SRX2034870	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S29_DNA_V1B	2016-08-27	31018	13715	2017-02-21	SRR4043965	SRS1628822	SRP082386	S29_DNA_V1B	DNA		NCI_PROMOTE	S29_DNA_V1B	Blood			phs001141	29		No				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	29		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292598	NCI-PHS001141	GRU	sra	SRX2034871	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S81_RNA_V1N	2016-10-20	22644	15200	2017-02-21	SRR4043966	SRS1628824	SRP082386	S81_RNA_V1N	RNA		NCI_PROMOTE	S81_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	81		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292599	NCI-PHS001141	GRU	sra	SRX2034872	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S25_RNA_V1N	2016-10-20	12422	7808	2017-02-21	SRR4043967	SRS1628825	SRP082386	S25_RNA_V1N	RNA		NCI_PROMOTE	S25_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	25		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292600	NCI-PHS001141	GRU	sra	SRX2034873	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S88_RNA_V1N	2016-10-20	12511	8817	2017-02-21	SRR4043968	SRS1628826	SRP082386	S88_RNA_V1N	RNA		NCI_PROMOTE	S88_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	88		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292601	NCI-PHS001141	GRU	sra	SRX2034874	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S20_DNA_V1B	2016-08-27	31289	13413	2017-02-21	SRR4043969	SRS1628827	SRP082386	S20_DNA_V1B	DNA		NCI_PROMOTE	S20_DNA_V1B	Blood			phs001141	20		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	20		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292602	NCI-PHS001141	GRU	sra	SRX2034875	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S10_DNA_V1N	2016-08-25	40182	14024	2017-02-21	SRR4043970	SRS1628828	SRP082386	S10_DNA_V1N	DNA		NCI_PROMOTE	S10_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	10		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292603	NCI-PHS001141	GRU	sra	SRX2034876	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S9_RNA_V1N	2016-10-20	15716	10664	2017-02-21	SRR4043971	SRS1628829	SRP082386	S9_RNA_V1N	RNA		NCI_PROMOTE	S9_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	9		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292604	NCI-PHS001141	GRU	sra	SRX2034877	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S15_RNA_V1N	2016-10-20	20810	14732	2017-02-21	SRR4043972	SRS1628830	SRP082386	S15_RNA_V1N	RNA		NCI_PROMOTE	S15_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	15		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292605	NCI-PHS001141	GRU	sra	SRX2034878	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S14_DNA_V1B	2016-08-26	29449	12824	2017-02-21	SRR4043973	SRS1628831	SRP082386	S14_DNA_V1B	DNA		NCI_PROMOTE	S14_DNA_V1B	Blood			phs001141	14		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	14		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292606	NCI-PHS001141	GRU	sra	SRX2034879	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S34_DNA_V1B	2016-08-28	19009	6102	2017-02-21	SRR4043974	SRS1628832	SRP082386	S34_DNA_V1B	DNA		NCI_PROMOTE	S34_DNA_V1B	Blood			phs001141	34		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	34		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292607	NCI-PHS001141	GRU	sra	SRX2034880	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S83_RNA_V1T	2016-10-20	16973	11620	2017-02-21	SRR4043975	SRS1628834	SRP082386	S83_RNA_V1T	RNA		NCI_PROMOTE	S83_RNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	83		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292608	NCI-PHS001141	GRU	sra	SRX2034881	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S65_DNA_V1B	2016-08-30	28182	13161	2017-02-21	SRR4043976	SRS1628833	SRP082386	S65_DNA_V1B	DNA		NCI_PROMOTE	S65_DNA_V1B	Blood			phs001141	65		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	65		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292609	NCI-PHS001141	GRU	sra	SRX2034882	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S79_DNA_V1N	2016-10-21	33710	15444	2017-02-21	SRR4043977	SRS1628835	SRP082386	S79_DNA_V1N	DNA		NCI_PROMOTE	S79_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	79		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292610	NCI-PHS001141	GRU	sra	SRX2034883	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S9_DNA_V1B	2016-09-01	28915	11977	2017-02-21	SRR4043978	SRS1628836	SRP082386	S9_DNA_V1B	DNA		NCI_PROMOTE	S9_DNA_V1B	Blood			phs001141	9		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	9		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292611	NCI-PHS001141	GRU	sra	SRX2034884	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S28_DNA_V1B	2016-08-27	32261	14344	2017-02-21	SRR4043979	SRS1628838	SRP082386	S28_DNA_V1B	DNA		NCI_PROMOTE	S28_DNA_V1B	Blood			phs001141	28		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	28		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292612	NCI-PHS001141	GRU	sra	SRX2034885	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S42_RNA_V1N	2016-10-20	15423	9616	2017-02-21	SRR4043980	SRS1628837	SRP082386	S42_RNA_V1N	RNA		NCI_PROMOTE	S42_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	42		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292613	NCI-PHS001141	GRU	sra	SRX2034886	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S44_DNA_V1N	2016-12-01	32402	13415	2017-02-21	SRR4043981	SRS1628839	SRP082386	S44_DNA_V1N	DNA		NCI_PROMOTE	S44_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	44		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292614	NCI-PHS001141	GRU	sra	SRX2034887	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S51_DNA_V1B	2016-08-29	25967	10447	2017-02-21	SRR4043982	SRS1628840	SRP082386	S51_DNA_V1B	DNA		NCI_PROMOTE	S51_DNA_V1B	Blood			phs001141	51		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	51		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292615	NCI-PHS001141	GRU	sra	SRX2034888	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S29_RNA_V1N	2016-10-20	15521	9131	2017-02-21	SRR4043983	SRS1628842	SRP082386	S29_RNA_V1N	RNA		NCI_PROMOTE	S29_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	29		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292616	NCI-PHS001141	GRU	sra	SRX2034889	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S86_RNA_V1N	2016-10-20	14069	9488	2017-02-21	SRR4043984	SRS1628841	SRP082386	S86_RNA_V1N	RNA		NCI_PROMOTE	S86_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	86		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292617	NCI-PHS001141	GRU	contigs sra	SRX2034890	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S67_RNA_V1T	2016-10-20	4820	2632	2017-02-21	SRR4043985	SRS1628843	SRP082386	S67_RNA_V1T	RNA		NCI_PROMOTE	S67_RNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	67		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292618	NCI-PHS001141	GRU	sra	SRX2034891	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S87_RNA_V1T	2016-10-20	20274	13719	2017-02-21	SRR4043986	SRS1628844	SRP082386	S87_RNA_V1T	RNA		NCI_PROMOTE	S87_RNA_V1T	supraclavicular aden			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	87		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292619	NCI-PHS001141	GRU	sra	SRX2034892	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S6_RNA_V1N	2016-10-20	15141	10610	2017-02-21	SRR4043987	SRS1628845	SRP082386	S6_RNA_V1N	RNA		NCI_PROMOTE	S6_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	6		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292620	NCI-PHS001141	GRU	sra	SRX2034893	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S84_DNA_V1T	2016-09-01	36525	17517	2017-02-21	SRR4043988	SRS1628847	SRP082386	S84_DNA_V1T	DNA		NCI_PROMOTE	S84_DNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	84		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292621	NCI-PHS001141	GRU	sra	SRX2034894	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S67_DNA_V1T	2016-08-30	33077	12854	2017-02-21	SRR4043989	SRS1628846	SRP082386	S67_DNA_V1T	DNA		NCI_PROMOTE	S67_DNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	67		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292622	NCI-PHS001141	GRU	sra	SRX2034895	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S37_DNA_V1N	2016-08-28	33429	13580	2017-02-21	SRR4043990	SRS1628848	SRP082386	S37_DNA_V1N	DNA		NCI_PROMOTE	S37_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	37		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292623	NCI-PHS001141	GRU	sra	SRX2034896	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S50_DNA_V1B	2016-08-29	32414	13315	2017-02-21	SRR4043991	SRS1628849	SRP082386	S50_DNA_V1B	DNA		NCI_PROMOTE	S50_DNA_V1B	Blood			phs001141	50		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	50		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292624	NCI-PHS001141	GRU	sra	SRX2034897	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S60_RNA_V1N	2016-10-20	15884	10440	2017-02-21	SRR4043992	SRS1628850	SRP082386	S60_RNA_V1N	RNA		NCI_PROMOTE	S60_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	60		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292625	NCI-PHS001141	GRU	sra	SRX2034898	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S78_DNA_V1N	2016-08-31	45260	16530	2017-02-21	SRR4043993	SRS1628852	SRP082386	S78_DNA_V1N	DNA		NCI_PROMOTE	S78_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	78		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292626	NCI-PHS001141	GRU	sra	SRX2034899	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S23_DNA_V1B	2016-08-27	29096	12370	2017-02-21	SRR4043994	SRS1628851	SRP082386	S23_DNA_V1B	DNA		NCI_PROMOTE	S23_DNA_V1B	Blood			phs001141	23		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	23		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292627	NCI-PHS001141	GRU	sra	SRX2034900	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S11_RNA_V1N	2016-10-20	12264	7210	2017-02-21	SRR4043995	SRS1628854	SRP082386	S11_RNA_V1N	RNA		NCI_PROMOTE	S11_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	11		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292628	NCI-PHS001141	GRU	sra	SRX2034901	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S47_DNA_V1B	2016-08-28	32270	13310	2017-02-21	SRR4043996	SRS1628853	SRP082386	S47_DNA_V1B	DNA		NCI_PROMOTE	S47_DNA_V1B	Blood			phs001141	47		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	47		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292629	NCI-PHS001141	GRU	sra	SRX2034902	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S24_DNA_V1N	2016-08-27	31286	12745	2017-02-21	SRR4043997	SRS1628855	SRP082386	S24_DNA_V1N	DNA		NCI_PROMOTE	S24_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	24		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292630	NCI-PHS001141	GRU	sra	SRX2034903	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S69_DNA_V1B	2016-08-30	34039	13551	2017-02-21	SRR4043998	SRS1628856	SRP082386	S69_DNA_V1B	DNA		NCI_PROMOTE	S69_DNA_V1B	Blood			phs001141	69		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	69		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292631	NCI-PHS001141	GRU	sra	SRX2034904	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S4_DNA_V1B	2016-08-29	34139	10782	2017-02-21	SRR4043999	SRS1628857	SRP082386	S4_DNA_V1B	DNA		NCI_PROMOTE	S4_DNA_V1B	Blood			phs001141	4		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	4		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292632	NCI-PHS001141	GRU	sra	SRX2034905	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S78_DNA_V1B	2016-08-31	23605	9953	2017-02-21	SRR4044000	SRS1628858	SRP082386	S78_DNA_V1B	DNA		NCI_PROMOTE	S78_DNA_V1B	Blood			phs001141	78		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	78		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292633	NCI-PHS001141	GRU	sra	SRX2034906	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S36_DNA_V1T	2016-08-28	30963	12188	2017-02-21	SRR4044001	SRS1628859	SRP082386	S36_DNA_V1T	DNA		NCI_PROMOTE	S36_DNA_V1T	Prostate Bed			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	36		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292634	NCI-PHS001141	GRU	sra	SRX2034907	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S42_DNA_V1N	2016-08-28	35339	15749	2017-02-21	SRR4044002	SRS1628860	SRP082386	S42_DNA_V1N	DNA		NCI_PROMOTE	S42_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	42		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292635	NCI-PHS001141	GRU	sra	SRX2034908	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S8_RNA_V1T	2016-10-20	21906	15054	2017-02-21	SRR4044003	SRS1628862	SRP082386	S8_RNA_V1T	RNA		NCI_PROMOTE	S8_RNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	8		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292636	NCI-PHS001141	GRU	sra	SRX2034909	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S47_DNA_V1N	2016-08-28	30591	13625	2017-02-21	SRR4044004	SRS1628863	SRP082386	S47_DNA_V1N	DNA		NCI_PROMOTE	S47_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	47		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292637	NCI-PHS001141	GRU	sra	SRX2034910	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S85_DNA_V1B	2016-09-01	27502	11287	2017-02-21	SRR4044005	SRS1628861	SRP082386	S85_DNA_V1B	DNA		NCI_PROMOTE	S85_DNA_V1B	Blood			phs001141	85		No				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	85		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292638	NCI-PHS001141	GRU	sra	SRX2034911	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S53_DNA_V1N	2016-08-30	34178	14649	2017-02-21	SRR4044006	SRS1628864	SRP082386	S53_DNA_V1N	DNA		NCI_PROMOTE	S53_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	53		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292639	NCI-PHS001141	GRU	sra	SRX2034912	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S88_DNA_V1B	2016-09-01	40309	14526	2017-02-21	SRR4044007	SRS1628865	SRP082386	S88_DNA_V1B	DNA		NCI_PROMOTE	S88_DNA_V1B	Blood			phs001141	88		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	88		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292640	NCI-PHS001141	GRU	sra	SRX2034913	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S77_RNA_V1N	2016-10-20	17558	11615	2017-02-21	SRR4044008	SRS1628866	SRP082386	S77_RNA_V1N	RNA		NCI_PROMOTE	S77_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	77		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292641	NCI-PHS001141	GRU	sra	SRX2034914	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S86_DNA_V1N	2016-09-01	29616	9137	2017-02-21	SRR4044009	SRS1628867	SRP082386	S86_DNA_V1N	DNA		NCI_PROMOTE	S86_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	86		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292642	NCI-PHS001141	GRU	sra	SRX2034915	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S66_RNA_V1T	2016-10-20	25787	16790	2017-02-21	SRR4044010	SRS1628869	SRP082386	S66_RNA_V1T	RNA		NCI_PROMOTE	S66_RNA_V1T	lung			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	66		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292643	NCI-PHS001141	GRU	sra	SRX2034916	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S83_DNA_V1B	2016-08-31	34244	15176	2017-02-21	SRR4044011	SRS1628868	SRP082386	S83_DNA_V1B	DNA		NCI_PROMOTE	S83_DNA_V1B	Blood			phs001141	83		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	83		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292644	NCI-PHS001141	GRU	sra	SRX2034917	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S50_DNA_V1N	2016-08-29	32802	14653	2017-02-21	SRR4044012	SRS1628870	SRP082386	S50_DNA_V1N	DNA		NCI_PROMOTE	S50_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	50		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292645	NCI-PHS001141	GRU	sra	SRX2034918	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S11_DNA_V1N	2016-08-26	34541	15084	2017-02-21	SRR4044013	SRS1628871	SRP082386	S11_DNA_V1N	DNA		NCI_PROMOTE	S11_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	11		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292646	NCI-PHS001141	GRU	sra	SRX2034919	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S8_DNA_V1T	2016-09-01	35767	11831	2017-02-21	SRR4044014	SRS1628872	SRP082386	S8_DNA_V1T	DNA		NCI_PROMOTE	S8_DNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	8		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292647	NCI-PHS001141	GRU	sra	SRX2034920	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S44_DNA_V1B	2016-08-28	26445	9860	2017-02-21	SRR4044015	SRS1628873	SRP082386	S44_DNA_V1B	DNA		NCI_PROMOTE	S44_DNA_V1B	Blood			phs001141	44		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	44		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292648	NCI-PHS001141	GRU	contigs sra	SRX2034921	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S82_RNA_V1N	2016-10-20	881	515	2017-02-21	SRR4044016	SRS1628874	SRP082386	S82_RNA_V1N	RNA		NCI_PROMOTE	S82_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	82		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292649	NCI-PHS001141	GRU	sra	SRX2034922	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S46_DNA_V1B	2016-08-28	32596	13440	2017-02-21	SRR4044017	SRS1628875	SRP082386	S46_DNA_V1B	DNA		NCI_PROMOTE	S46_DNA_V1B	Blood			phs001141	46		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	46		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292650	NCI-PHS001141	GRU	sra	SRX2034923	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S64_DNA_V1B	2016-08-30	27056	11833	2017-02-21	SRR4044018	SRS1628877	SRP082386	S64_DNA_V1B	DNA		NCI_PROMOTE	S64_DNA_V1B	Blood			phs001141	64		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	64		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292651	NCI-PHS001141	GRU	sra	SRX2034924	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S31_DNA_V1B	2016-08-28	28238	10699	2017-02-21	SRR4044019	SRS1628876	SRP082386	S31_DNA_V1B	DNA		NCI_PROMOTE	S31_DNA_V1B	Blood			phs001141	31		No				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	31		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292652	NCI-PHS001141	GRU	sra	SRX2034925	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S50_RNA_V1N	2016-10-20	16147	9502	2017-02-21	SRR4044020	SRS1628879	SRP082386	S50_RNA_V1N	RNA		NCI_PROMOTE	S50_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	50		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292653	NCI-PHS001141	GRU	sra	SRX2034926	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S51_RNA_V1T	2016-10-20	16722	10909	2017-02-21	SRR4044021	SRS1628878	SRP082386	S51_RNA_V1T	RNA		NCI_PROMOTE	S51_RNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	51		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292654	NCI-PHS001141	GRU	sra	SRX2034927	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S68_DNA_V1B	2016-08-30	28046	12757	2017-02-21	SRR4044022	SRS1628880	SRP082386	S68_DNA_V1B	DNA		NCI_PROMOTE	S68_DNA_V1B	Blood			phs001141	68		No		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	68		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	202	PRJNA325181	SAMN05292655	NCI-PHS001141	GRU	sra	SRX2034928	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S3_DNA_V1N	2016-08-28	30737	12348	2017-02-21	SRR4044023	SRS1628881	SRP082386	S3_DNA_V1N	DNA		NCI_PROMOTE	S3_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	3		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS	GCA_000001405.13	201	PRJNA325181	SAMN05292656	NCI-PHS001141	GRU	sra	SRX2034929	0	Illumina HiSeq 2500	PAIRED	RANDOM	GENOMIC	S71_DNA_V1N	2016-08-30	33046	13556	2017-02-21	SRR4044024	SRS1628884	SRP082386	S71_DNA_V1N	DNA		NCI_PROMOTE	S71_DNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes		Seq_DNA_SNP		Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	71		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292657	NCI-PHS001141	GRU	contigs sra	SRX2034930	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S45_RNA_V1N	2016-10-20	7734	4650	2017-02-21	SRR4044025	SRS1628882	SRP082386	S45_RNA_V1N	RNA		NCI_PROMOTE	S45_RNA_V1N	bone			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	45		ncbi	Homo sapiens	ILLUMINA	male	Yes
RNA-Seq		202	PRJNA325181	SAMN05292658	NCI-PHS001141	GRU	sra	SRX2034931	0	Illumina HiSeq 2500	PAIRED	cDNA	TRANSCRIPTOMIC	S49_RNA_V1T	2016-10-20	13578	9149	2017-02-21	SRR4044026	SRS1628883	SRP082386	S49_RNA_V1T	RNA		NCI_PROMOTE	S49_RNA_V1T	lymph node			phs001141	Adenocarcinoma or Poorly differentiated carcinoma NOS		Yes				Case Set	Prostatic Neoplasms, Castration-Resistant	PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)	49		ncbi	Homo sapiens	ILLUMINA	male	Yes
WXS		78	PRJNA177194	SAMN01931651	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044201	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_T8	2017-08-02	5006	3145	2017-10-16	SRR5876699	SRS2391881	SRP113721	MCTP-S1	DNA		CastrateResistant_ProstateCancer	MCTP-S1	Prostate			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	1		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931667	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044202	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_T96	2017-07-27	18946	12631	2017-10-16	SRR5876700	SRS2391882	SRP113721	MCTP-S10	DNA		CastrateResistant_ProstateCancer	MCTP-S10	Prostate			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	10		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931726	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044203	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA38-matched	2017-07-27	11003	7687	2017-10-16	SRR5876701	SRS2391883	SRP113721	MCTP-S100	DNA		CastrateResistant_ProstateCancer	MCTP-S100	Spleen			phs000554	Normal Spleen		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	39		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931645	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044204	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA39-matched	2017-07-27	13182	9318	2017-10-16	SRR5876702	SRS2391884	SRP113721	MCTP-S101	DNA		CastrateResistant_ProstateCancer	MCTP-S101	Liver			phs000554	Normal Liver		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	40		ncbi	Homo sapiens	ILLUMINA	male	
WXS		78	PRJNA177194	SAMN01931694	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044205	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA40-matched	2017-08-07	3482	2233	2017-10-16	SRR5876703	SRS2391885	SRP113721	MCTP-S102	DNA		CastrateResistant_ProstateCancer	MCTP-S102	Kidney			phs000554	Normal Kidney		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	41		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931621	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044206	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA41-matched	2017-08-04	12775	8662	2017-10-16	SRR5876704	SRS2391886	SRP113721	MCTP-S103	DNA		CastrateResistant_ProstateCancer	MCTP-S103	Liver			phs000554	Normal Liver		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	42		ncbi	Homo sapiens	ILLUMINA	male	
WXS		206	PRJNA177194	SAMN01931669	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044207	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA42-matched	2017-07-27	15769	8818	2017-10-16	SRR5876705	SRS2391888	SRP113721	MCTP-S104	DNA		CastrateResistant_ProstateCancer	MCTP-S104	Kidney			phs000554	Normal Kidney		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	43		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931715	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044208	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA43-matched	2017-08-07	10775	5509	2017-10-16	SRR5876706	SRS2391887	SRP113721	MCTP-S105	DNA		CastrateResistant_ProstateCancer	MCTP-S105	Pancreas			phs000554	Normal Pancreas		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	44		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931714	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044209	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA46-matched	2017-08-07	17165	10378	2017-10-16	SRR5876707	SRS2391890	SRP113721	MCTP-S106	DNA		CastrateResistant_ProstateCancer	MCTP-S106	Spleen			phs000554	Normal Spleen		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	45		ncbi	Homo sapiens	ILLUMINA	male	
WXS		156	PRJNA177194	SAMN01931670	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044210	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA47-matched	2017-08-07	3694	2336	2017-10-16	SRR5876708	SRS2391889	SRP113721	MCTP-S107	DNA		CastrateResistant_ProstateCancer	MCTP-S107	Liver			phs000554	Normal Liver		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	46		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931620	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044211	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA48-matched	2017-07-27	13809	9512	2017-10-16	SRR5876709	SRS2391891	SRP113721	MCTP-S108	DNA		CastrateResistant_ProstateCancer	MCTP-S108	Liver			phs000554	Normal Liver		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	47		ncbi	Homo sapiens	ILLUMINA	male	
WXS		206	PRJNA177194	SAMN01931695	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044212	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA49-matched	2017-07-27	14826	8296	2017-10-16	SRR5876710	SRS2391892	SRP113721	MCTP-S109	DNA		CastrateResistant_ProstateCancer	MCTP-S109	Liver			phs000554	Normal Liver		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	48		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931628	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044213	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_T97	2017-07-27	22317	14994	2017-10-16	SRR5876711	SRS2391894	SRP113721	MCTP-S11	DNA		CastrateResistant_ProstateCancer	MCTP-S11	Prostate			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	11		ncbi	Homo sapiens	ILLUMINA	male	
WXS		206	PRJNA177194	SAMN01931677	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044214	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA50-matched	2017-07-27	14383	8009	2017-10-16	SRR5876712	SRS2391893	SRP113721	MCTP-S110	DNA		CastrateResistant_ProstateCancer	MCTP-S110	Liver			phs000554	Normal Liver		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	49		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931637	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044215	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA51-matched	2017-08-07	16783	9881	2017-10-16	SRR5876713	SRS2391895	SRP113721	MCTP-S111	DNA		CastrateResistant_ProstateCancer	MCTP-S111	Liver			phs000554	Normal Liver		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	50		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931638	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044216	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA52-matched	2017-08-07	17942	10626	2017-10-16	SRR5876714	SRS2391896	SRP113721	MCTP-S112	DNA		CastrateResistant_ProstateCancer	MCTP-S112	Spleen			phs000554	Normal Spleen		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	51		ncbi	Homo sapiens	ILLUMINA	male	
WXS		196	PRJNA177194	SAMN01931713	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044217	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA53-matched	2017-08-16	15031	9209	2017-10-16	SRR5876715	SRS2391897	SRP113721	MCTP-S113	DNA		CastrateResistant_ProstateCancer	MCTP-S113	Liver			phs000554	Normal Liver		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	52		ncbi	Homo sapiens	ILLUMINA	male	
WXS		196	PRJNA177194	SAMN01931657	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044218	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA54-matched	2017-07-27	15784	9847	2017-10-16	SRR5876716	SRS2391898	SRP113721	MCTP-S114	DNA		CastrateResistant_ProstateCancer	MCTP-S114	Liver			phs000554	Normal Liver		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	53		ncbi	Homo sapiens	ILLUMINA	male	
WXS		196	PRJNA177194	SAMN01931617	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044219	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA55-matched	2017-07-27	15701	9788	2017-10-16	SRR5876717	SRS2391899	SRP113721	MCTP-S115	DNA		CastrateResistant_ProstateCancer	MCTP-S115	Liver			phs000554	Normal Liver		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	54		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931701	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044220	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA56-matched	2017-08-07	17028	10058	2017-10-16	SRR5876718	SRS2391900	SRP113721	MCTP-S116	DNA		CastrateResistant_ProstateCancer	MCTP-S116	Spleen			phs000554	Normal Spleen		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	55		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931655	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044221	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA57-matched	2017-08-07	16680	10349	2017-10-16	SRR5876719	SRS2391901	SRP113721	MCTP-S117	DNA		CastrateResistant_ProstateCancer	MCTP-S117	Spleen			phs000554	Normal Spleen		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	56		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931733	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044222	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA58-matched	2017-08-15	11176	7497	2017-10-16	SRR5876720	SRS2391902	SRP113721	MCTP-S118	DNA		CastrateResistant_ProstateCancer	MCTP-S118	Spleen			phs000554	Normal Spleen		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	57		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931630	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044223	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA59-matched	2017-08-07	16469	10228	2017-10-16	SRR5876721	SRS2391904	SRP113721	MCTP-S119	DNA		CastrateResistant_ProstateCancer	MCTP-S119	Liver			phs000554	Normal Liver		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	58		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931691	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044224	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA3	2017-07-27	18910	12420	2017-10-16	SRR5876722	SRS2391903	SRP113721	MCTP-S12	DNA		CastrateResistant_ProstateCancer	MCTP-S12	Soft tissue			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	12		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931724	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044225	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA60-matched	2017-08-15	15796	9733	2017-10-16	SRR5876723	SRS2391905	SRP113721	MCTP-S120	DNA		CastrateResistant_ProstateCancer	MCTP-S120	Liver			phs000554	Normal Liver		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	59		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931647	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044226	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA7	2017-07-27	23050	16217	2017-10-16	SRR5876724	SRS2391906	SRP113721	MCTP-S13	DNA		CastrateResistant_ProstateCancer	MCTP-S13	Soft tissue			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	13		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931659	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044227	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA10	2017-07-27	20318	14081	2017-10-16	SRR5876725	SRS2391908	SRP113721	MCTP-S14	DNA		CastrateResistant_ProstateCancer	MCTP-S14	Liver			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	14		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931623	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044228	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA11	2017-07-27	22470	15015	2017-10-16	SRR5876726	SRS2391907	SRP113721	MCTP-S15	DNA		CastrateResistant_ProstateCancer	MCTP-S15	Lung			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	15		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931696	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044229	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA12	2017-07-28	26903	18320	2017-10-16	SRR5876727	SRS2391909	SRP113721	MCTP-S16	DNA		CastrateResistant_ProstateCancer	MCTP-S16	Soft tissue			phs000554	Prostatic Small Cell Carcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	16		ncbi	Homo sapiens	ILLUMINA	male	
WXS		201	PRJNA177194	SAMN01931732	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044230	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA13	2017-08-07	23007	14273	2017-10-16	SRR5876728	SRS2391910	SRP113721	MCTP-S17	DNA		CastrateResistant_ProstateCancer	MCTP-S17	Soft tissue			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	17		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931686	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044231	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA14	2017-07-27	18615	12906	2017-10-16	SRR5876729	SRS2391911	SRP113721	MCTP-S18	DNA		CastrateResistant_ProstateCancer	MCTP-S18	Prostate			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	18		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931702	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044232	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA15	2017-08-15	21333	14347	2017-10-16	SRR5876730	SRS2391912	SRP113721	MCTP-S19	DNA		CastrateResistant_ProstateCancer	MCTP-S19	Lymph node			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	19		ncbi	Homo sapiens	ILLUMINA	male	
WXS		78	PRJNA177194	SAMN01931641	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044233	0	Illumina Genome Analyzer II	SINGLE	Hybrid Selection	GENOMIC	MCTP_CRPC_T12	2017-08-07	4778	3091	2017-10-16	SRR5876731	SRS2391913	SRP113721	MCTP-S2	DNA		CastrateResistant_ProstateCancer	MCTP-S2	Prostate			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	2		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931705	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044234	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA16	2017-07-28	21163	14439	2017-10-16	SRR5876732	SRS2391914	SRP113721	MCTP-S20	DNA		CastrateResistant_ProstateCancer	MCTP-S20	Diaphragm			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	20		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931728	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044235	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA17	2017-07-28	26583	18087	2017-10-16	SRR5876733	SRS2391915	SRP113721	MCTP-S21	DNA		CastrateResistant_ProstateCancer	MCTP-S21	Liver			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	21		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931681	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044236	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA18	2017-07-28	21083	14263	2017-10-16	SRR5876734	SRS2391916	SRP113721	MCTP-S22	DNA		CastrateResistant_ProstateCancer	MCTP-S22	Liver			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	22		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931716	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044237	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA19	2017-07-28	17397	12134	2017-10-16	SRR5876735	SRS2391918	SRP113721	MCTP-S23	DNA		CastrateResistant_ProstateCancer	MCTP-S23	Soft tissue			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	23		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931666	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044238	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA20	2017-07-28	24028	15611	2017-10-16	SRR5876736	SRS2391917	SRP113721	MCTP-S24	DNA		CastrateResistant_ProstateCancer	MCTP-S24	Liver			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	24		ncbi	Homo sapiens	ILLUMINA	male	
WXS		201	PRJNA177194	SAMN01931689	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044239	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA22	2017-08-07	15810	10744	2017-10-16	SRR5876737	SRS2391919	SRP113721	MCTP-S25	DNA		CastrateResistant_ProstateCancer	MCTP-S25	Prostate			phs000554	Prostatic Small Cell Carcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	25		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931643	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044240	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA23	2017-07-28	20798	13409	2017-10-16	SRR5876738	SRS2391920	SRP113721	MCTP-S26	DNA		CastrateResistant_ProstateCancer	MCTP-S26	Bone marrow			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	26		ncbi	Homo sapiens	ILLUMINA	male	
WXS		201	PRJNA177194	SAMN01931648	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044241	0	Illumina HiSeq 2000	SINGLE	Hybrid Selection	GENOMIC	MCTP_CRPC_WA24	2017-08-07	13490	9516	2017-10-16	SRR5876739	SRS2391921	SRP113721	MCTP-S27	DNA		CastrateResistant_ProstateCancer	MCTP-S27	Liver			phs000554	Prostatic Small Cell Carcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	27		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931727	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044242	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA25	2017-07-27	21717	14138	2017-10-16	SRR5876740	SRS2391922	SRP113721	MCTP-S28	DNA		CastrateResistant_ProstateCancer	MCTP-S28	Soft tissue			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	28		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931622	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044243	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA26	2017-07-27	22832	14607	2017-10-16	SRR5876741	SRS2391923	SRP113721	MCTP-S29	DNA		CastrateResistant_ProstateCancer	MCTP-S29	Lung			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	29		ncbi	Homo sapiens	ILLUMINA	male	
WXS		78	PRJNA177194	SAMN01931626	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044244	0	Illumina Genome Analyzer II	SINGLE	Hybrid Selection	GENOMIC	MCTP_CRPC_T32	2017-08-07	5590	3048	2017-10-16	SRR5876742	SRS2391925	SRP113721	MCTP-S3	DNA		CastrateResistant_ProstateCancer	MCTP-S3	Prostate			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	3		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931736	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044245	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA27	2017-07-28	19284	13314	2017-10-16	SRR5876743	SRS2391924	SRP113721	MCTP-S30	DNA		CastrateResistant_ProstateCancer	MCTP-S30	Soft tissue			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	30		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931688	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044246	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA28	2017-07-27	20105	12835	2017-10-16	SRR5876744	SRS2391926	SRP113721	MCTP-S31	DNA		CastrateResistant_ProstateCancer	MCTP-S31	Periaortic lymph node			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	31		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931717	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044247	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA29	2017-07-27	20313	12935	2017-10-16	SRR5876745	SRS2391927	SRP113721	MCTP-S32	DNA		CastrateResistant_ProstateCancer	MCTP-S32	Soft tissue			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	32		ncbi	Homo sapiens	ILLUMINA	male	
WXS		156	PRJNA177194	SAMN01931668	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044248	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA30	2017-08-07	7465	4709	2017-10-16	SRR5876746	SRS2391928	SRP113721	MCTP-S33	DNA		CastrateResistant_ProstateCancer	MCTP-S33	Soft tissue			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	33		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931624	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044249	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA31	2017-07-27	23679	15299	2017-10-16	SRR5876747	SRS2391929	SRP113721	MCTP-S34	DNA		CastrateResistant_ProstateCancer	MCTP-S34	Liver			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	34		ncbi	Homo sapiens	ILLUMINA	male	
WXS		156	PRJNA177194	SAMN01931642	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044250	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA32	2017-08-07	3878	2409	2017-10-16	SRR5876748	SRS2391930	SRP113721	MCTP-S35	DNA		CastrateResistant_ProstateCancer	MCTP-S35	Liver			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	35		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931720	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044251	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA33	2017-08-15	21705	13839	2017-10-16	SRR5876749	SRS2391931	SRP113721	MCTP-S36	DNA		CastrateResistant_ProstateCancer	MCTP-S36	Supraclavicular lymph node			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	36		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931618	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044252	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA35	2017-08-07	16788	10424	2017-10-16	SRR5876750	SRS2391932	SRP113721	MCTP-S37	DNA		CastrateResistant_ProstateCancer	MCTP-S37	Mesentery			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	37		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931692	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044253	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA37	2017-07-27	21341	14892	2017-10-16	SRR5876751	SRS2391933	SRP113721	MCTP-S38	DNA		CastrateResistant_ProstateCancer	MCTP-S38	Lung hilar lymph node			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	38		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931711	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044254	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA38	2017-07-27	21183	14784	2017-10-16	SRR5876752	SRS2391935	SRP113721	MCTP-S39	DNA		CastrateResistant_ProstateCancer	MCTP-S39	Liver			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	39		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931729	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044255	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_T90	2017-07-27	22747	15526	2017-10-16	SRR5876753	SRS2391934	SRP113721	MCTP-S4	DNA		CastrateResistant_ProstateCancer	MCTP-S4	Prostate			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	4		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931731	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044256	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA39	2017-07-27	18180	12742	2017-10-16	SRR5876754	SRS2391936	SRP113721	MCTP-S40	DNA		CastrateResistant_ProstateCancer	MCTP-S40	Periaortic lymph node			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	40		ncbi	Homo sapiens	ILLUMINA	male	
WXS		78	PRJNA177194	SAMN01931649	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044257	0	Illumina Genome Analyzer II	SINGLE	Hybrid Selection	GENOMIC	MCTP_CRPC_WA40	2017-08-07	5479	2816	2017-10-16	SRR5876755	SRS2391937	SRP113721	MCTP-S41	DNA		CastrateResistant_ProstateCancer	MCTP-S41	Liver			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	41		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931684	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044258	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA41	2017-07-27	21023	14180	2017-10-16	SRR5876756	SRS2391938	SRP113721	MCTP-S42	DNA		CastrateResistant_ProstateCancer	MCTP-S42	Dura			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	42		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931663	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044259	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA42	2017-08-07	16622	9225	2017-10-16	SRR5876757	SRS2391939	SRP113721	MCTP-S43	DNA		CastrateResistant_ProstateCancer	MCTP-S43	Adrenal			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	43		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931654	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044260	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA43-44	2017-08-07	11772	6073	2017-10-16	SRR5876758	SRS2391940	SRP113721	MCTP-S44	DNA		CastrateResistant_ProstateCancer	MCTP-S44	Bladder			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	44		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931640	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044261	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA43-27	2017-08-07	10432	5307	2017-10-16	SRR5876759	SRS2391941	SRP113721	MCTP-S45	DNA		CastrateResistant_ProstateCancer	MCTP-S45	Celiac lymph node			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	44		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931710	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044262	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA43-71	2017-08-07	11386	5730	2017-10-16	SRR5876760	SRS2391942	SRP113721	MCTP-S46	DNA		CastrateResistant_ProstateCancer	MCTP-S46	Lung			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	44		ncbi	Homo sapiens	ILLUMINA	male	
WXS		206	PRJNA177194	SAMN01931693	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044263	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA46	2017-07-27	17104	10601	2017-10-16	SRR5876761	SRS2391943	SRP113721	MCTP-S47	DNA		CastrateResistant_ProstateCancer	MCTP-S47	Periaortic lymph node			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	45		ncbi	Homo sapiens	ILLUMINA	male	
WXS		156	PRJNA177194	SAMN01931685	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044264	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA47	2017-08-07	3783	2380	2017-10-16	SRR5876762	SRS2391945	SRP113721	MCTP-S48	DNA		CastrateResistant_ProstateCancer	MCTP-S48	Adrenal gland			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	46		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931665	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044265	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA48	2017-07-27	20585	14151	2017-10-16	SRR5876763	SRS2391944	SRP113721	MCTP-S49	DNA		CastrateResistant_ProstateCancer	MCTP-S49	Bone marrow			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	47		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931706	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044266	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_T91	2017-07-27	23029	16085	2017-10-16	SRR5876764	SRS2391946	SRP113721	MCTP-S5	DNA		CastrateResistant_ProstateCancer	MCTP-S5	Prostate			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	5		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931718	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044267	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA49	2017-08-07	15233	8449	2017-10-16	SRR5876765	SRS2391947	SRP113721	MCTP-S50	DNA		CastrateResistant_ProstateCancer	MCTP-S50	Periaortic lymph node			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	48		ncbi	Homo sapiens	ILLUMINA	male	
WXS		206	PRJNA177194	SAMN01931699	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044268	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA50	2017-07-27	14874	8200	2017-10-16	SRR5876766	SRS2391948	SRP113721	MCTP-S51	DNA		CastrateResistant_ProstateCancer	MCTP-S51	Subcarinal lymph node			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	49		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931719	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044269	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA51	2017-08-07	16277	9565	2017-10-16	SRR5876767	SRS2391949	SRP113721	MCTP-S52	DNA		CastrateResistant_ProstateCancer	MCTP-S52	Bone marrow			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	50		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931678	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044270	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA52	2017-08-07	19285	11799	2017-10-16	SRR5876768	SRS2391950	SRP113721	MCTP-S53	DNA		CastrateResistant_ProstateCancer	MCTP-S53	Lung			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	51		ncbi	Homo sapiens	ILLUMINA	male	
WXS		196	PRJNA177194	SAMN01931631	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044271	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA53	2017-07-27	15892	9861	2017-10-16	SRR5876769	SRS2391952	SRP113721	MCTP-S54	DNA		CastrateResistant_ProstateCancer	MCTP-S54	Liver			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	52		ncbi	Homo sapiens	ILLUMINA	male	
WXS		196	PRJNA177194	SAMN01931671	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044272	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA54	2017-07-27	15411	9541	2017-10-16	SRR5876770	SRS2391951	SRP113721	MCTP-S55	DNA		CastrateResistant_ProstateCancer	MCTP-S55	Liver			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	53		ncbi	Homo sapiens	ILLUMINA	male	
WXS		196	PRJNA177194	SAMN01931700	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044273	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA55	2017-07-27	15858	9878	2017-10-16	SRR5876771	SRS2391953	SRP113721	MCTP-S56	DNA		CastrateResistant_ProstateCancer	MCTP-S56	Liver			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	54		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931625	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044274	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA56	2017-08-07	16810	9931	2017-10-16	SRR5876772	SRS2391954	SRP113721	MCTP-S57	DNA		CastrateResistant_ProstateCancer	MCTP-S57	Lymph node			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	55		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931662	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044275	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA57	2017-08-07	16970	10422	2017-10-16	SRR5876773	SRS2391955	SRP113721	MCTP-S58	DNA		CastrateResistant_ProstateCancer	MCTP-S58	Liver			phs000554	Prostatic Small Cell Carcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	56		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931708	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044276	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA58	2017-07-27	16333	11119	2017-10-16	SRR5876774	SRS2391956	SRP113721	MCTP-S59	DNA		CastrateResistant_ProstateCancer	MCTP-S59	Lung			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	57		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931698	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044277	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_T92	2017-07-27	18956	12565	2017-10-16	SRR5876775	SRS2391957	SRP113721	MCTP-S6	DNA		CastrateResistant_ProstateCancer	MCTP-S6	Prostate			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	6		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931634	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044278	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA59	2017-08-07	15670	9672	2017-10-16	SRR5876776	SRS2391958	SRP113721	MCTP-S60	DNA		CastrateResistant_ProstateCancer	MCTP-S60	Iliac lymph node			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	58		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931694	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044205	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA40-matched	2017-08-07	23849	15627	2017-10-16	SRR5905972	SRS2391885	SRP113721	MCTP-S102	DNA		CastrateResistant_ProstateCancer	MCTP-S102	Kidney			phs000554	Normal Kidney		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	41		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931670	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044210	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA47-matched	2017-08-07	19639	12682	2017-10-16	SRR5906383	SRS2391889	SRP113721	MCTP-S107	DNA		CastrateResistant_ProstateCancer	MCTP-S107	Liver			phs000554	Normal Liver		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	46		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931668	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044248	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA30	2017-08-07	25745	17065	2017-10-16	SRR5906384	SRS2391928	SRP113721	MCTP-S33	DNA		CastrateResistant_ProstateCancer	MCTP-S33	Soft tissue			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	33		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931642	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044250	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA32	2017-08-07	21812	14283	2017-10-16	SRR5906385	SRS2391930	SRP113721	MCTP-S35	DNA		CastrateResistant_ProstateCancer	MCTP-S35	Liver			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	35		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931649	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044257	0	Illumina Genome Analyzer II	SINGLE	Hybrid Selection	GENOMIC	MCTP_CRPC_WA40	2017-08-07	21480	13980	2017-10-16	SRR5906520	SRS2391937	SRP113721	MCTP-S41	DNA		CastrateResistant_ProstateCancer	MCTP-S41	Liver			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	41		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931685	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044264	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA47	2017-08-07	23925	15746	2017-10-16	SRR5905973	SRS2391945	SRP113721	MCTP-S48	DNA		CastrateResistant_ProstateCancer	MCTP-S48	Adrenal gland			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	46		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931679	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044279	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA60	2017-08-07	16395	10212	2017-10-16	SRR5876777	SRS2391959	SRP113721	MCTP-S61	DNA		CastrateResistant_ProstateCancer	MCTP-S61	Paratracheal lymph node			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	59		ncbi	Homo sapiens	ILLUMINA	male	
WXS		78	PRJNA177194	SAMN01931673	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044280	0	Illumina Genome Analyzer II	SINGLE	Hybrid Selection	GENOMIC	MCTP_CRPC_T8-matched	2017-08-07	7763	4286	2017-10-16	SRR5876778	SRS2391960	SRP113721	MCTP-S62	DNA		CastrateResistant_ProstateCancer	MCTP-S62	Prostate			phs000554	Normal Prostate		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	1		ncbi	Homo sapiens	ILLUMINA	male	
WXS		78	PRJNA177194	SAMN01931723	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044281	0	Illumina Genome Analyzer II	SINGLE	Hybrid Selection	GENOMIC	MCTP_CRPC_T12-matched	2017-08-07	5091	3268	2017-10-16	SRR5876779	SRS2391962	SRP113721	MCTP-S63	DNA		CastrateResistant_ProstateCancer	MCTP-S63	Prostate			phs000554	Normal Prostate		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	2		ncbi	Homo sapiens	ILLUMINA	male	
WXS		78	PRJNA177194	SAMN01931697	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044282	0	Illumina Genome Analyzer II	SINGLE	Hybrid Selection	GENOMIC	MCTP_CRPC_T32-matched	2017-08-02	3674	1829	2017-10-16	SRR5876780	SRS2391961	SRP113721	MCTP-S64	DNA		CastrateResistant_ProstateCancer	MCTP-S64	Prostate			phs000554	Normal Prostate		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	3		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931629	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044283	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_T90-matched	2017-07-28	12122	8302	2017-10-16	SRR5876781	SRS2391963	SRP113721	MCTP-S65	DNA		CastrateResistant_ProstateCancer	MCTP-S65	Prostate			phs000554	Normal Prostate		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	4		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931734	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044284	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_T91-matched	2017-07-27	11782	8237	2017-10-16	SRR5876782	SRS2391964	SRP113721	MCTP-S66	DNA		CastrateResistant_ProstateCancer	MCTP-S66	Prostate			phs000554	Normal Prostate		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	5		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931653	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044285	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_T92-matched	2017-07-28	13343	8901	2017-10-16	SRR5876783	SRS2391965	SRP113721	MCTP-S67	DNA		CastrateResistant_ProstateCancer	MCTP-S67	Prostate			phs000554	Normal Prostate		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	6		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931644	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044286	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_T93-matched	2017-07-28	11602	8038	2017-10-16	SRR5876784	SRS2391966	SRP113721	MCTP-S68	DNA		CastrateResistant_ProstateCancer	MCTP-S68	Prostate			phs000554	Normal Prostate		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	7		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931725	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044287	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_T94-matched	2017-07-28	13172	9148	2017-10-16	SRR5876785	SRS2391967	SRP113721	MCTP-S69	DNA		CastrateResistant_ProstateCancer	MCTP-S69	Prostate			phs000554	Normal Prostate		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	8		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931682	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044288	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_T93	2017-07-28	21694	14968	2017-10-16	SRR5876786	SRS2391969	SRP113721	MCTP-S7	DNA		CastrateResistant_ProstateCancer	MCTP-S7	Prostate			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	7		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931712	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044289	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_T95-matched	2017-07-28	10772	7646	2017-10-16	SRR5876787	SRS2391968	SRP113721	MCTP-S70	DNA		CastrateResistant_ProstateCancer	MCTP-S70	Prostate			phs000554	Normal Prostate		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	9		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931661	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044290	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_T96-matched	2017-07-28	14792	9797	2017-10-16	SRR5876788	SRS2391970	SRP113721	MCTP-S71	DNA		CastrateResistant_ProstateCancer	MCTP-S71	Prostate			phs000554	Normal Prostate		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	10		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931656	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044291	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_T97-matched	2017-07-28	13777	9236	2017-10-16	SRR5876789	SRS2391971	SRP113721	MCTP-S72	DNA		CastrateResistant_ProstateCancer	MCTP-S72	Prostate			phs000554	Normal Prostate		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	11		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931735	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044292	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA3-matched	2017-07-27	11161	7337	2017-10-16	SRR5876790	SRS2391972	SRP113721	MCTP-S73	DNA		CastrateResistant_ProstateCancer	MCTP-S73	Liver			phs000554	Normal Liver		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	12		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931680	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044293	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA7-matched	2017-07-28	13156	9288	2017-10-16	SRR5876791	SRS2391973	SRP113721	MCTP-S74	DNA		CastrateResistant_ProstateCancer	MCTP-S74	Pancreas			phs000554	Normal Pancreas		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	13		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931632	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044294	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA10-matched	2017-07-28	14121	9793	2017-10-16	SRR5876792	SRS2391974	SRP113721	MCTP-S75	DNA		CastrateResistant_ProstateCancer	MCTP-S75	Spleen			phs000554	Normal Spleen		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	14		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931730	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044295	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA11-matched	2017-07-28	23939	16097	2017-10-16	SRR5876793	SRS2391976	SRP113721	MCTP-S76	DNA		CastrateResistant_ProstateCancer	MCTP-S76	Lung			phs000554	Normal Lung		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	15		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931619	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044296	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA12-matched	2017-07-28	11532	7880	2017-10-16	SRR5876794	SRS2391975	SRP113721	MCTP-S77	DNA		CastrateResistant_ProstateCancer	MCTP-S77	Liver			phs000554	Normal Liver		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	16		ncbi	Homo sapiens	ILLUMINA	male	
WXS		201	PRJNA177194	SAMN01931627	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044297	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA13-matched	2017-08-07	13851	8660	2017-10-16	SRR5876795	SRS2391977	SRP113721	MCTP-S78	DNA		CastrateResistant_ProstateCancer	MCTP-S78	Bone marrow			phs000554	Normal Bone marrow		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	17		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931650	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044298	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA14-matched	2017-07-28	9969	6862	2017-10-16	SRR5876796	SRS2391978	SRP113721	MCTP-S79	DNA		CastrateResistant_ProstateCancer	MCTP-S79	Dura			phs000554	Normal Dura		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	18		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931674	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044299	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_T94	2017-07-28	19749	13695	2017-10-16	SRR5876797	SRS2391979	SRP113721	MCTP-S8	DNA		CastrateResistant_ProstateCancer	MCTP-S8	Prostate			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	8		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931658	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044300	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA15-matched	2017-07-28	16912	11539	2017-10-16	SRR5876798	SRS2391980	SRP113721	MCTP-S80	DNA		CastrateResistant_ProstateCancer	MCTP-S80	Prostate			phs000554	Normal Prostate		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	19		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931704	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044301	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA16-matched	2017-07-28	13578	9312	2017-10-16	SRR5876799	SRS2391981	SRP113721	MCTP-S81	DNA		CastrateResistant_ProstateCancer	MCTP-S81	Kidney			phs000554	Normal Kidney		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	20		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931636	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044302	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA17-matched	2017-07-28	11790	8029	2017-10-16	SRR5876800	SRS2391982	SRP113721	MCTP-S82	DNA		CastrateResistant_ProstateCancer	MCTP-S82	Liver			phs000554	Normal Liver		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	21		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931676	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044303	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA18-matched	2017-07-28	13193	8946	2017-10-16	SRR5876801	SRS2391983	SRP113721	MCTP-S83	DNA		CastrateResistant_ProstateCancer	MCTP-S83	Kidney			phs000554	Normal Kidney		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	22		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931664	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044304	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA19-matched	2017-07-28	12804	8964	2017-10-16	SRR5876802	SRS2391984	SRP113721	MCTP-S84	DNA		CastrateResistant_ProstateCancer	MCTP-S84	Adrenal gland			phs000554	Normal Adrenal gland		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	23		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931709	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044305	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA20-matched	2017-07-28	13517	8808	2017-10-16	SRR5876803	SRS2391985	SRP113721	MCTP-S85	DNA		CastrateResistant_ProstateCancer	MCTP-S85	Spleen			phs000554	Normal Spleen		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	24		ncbi	Homo sapiens	ILLUMINA	male	
WXS		201	PRJNA177194	SAMN01931675	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044306	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA22-matched	2017-08-07	14240	9643	2017-10-16	SRR5876804	SRS2391986	SRP113721	MCTP-S86	DNA		CastrateResistant_ProstateCancer	MCTP-S86	Kidney			phs000554	Normal Kidney		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	25		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931722	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044307	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA23-matched	2017-07-28	14353	9261	2017-10-16	SRR5876805	SRS2391987	SRP113721	MCTP-S87	DNA		CastrateResistant_ProstateCancer	MCTP-S87	Cerebellum			phs000554	Normal Cerebellum		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	26		ncbi	Homo sapiens	ILLUMINA	male	
WXS		201	PRJNA177194	SAMN01931646	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044308	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA24-matched	2017-08-07	16931	11885	2017-10-16	SRR5876806	SRS2391988	SRP113721	MCTP-S88	DNA		CastrateResistant_ProstateCancer	MCTP-S88	Brain			phs000554	Normal Brain		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	27		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931633	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044309	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA25-matched	2017-07-28	12898	8427	2017-10-16	SRR5876807	SRS2391989	SRP113721	MCTP-S89	DNA		CastrateResistant_ProstateCancer	MCTP-S89	Kidney			phs000554	Normal Kidney		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	28		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931721	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044310	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_T95	2017-07-28	18550	13132	2017-10-16	SRR5876808	SRS2391990	SRP113721	MCTP-S9	DNA		CastrateResistant_ProstateCancer	MCTP-S9	Prostate			phs000554	Prostatic Adenocarcinoma		Yes				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	9		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931687	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044311	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA26-matched	2017-07-28	10953	7066	2017-10-16	SRR5876809	SRS2391992	SRP113721	MCTP-S90	DNA		CastrateResistant_ProstateCancer	MCTP-S90	Liver			phs000554	Normal Liver		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	29		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931703	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044312	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA27-matched	2017-07-28	15334	10626	2017-10-16	SRR5876810	SRS2391991	SRP113721	MCTP-S91	DNA		CastrateResistant_ProstateCancer	MCTP-S91	Spleen			phs000554	Normal Spleen		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	30		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931660	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044313	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA28-matched	2017-07-28	13123	8464	2017-10-16	SRR5876811	SRS2391993	SRP113721	MCTP-S92	DNA		CastrateResistant_ProstateCancer	MCTP-S92	Kidney			phs000554	Normal Kidney		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	31		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931683	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044314	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA29-matched	2017-07-28	13005	8299	2017-10-16	SRR5876812	SRS2391994	SRP113721	MCTP-S93	DNA		CastrateResistant_ProstateCancer	MCTP-S93	Liver			phs000554	Normal Liver		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	32		ncbi	Homo sapiens	ILLUMINA	male	
WXS		156	PRJNA177194	SAMN01931635	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044315	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA30-matched	2017-08-07	6911	4368	2017-10-16	SRR5876813	SRS2391995	SRP113721	MCTP-S94	DNA		CastrateResistant_ProstateCancer	MCTP-S94	Soft tissue			phs000554	Normal Soft tissue		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	33		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931635	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044315	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA30-matched	2017-08-07	23672	15576	2017-10-16	SRR5906388	SRS2391995	SRP113721	MCTP-S94	DNA		CastrateResistant_ProstateCancer	MCTP-S94	Soft tissue			phs000554	Normal Soft tissue		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	33		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931707	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044316	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA31-matched	2017-07-28	13297	8614	2017-10-16	SRR5876814	SRS2391996	SRP113721	MCTP-S95	DNA		CastrateResistant_ProstateCancer	MCTP-S95	Spleen			phs000554	Normal Spleen		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	34		ncbi	Homo sapiens	ILLUMINA	male	
WXS		156	PRJNA177194	SAMN01931672	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044317	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA32-matched	2017-08-07	3386	2012	2017-10-16	SRR5876815	SRS2391997	SRP113721	MCTP-S96	DNA		CastrateResistant_ProstateCancer	MCTP-S96	Kidney			phs000554	Normal Kidney		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	35		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931672	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044317	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA32-matched	2017-08-07	24544	16255	2017-10-16	SRR5906389	SRS2391997	SRP113721	MCTP-S96	DNA		CastrateResistant_ProstateCancer	MCTP-S96	Kidney			phs000554	Normal Kidney		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	35		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931690	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044318	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA33-matched	2017-07-28	14959	9672	2017-10-16	SRR5876816	SRS2391998	SRP113721	MCTP-S97	DNA		CastrateResistant_ProstateCancer	MCTP-S97	Brain			phs000554	Normal Brain		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	36		ncbi	Homo sapiens	ILLUMINA	male	
WXS		205	PRJNA177194	SAMN01931639	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044319	0	Illumina Genome Analyzer II	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA35-matched	2017-08-07	15503	9565	2017-10-16	SRR5876817	SRS2391999	SRP113721	MCTP-S98	DNA		CastrateResistant_ProstateCancer	MCTP-S98	Liver			phs000554	Normal Liver		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	37		ncbi	Homo sapiens	ILLUMINA	male	
WXS		202	PRJNA177194	SAMN01931652	UMICH-PHS00055	DS-CA-MDS	sra	SRX3044320	0	Illumina HiSeq 2000	PAIRED	Hybrid Selection	GENOMIC	MCTP_CRPC_WA37-matched	2017-07-28	11478	8031	2017-10-16	SRR5876818	SRS2392000	SRP113721	MCTP-S99	DNA		CastrateResistant_ProstateCancer	MCTP-S99	Kidney			phs000554	Normal Kidney		No				Tumor vs. Matched-Normal		Mutational Landscape of Lethal Castrate Resistant Prostate Cancer	38		ncbi	Homo sapiens	ILLUMINA	male	
